{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T22:42:24Z","timestamp":1792622544808,"version":"4.5.0"},"reference-count":1089,"publisher":"Georg Thieme Verlag KG","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Z Gastroenterol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1055\/a-2853-0320","type":"journal-article","created":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T22:30:32Z","timestamp":1792621832000},"page":"1506-1697","source":"Crossref","is-referenced-by-count":0,"title":["S3-Leitlinie Kolorektales Karzinom"],"prefix":"10.1055","volume":"64","author":[{"given":"Christian P.","family":"Pox","sequence":"additional","affiliation":[{"name":"Medizinische Klinik, St.-Joseph-Stift Hospital Bremen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Reichermeier","sequence":"additional","affiliation":[{"name":"Medizinische Klinik II, Donauisar Klinikum Deggendorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Aretz","sequence":"additional","affiliation":[{"name":"Institut f\u00fcr Humangenetik, Centrum f\u00fcr Integrierte Onkologie, Bonn, Germany"},{"name":"Nationales Zentrum f\u00fcr erbliche Tumorsyndrome, University Hospital Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ullrich","family":"Graeven","sequence":"additional","affiliation":[{"name":"Medizinische Klinik, Kliniken Maria Hilf GmbH, M\u00f6nchengladbach, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"H\u00fcneburg","sequence":"additional","affiliation":[{"name":"Nationales Zentrum f\u00fcr erbliche Tumorsyndrome, University Hospital Bonn, Germany"},{"name":"Medizinische Klinik und Poliklinik I Universit\u00e4tsklinikum Bonn, Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dietrich","family":"H\u00fcppe","sequence":"additional","affiliation":[{"name":"Gastroenterologische Gemeinschaftspraxis Herne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Koch","sequence":"additional","affiliation":[{"name":"Medizinische Klinik I Gastroenterologie, Hepatologie, Universit\u00e4tsklinikum Frankfurt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus-Henning","family":"K\u00f6hne","sequence":"additional","affiliation":[{"name":"Universit\u00e4tsklinik f\u00fcr Innere Medizin Onkologie und H\u00e4matologie, Klinikum Oldenburg AoR, Oldenburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Kolligs","sequence":"additional","affiliation":[{"name":"Gastroenterologie, Hepatologie und Diabetologie, HELIOS\u00a0Klinikum Berlin-Buch, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3322-2948","authenticated-orcid":false,"given":"Leopold","family":"Ludwig","sequence":"additional","affiliation":[{"name":"Gastroenterologische Schwerpunktpraxis Praxis Ludwig & G\u00fcthle, Dornstadt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Neumann","sequence":"additional","affiliation":[{"name":"Universit\u00e4tsinstitut f\u00fcr Pathologie, Klinikum N\u00fcrnberg, N\u00fcrnberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann","family":"Ockenga","sequence":"additional","affiliation":[{"name":"Medizinische Klinik II, Klinikum Bremen-Mitte gGmbH, Bremen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1486-9298","authenticated-orcid":false,"given":"Andreas","family":"Probst","sequence":"additional","affiliation":[{"name":"III. Medizinische Klinik mit Schwerpunkt Gastroenterologie, Universit\u00e4tsklinikum Augsburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"R\u00f6del","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Strahlentherapie, Universit\u00e4tsklinikum Frankfurt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Rubin","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Innere Medizin mit Schwerpunkt Gastroenterologie, Vivantes Klinikum Spandau, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Schiedeck","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Allgemein-, Viszeral-, Thorax- und Kinderchirurgie, Klinikum Ludwigsburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Seufferlein","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Innere Medizin I, Universit\u00e4tsklinikum Ulm, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Ebert","sequence":"additional","affiliation":[{"name":"II. Medizinische Klinik, Medizinische Fakult\u00e4t Mannheim, Universit\u00e4t Heidelberg, Mannheim, Germany"},{"name":"DKFZ-Hector Cancer Institute at the University Medical Center, Mannheim, Germany"},{"name":"Molecular Medicine Partnership Unit, European Molecular Biology Laboratory, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Weitere Mitglieder der Leitlinienkommission","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2026,10,21]]},"reference":[{"issue":"04","key":"ref2","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1136\/oemed-2020-107253","article-title":"Association of sedentary work with colon and rectal cancer: systematic review and meta-analysis","volume":"79","author":"J Lee","year":"2022","journal-title":"Occup Environ Med"},{"issue":"01","key":"ref3","first-page":"29","article-title":"Effects of behavioral change techniques on diet and physical activity in colorectal cancer patients: a systematic review and meta-analysis","volume":"31","author":"X Wang","year":"2022","journal-title":"Support Care Cancer"},{"issue":"10","key":"ref4","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1136\/bjsports-2018-100350","article-title":"Physically active individuals have a 23% lower risk of any colorectal neoplasia and a 27% lower risk of advanced colorectal neoplasia than their non-active counterparts: systematic review and meta-analysis of observational studies","volume":"54","author":"J Wang","year":"2020","journal-title":"Br J Sports Med"},{"issue":"01","key":"ref5","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jshs.2020.09.009","article-title":"Association between physical activity and digestive-system cancer: An updated systematic review and meta-analysis","volume":"10","author":"F Xie","year":"2021","journal-title":"J Sport Health Sci"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"103232","DOI":"10.1016\/j.critrevonc.2021.103232","article-title":"The impact of anthropometric parameters on colorectal cancer prognosis: A systematic review and meta-analysis","volume":"159","author":"V Jaspan","year":"2021","journal-title":"Crit Rev Oncol Hematol"},{"issue":"11","key":"ref7","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.14309\/ajg.0000000000001393","article-title":"Association of Body Mass Index With Risk of Early-Onset Colorectal Cancer: Systematic Review and Meta-Analysis","volume":"116","author":"H Li","year":"2021","journal-title":"Am J Gastroenterol"},{"issue":"05","key":"ref8","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.3390\/nu13051736","article-title":"A Meta-Analysis of Obesity and Risk of Colorectal Cancer in Patients with Lynch Syndrome: The Impact of Sex and Genetics","volume":"13","author":"M Lazzeroni","year":"2021","journal-title":"Nutrients"},{"issue":"01","key":"ref9","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12916-022-02702-9","article-title":"Separating the effects of early and later life adiposity on colorectal cancer risk: a Mendelian randomization study","volume":"21","author":"N Papadimitriou","year":"2023","journal-title":"BMC Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0140-6736(08)60269-X","article-title":"Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies","volume":"371","author":"A G Renehan","year":"2008","journal-title":"Lancet"},{"issue":"12","key":"ref11","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.14309\/ajg.0000000000000803","article-title":"Smoking and Colorectal Cancer Risk, Overall and by Molecular Subtypes: A Meta-Analysis","volume":"115","author":"E Botteri","year":"2020","journal-title":"Am J Gastroenterol"},{"issue":"18","key":"ref12","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.2217\/fon-2023-0165","article-title":"Risk factors for advanced colorectal neoplasm in young adults: a meta-analysis","volume":"19","author":"X Ye","year":"2023","journal-title":"Future Oncol"},{"issue":"01","key":"ref14","doi-asserted-by":"crossref","first-page":"4579","DOI":"10.1038\/s41467-021-24861-8","article-title":"An umbrella review of the evidence associating diet and cancer risk at 11 anatomical sites","volume":"12","author":"N Papadimitriou","year":"2021","journal-title":"Nat Commun"},{"issue":"06","key":"ref15","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s10654-022-00881-6","article-title":"Nuts and legumes consumption and risk of colorectal cancer: a systematic review and meta-analysis","volume":"37","author":"S Jin","year":"2022","journal-title":"Eur J Epidemiol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"e2023092","DOI":"10.4178\/epih.e2023092","article-title":"Cancer risk based on alcohol consumption levels: a comprehensive systematic review and meta-analysis","volume":"45","author":"S Jun","year":"2023","journal-title":"Epidemiol Health"},{"issue":"04","key":"ref18","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.cgh.2021.04.028","article-title":"A Prospective Diet-Wide Association Study for Risk of Colorectal Cancer in EPIC","volume":"20","author":"N Papadimitriou","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"603","DOI":"10.7326\/0003-4819-140-8-200404200-00007","article-title":"Alcohol intake and colorectal cancer: a pooled analysis of 8 cohort studies","volume":"140","author":"E Cho","year":"2004","journal-title":"Ann Intern Med"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/ijc.22299","article-title":"Alcohol intake and colorectal cancer risk: a dose-response meta-analysis of published cohort studies","volume":"120","author":"A Moskal","year":"2007","journal-title":"Int J Cancer"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1056\/NEJMoa055222","article-title":"Calcium plus vitamin D supplementation and the risk of colorectal cancer","volume":"354","author":"J Wactawski-Wende","year":"2006","journal-title":"N Engl J Med"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1093\/jnci\/djh165","article-title":"Effect of calcium supplementation on the risk of large bowel polyps","volume":"96","author":"K Wallace","year":"2004","journal-title":"J Natl Cancer Inst"},{"issue":"06","key":"ref23","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1016\/j.clnu.2017.10.010","article-title":"Folic acid intake and folate status and colorectal cancer risk: A systematic review and meta-analysis","volume":"37","author":"S Moazzen","year":"2018","journal-title":"Clin Nutr"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"108252","DOI":"10.1016\/j.pharmthera.2022.108252","article-title":"Vitamin D as a chemopreventive agent in colorectal neoplasms A systematic review and meta-analysis of randomized controlled trials","volume":"237","author":"G Emmanouilidou","year":"2022","journal-title":"Pharmacol Ther"},{"issue":"12","key":"ref25","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1136\/gutjnl-2020-320990","article-title":"Recent advances in clinical practice: colorectal cancer chemoprevention in the average-risk population","volume":"69","author":"N Chapelle","year":"2020","journal-title":"Gut"},{"issue":"01","key":"ref26","first-page":"CD005195","article-title":"Selenium for preventing cancer","volume":"1","author":"M Vinceti","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"ref27","first-page":"CD003548","article-title":"Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps","author":"M A Weingarten","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/jnci\/djk016","article-title":"Prolonged effect of calcium supplementation on risk of colorectal adenomas in a randomized trial","volume":"99","author":"M V Grau","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1093\/jnci\/djh165","article-title":"Effect of calcium supplementation on the risk of large bowel polyps","volume":"96","author":"K Wallace","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1056\/NEJMoa055222","article-title":"Calcium plus vitamin D supplementation and the risk of colorectal cancer","volume":"354","author":"J Wactawski-Wende","year":"2006","journal-title":"N Engl J Med"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1001\/jama.297.8.842","article-title":"Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis","volume":"297","author":"G Bjelakovic","year":"2007","journal-title":"JAMA"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1093\/jnci\/djh310","article-title":"Selenium and colorectal adenoma: results of a pooled analysis","volume":"96","author":"E T Jacobs","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1158\/1055-9965.EPI-05-0471","article-title":"High serum selenium and reduced risk of advanced colorectal adenoma in a colorectal cancer early detection program","volume":"15","author":"U Peters","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"02","key":"ref34","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/apt.13857","article-title":"Systematic review with meta-analysis: the comparative effectiveness of aspirin vs screening for colorectal cancer prevention","volume":"45","author":"L Emilsson","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"107169","DOI":"10.1016\/j.ypmed.2022.107169","article-title":"The efficacy of chemopreventive agents on the incidence of colorectal adenomas: A systematic review and network meta-analysis","volume":"162","author":"E Heer","year":"2022","journal-title":"Prev Med"},{"issue":"16","key":"ref36","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1001\/jama.2022.3337","article-title":"Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force","volume":"327","author":"J Guirguis-Blake","year":"2022","journal-title":"JAMA"},{"issue":"07","key":"ref37","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1097\/CM9.0000000000002514","article-title":"Chemoprevention of colorectal cancer in general population and high-risk population: a systematic review and network meta-analysis","volume":"136","author":"Y Ma","year":"2023","journal-title":"Chin Med J (Engl)"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1136\/gut.2009.190900","article-title":"Effect of statin therapy on colorectal cancer","volume":"59","author":"M Bardou","year":"2010","journal-title":"Gut"},{"issue":"04","key":"ref39","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1055\/a-0668-5692","article-title":"Statins and Colorectal Cancer \u2013 A Systematic Review","volume":"128","author":"M Dobrzycka","year":"2020","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"ref40","first-page":"CD004143","article-title":"Long term hormone therapy for perimenopausal and postmenopausal women","author":"C Farquhar","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"17","key":"ref41","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1001\/jama.2022.18324","article-title":"Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Persons: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force","volume":"328","author":"G Gartlehner","year":"2022","journal-title":"JAMA"},{"issue":"22","key":"ref42","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1001\/jama.2017.18261","article-title":"Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Women: US Preventive Services Task Force Recommendation Statement","volume":"318","author":"D Grossman","year":"2017","journal-title":"JAMA"},{"issue":"03","key":"ref43","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/cen.14469","article-title":"Impact of menopausal hormone therapy on colorectal cancer risk-A systematic review","volume":"95","author":"L Nakhostin","year":"2021","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"19","key":"ref44","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1001\/jama.2021.5746","article-title":"Colorectal Cancer Screening: An Updated Modeling Study for the US Preventive Services Task Force","volume":"325","author":"A Knudsen","year":"2021","journal-title":"JAMA"},{"issue":"01","key":"ref45","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12885-022-10418-5","article-title":"Should we screen for colorectal cancer in people aged 75 and over? A systematic review \u2013 collaborative work of the French geriatric oncology society (SOFOG) and the French federation of digestive oncology (FFCD)","volume":"23","author":"L Guittet","year":"2023","journal-title":"BMC Cancer"},{"issue":"08","key":"ref46","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1007\/s10620-021-07198-6","article-title":"Yield of Surveillance Colonoscopy in Older Adults with a History of Polyps: A Systematic Review and Meta-Analysis","volume":"67","author":"G Williams","year":"2022","journal-title":"Dig Dis Sci"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1056\/NEJM199312303292701","article-title":"Prevention of colorectal cancer by colonoscopic polypectomy The National Polyp Study Workgroup","volume":"329","author":"S J Winawer","year":"1993","journal-title":"N Engl J Med"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1136\/gut.48.6.812","article-title":"Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence","volume":"48","author":"F Citarda","year":"2001","journal-title":"Gut"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1056\/NEJMoa1100370","article-title":"Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths","volume":"366","author":"A G Zauber","year":"2012","journal-title":"N Engl J Med"},{"issue":"12","key":"ref50","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1056\/NEJMoa1301969","article-title":"Long-term colorectal-cancer incidence and mortality after lower endoscopy","volume":"369","author":"R Nishihara","year":"2013","journal-title":"N Engl J Med"},{"issue":"17","key":"ref51","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa2208375","article-title":"Effect of Colonoscopy Screening on Risks of Colorectal Cancer and Related Death","volume":"387","author":"M Bretthauer","year":"2022","journal-title":"N Engl J Med"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1136\/gut.2009.177089","article-title":"Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy","volume":"59","author":"L Hol","year":"2010","journal-title":"Gut"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1056\/NEJMoa1108895","article-title":"Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening","volume":"366","author":"E Quintero","year":"2012","journal-title":"N Engl J Med"},{"issue":"03","key":"ref54","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.cgh.2019.08.015","article-title":"Diagnostic Yield of One-Time Colonoscopy vs One-Time Flexible Sigmoidoscopy vs Multiple Rounds of Mailed Fecal Immunohistochemical Tests in Colorectal Cancer Screening","volume":"18","author":"E Grobbee","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"10","key":"ref55","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1016\/j.cgh.2019.01.014","article-title":"Cost-Effectiveness of Colorectal Cancer Screening Strategies-A Systematic Review","volume":"17","author":"T Ran","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"06","key":"ref56","first-page":"e13673","article-title":"Cost-effectiveness of colorectal cancer screening strategies: A systematic review","volume":"31","author":"F Gheysariyeha","year":"2022","journal-title":"Eur J Cancer Care (Engl)"},{"issue":"07","key":"ref57","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1111\/jgh.15860","article-title":"Cost-effectiveness of risk-tailored screening strategy for colorectal cancer: A systematic review","volume":"37","author":"L Wang","year":"2022","journal-title":"J Gastroenterol Hepatol"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"100203","DOI":"10.1016\/j.clinsp.2023.100203","article-title":"Economic evaluations of colorectal cancer screening: A systematic review and quality assessment","volume":"78","author":"M Ramos","year":"2023","journal-title":"Clinics (Sao Paulo)"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/S0140-6736(02)08268-5","article-title":"Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicentre randomised trial","volume":"359","author":"W Atkin","year":"2002","journal-title":"Lancet"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.1200\/JCO.2011.35.9307","article-title":"Long-term risk of colorectal cancer after negative colonoscopy","volume":"29","author":"H Brenner","year":"2011","journal-title":"J Clin Oncol"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"22","DOI":"10.7326\/0003-4819-154-1-201101040-00004","article-title":"Protection from colorectal cancer after colonoscopy: a population-based, case-control study","volume":"154","author":"H Brenner","year":"2011","journal-title":"Ann Intern Med"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/jnci\/djp436","article-title":"Protection from right- and left-sided colorectal neoplasms after colonoscopy: population-based study","volume":"102","author":"H Brenner","year":"2010","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1056\/NEJM200007203430302","article-title":"Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings","volume":"343","author":"T F Imperiale","year":"2000","journal-title":"N Engl J Med"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.cgh.2008.12.030","article-title":"Effect of screening colonoscopy on colorectal cancer incidence and mortality","volume":"7","author":"C J Kahi","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1056\/NEJM200007203430301","article-title":"Use of colonoscopy to screen asymptomatic adults for colorectal cancer Veterans Affairs Cooperative Study Group 380","volume":"343","author":"D A Lieberman","year":"2000","journal-title":"N Engl J Med"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0016-5085(97)70214-2","article-title":"Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies","volume":"112","author":"D Rex","year":"1997","journal-title":"Gastroenterology"},{"issue":"06","key":"ref67","doi-asserted-by":"crossref","first-page":"eL230025","DOI":"10.7326\/L23-0025","article-title":"15-Year Benefits of Sigmoidoscopy Screening on Colorectal Cancer Incidence and Mortality","volume":"176","author":"F Juul","year":"2023","journal-title":"Ann Intern Med"},{"issue":"14","key":"ref68","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1016\/j.ejca.2013.04.023","article-title":"Superior diagnostic performance of faecal immunochemical tests for haemoglobin in a head-to-head comparison with guaiac based faecal occult blood test among 2235 participants of screening colonoscopy","volume":"49","author":"H Brenner","year":"2013","journal-title":"Eur J Cancer"},{"issue":"01","key":"ref69","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1053\/j.gastro.2017.09.018","article-title":"Direct Comparison of Diagnostic Performance of 9 Quantitative Fecal Immunochemical Tests for Colorectal Cancer Screening","volume":"154","author":"A Gies","year":"2018","journal-title":"Gastroenterology"},{"issue":"05","key":"ref70","doi-asserted-by":"crossref","first-page":"967","DOI":"10.14309\/ajg.0000000000001146","article-title":"Strong Reduction of Colorectal Cancer Incidence and Mortality After Screening Colonoscopy: Prospective Cohort Study From Germany","volume":"116","author":"F Guo","year":"2021","journal-title":"Am J Gastroenterol"},{"issue":"18","key":"ref71","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1002\/cncr.29462","article-title":"Effectiveness of fecal immunochemical testing in reducing colorectal cancer mortality from the One Million Taiwanese Screening Program","volume":"121","author":"H Chiu","year":"2015","journal-title":"Cancer"},{"issue":"12","key":"ref73","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1056\/NEJMoa1300720","article-title":"Long-term mortality after screening for colorectal cancer","volume":"369","author":"A Shaukat","year":"2013","journal-title":"N Engl J Med"},{"issue":"08","key":"ref74","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1002\/bjs.6136","article-title":"Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer","volume":"95","author":"E Lindholm","year":"2008","journal-title":"Br J Surg"},{"issue":"07","key":"ref75","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1053\/j.gastro.2004.02.018","article-title":"Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study","volume":"126","author":"J Faivre","year":"2004","journal-title":"Gastroenterology"},{"issue":"07","key":"ref76","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1136\/gutjnl-2011-300774","article-title":"Nottingham trial of faecal occult blood testing for colorectal cancer: a 20-year follow-up","volume":"61","author":"J Scholefield","year":"2012","journal-title":"Gut"},{"issue":"09","key":"ref77","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1080\/00365520410003182","article-title":"Randomized study of biennial screening with a faecal occult blood test: results after nine screening rounds","volume":"39","author":"O Kronborg","year":"2004","journal-title":"Scand J Gastroenterol"},{"issue":"11","key":"ref78","doi-asserted-by":"crossref","first-page":"775","DOI":"10.7326\/M17-1441","article-title":"Long-Term Effectiveness of Sigmoidoscopy Screening on Colorectal Cancer Incidence and Mortality in Women and Men: A Randomized Trial","volume":"168","author":"\u00d8 Holme","year":"2018","journal-title":"Ann Intern Med"},{"issue":"02","key":"ref79","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S2468-1253(18)30358-3","article-title":"Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: long-term follow-up of the randomised US PLCO cancer screening trial","volume":"4","author":"E Miller","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/S0140-6736(17)30396-3","article-title":"Long term effects of once-only flexible sigmoidoscopy screening after 17 years of follow-up: the UK Flexible Sigmoidoscopy Screening randomised controlled trial","volume":"389","author":"W Atkin","year":"2017","journal-title":"Lancet"},{"issue":"17","key":"ref81","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1093\/jnci\/djr284","article-title":"Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian Randomized Controlled Trial--SCORE","volume":"103","author":"N Segnan","year":"2011","journal-title":"J Natl Cancer Inst"},{"issue":"20","key":"ref82","doi-asserted-by":"crossref","first-page":"5953","DOI":"10.7150\/jca.46661","article-title":"Colonoscopic screening is associated with reduced Colorectal Cancer incidence and mortality: a systematic review and meta-analysis","volume":"11","author":"J Zhang","year":"2020","journal-title":"J Cancer"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"g2467","DOI":"10.1136\/bmj.g2467","article-title":"Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies","volume":"348","author":"H Brenner","year":"2014","journal-title":"BMJ"},{"issue":"01","key":"ref84","doi-asserted-by":"crossref","first-page":"18","DOI":"10.7326\/M16-0758","article-title":"Effectiveness of Screening Colonoscopy to Prevent Colorectal Cancer Among Medicare Beneficiaries Aged 70 to 79 Years: A Prospective Observational Study","volume":"166","author":"X Garc\u00eda-Alb\u00e9niz","year":"2017","journal-title":"Ann Intern Med"},{"issue":"08","key":"ref85","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/s41575-022-00612-y","article-title":"Current and future colorectal cancer screening strategies","volume":"19","author":"A Shaukat","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"07","key":"ref86","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S1470-2045(21)00199-6","article-title":"Colorectal cancer incidence, mortality, and stage distribution in European countries in the colorectal cancer screening era: an international population-based study","volume":"22","author":"R Cardoso","year":"2021","journal-title":"Lancet Oncol"},{"issue":"07","key":"ref87","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1001\/jamaoncol.2024.0827","article-title":"Longer Interval Between First Colonoscopy With Negative Findings for Colorectal Cancer and Repeat Colonoscopy","volume":"10","author":"Q Liang","year":"2024","journal-title":"JAMA Oncol"},{"issue":"03","key":"ref88","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1136\/gutjnl-2011-301583","article-title":"Random comparison of repeated faecal immunochemical testing at different intervals for population-based colorectal cancer screening","volume":"62","author":"A Roon","year":"2013","journal-title":"Gut"},{"issue":"19","key":"ref89","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1001\/jama.2021.4417","article-title":"Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force","volume":"325","author":"J Lin","year":"2021","journal-title":"JAMA"},{"issue":"06","key":"ref90","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1053\/gast.2002.37064","article-title":"Complications of screening flexible sigmoidoscopy","volume":"123","author":"T Levin","year":"2002","journal-title":"Gastroenterology"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1007\/s00330-011-2104-8","article-title":"Diagnostic value of CT-colonography as compared to colonoscopy in an asymptomatic screening population: a meta-analysis","volume":"21","author":"M C Haan","year":"2011","journal-title":"Eur Radiol"},{"key":"ref92","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.acra.2009.01.008","article-title":"CT colonography versus optical colonoscopy for screening asymptomatic patients for colorectal cancer a patient, intervention, comparison, outcome (PICO) analysis","volume":"16","author":"R H El-Maraghi","year":"2009","journal-title":"Acad Radiol"},{"issue":"05","key":"ref93","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1053\/j.gastro.2015.01.025","article-title":"Accuracy of capsule colonoscopy in detecting colorectal polyps in a screening population","volume":"148","author":"D Rex","year":"2015","journal-title":"Gastroenterology"},{"issue":"02","key":"ref94","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.gie.2019.09.041","article-title":"Accuracy of colon capsule endoscopy for advanced neoplasia","volume":"91","author":"S Pecere","year":"2020","journal-title":"Gastrointest Endosc"},{"issue":"11","key":"ref95","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1136\/gutjnl-2020-322578","article-title":"Multicentre, prospective, randomised study comparing the diagnostic yield of colon capsule endoscopy versus CT colonography in a screening population (the TOPAZ study)","volume":"70","author":"B Cash","year":"2021","journal-title":"Gut"},{"issue":"14","key":"ref96","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMoa1311194","article-title":"Multitarget stool DNA testing for colorectal-cancer screening","volume":"370","author":"T Imperiale","year":"2014","journal-title":"N Engl J Med"},{"key":"ref97","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2147\/CLEP.S136565","article-title":"Fecal occult blood versus DNA testing: indirect comparison in a colorectal cancer screening population","volume":"9","author":"H Brenner","year":"2017","journal-title":"Clin Epidemiol"},{"issue":"05","key":"ref98","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1111\/codi.15521","article-title":"Performance evaluation of stool DNA methylation tests in colorectal cancer screening: a systematic review and meta-analysis","volume":"23","author":"M Gachabayov","year":"2021","journal-title":"Colorectal Dis"},{"issue":"06","key":"ref99","doi-asserted-by":"crossref","first-page":"e98238","DOI":"10.1371\/journal.pone.0098238","article-title":"Plasma Septin9 versus fecal immunochemical testing for colorectal cancer screening: a prospective multicenter study","volume":"9","author":"D Johnson","year":"2014","journal-title":"PLoS One"},{"issue":"01","key":"ref100","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1038\/s41598-022-06689-4","article-title":"Comparison of faecal protein biomarkers\u02bc diagnostic accuracy for colorectal advanced neoplasms: a systematic review and meta-analysis","volume":"12","author":"Kansestani A Nasir","year":"2022","journal-title":"Sci Rep"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1136\/gut.2009.183046","article-title":"Role of CT colonography in colorectal cancer screening: risks and benefits","volume":"59","author":"C P Pox","year":"2010","journal-title":"Gut"},{"issue":"04","key":"ref102","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1053\/j.gastro.2012.12.041","article-title":"Magnetic resonance colonography for the detection of colorectal neoplasia in asymptomatic adults","volume":"144","author":"A Graser","year":"2013","journal-title":"Gastroenterology"},{"issue":"02","key":"ref103","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1136\/gutjnl-2013-306550","article-title":"Colon capsule versus CT colonography in patients with incomplete colonoscopy: a prospective, comparative trial","volume":"64","author":"C Spada","year":"2015","journal-title":"Gut"},{"key":"ref104","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa012294","article-title":"Detection of APC mutations in fecal DNA from patients with colorectal tumors","volume":"346","author":"G Traverso","year":"2002","journal-title":"N Engl J Med"},{"key":"ref105","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1053\/gast.2000.19580","article-title":"Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel","volume":"119","author":"D A Ahlquist","year":"2000","journal-title":"Gastroenterology"},{"key":"ref106","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1093\/jnci\/93.11.858","article-title":"Detecting colorectal cancer in stool with the use of multiple genetic targets","volume":"93","author":"S M Dong","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"ref107","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1056\/NEJMoa033403","article-title":"Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population","volume":"351","author":"T F Imperiale","year":"2004","journal-title":"N Engl J Med"},{"key":"ref108","doi-asserted-by":"crossref","first-page":"441","DOI":"10.7326\/0003-4819-149-7-200810070-00004","article-title":"Stool DNA and occult blood testing for screen detection of colorectal neoplasia","volume":"149","author":"D A Ahlquist","year":"2008","journal-title":"Ann Intern Med"},{"key":"ref109","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1016\/S0959-8049(00)00293-8","article-title":"Family history of colorectal adenomatous polyps as a risk factor for colorectal cancer","volume":"36","author":"H Nakama","year":"2000","journal-title":"Eur J Cancer"},{"issue":"05","key":"ref110","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1053\/j.gastro.2023.06.033","article-title":"AGA Clinical Practice Update on Risk Stratification for Colorectal Cancer Screening and Post-Polypectomy Surveillance: Expert Review","volume":"165","author":"R Issaka","year":"2023","journal-title":"Gastroenterology"},{"issue":"23","key":"ref111","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1001\/jama.2016.5989","article-title":"Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement","volume":"315","author":"K Bibbins-Domingo","year":"2016","journal-title":"JAMA"},{"key":"ref112","first-page":"Doc06","article-title":"Stool DNA testing for early detection of colorectal cancer: systematic review using the HTA Core Model","volume":"21","author":"H St\u00fcrzlinger","year":"2023","journal-title":"Ger Med Sci"},{"issue":"06","key":"ref113","doi-asserted-by":"crossref","first-page":"e00499","DOI":"10.14309\/ctg.0000000000000499","article-title":"Lessons From a Systematic Literature Search on Diagnostic DNA Methylation Biomarkers for Colorectal Cancer: How to Increase Research Value and Decrease Research Waste?","volume":"13","author":"Z Feng","year":"2022","journal-title":"Clin Transl Gastroenterol"},{"issue":"01","key":"ref114","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13148-020-00904-7","article-title":"Fecal DNA methylation markers for detecting stages of colorectal cancer and its precursors: a systematic review","volume":"12","author":"J Raut","year":"2020","journal-title":"Clin Epigenetics"},{"issue":"05","key":"ref115","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/jgh.12855","article-title":"Performance of a second-generation methylated SEPT9 test in detecting colorectal neoplasm","volume":"30","author":"P Jin","year":"2015","journal-title":"J Gastroenterol Hepatol"},{"issue":"09","key":"ref116","doi-asserted-by":"crossref","first-page":"e46000","DOI":"10.1371\/journal.pone.0046000","article-title":"Detection of methylated SEPT9 in plasma is a reliable screening method for both left- and right-sided colon cancers","volume":"7","author":"K T\u00f3th","year":"2012","journal-title":"PLoS One"},{"issue":"05","key":"ref117","first-page":"641","article-title":"The Usefulness of a Novel Screening Kit for Colorectal Cancer Using the Immunochromatographic Fecal Tumor M2 Pyruvate Kinase Test","volume":"9","author":"Y Kim","year":"2015","journal-title":"Gut Liver"},{"issue":"03","key":"ref118","doi-asserted-by":"crossref","first-page":"381","DOI":"10.14309\/ajg.0000000000001614","article-title":"Colonoscopy-Related Adverse Events in Patients With Abnormal Stool-Based Tests: A Systematic Review of Literature and Meta-analysis of Outcomes","volume":"117","author":"S Chandan","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"ref119","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/1097-0142(197107)28:1<131::AID-CNCR2820280125>3.0.CO;2-I","article-title":"Occult blood testing for detection of asymptomatic colon cancer","volume":"28","author":"D Greegor","year":"1971","journal-title":"Cancer"},{"key":"ref120","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1002\/1097-0142(19900501)63:9<1826::AID-CNCR2820630928>3.0.CO;2-P","article-title":"Patterns of occult bleeding in asymptomatic colorectal cancer","volume":"63","author":"D A Ahlquist","year":"1989","journal-title":"Cancer"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0016-5085(82)80253-9","article-title":"Optimal dietary conditions for hemoccult testing","volume":"82","author":"F A Macrae","year":"1982","journal-title":"Gastroenterology"},{"key":"ref122","doi-asserted-by":"crossref","first-page":"162","DOI":"10.7326\/0003-4819-150-3-200902030-00005","article-title":"Comparative evaluation of immunochemical fecal occult blood tests for colorectal adenoma detection","volume":"150","author":"S Hundt","year":"2009","journal-title":"Ann Intern Med"},{"issue":"01","key":"ref123","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s12916-017-0944-z","article-title":"Faecal immunochemical tests (FIT) can help to rule out colorectal cancer in patients presenting in primary care with lower abdominal symptoms: a systematic review conducted to inform new NICE DG30 diagnostic guidance","volume":"15","author":"M Westwood","year":"2017","journal-title":"BMC Med"},{"issue":"S 03","key":"ref124","first-page":"SE65","article-title":"European guidelines for quality assurance in colorectal cancer screening and diagnosis First Edition--Faecal occult blood testing","volume":"44","author":"S Halloran","year":"2012","journal-title":"Endoscopy"},{"key":"ref125","doi-asserted-by":"crossref","first-page":"162","DOI":"10.7326\/0003-4819-150-3-200902030-00005","article-title":"Comparative evaluation of immunochemical fecal occult blood tests for colorectal adenoma detection","volume":"150","author":"S Hundt","year":"2009","journal-title":"Ann Intern Med"},{"key":"ref126","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1002\/ijc.25154","article-title":"Inter-test agreement and quantitative cross-validation of immunochromatographical fecal occult blood tests","volume":"127","author":"H Brenner","year":"2010","journal-title":"Int J Cancer"},{"key":"ref127","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1093\/jnci\/djm150","article-title":"Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics","volume":"99","author":"J E Allison","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"ref128","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1038\/ajg.2010.179","article-title":"Comparison of guaiac-based and quantitative immunochemical fecal occult blood testing in a population at average risk undergoing colorectal cancer screening","volume":"105","author":"D I Park","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"ref129","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/ijc.20921","article-title":"Evaluation of an immunochemical fecal occult blood test with automated reading in screening for colorectal cancer in a general average-risk population","volume":"115","author":"G D Launoy","year":"2005","journal-title":"Int J Cancer"},{"key":"ref130","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.cgh.2010.12.012","article-title":"Diagnostic yield improves with collection of 2 samples in fecal immunochemical test screening without affecting attendance","volume":"9","author":"A H Roon","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref131","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1056\/NEJM199305133281901","article-title":"Reducing mortality from colorectal cancer by screening for fecal occult blood Minnesota Colon Cancer Control Study","volume":"328","author":"J S Mandel","year":"1993","journal-title":"N Engl J Med"},{"key":"ref132","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1016\/S0140-6736(96)03386-7","article-title":"Randomised controlled trial of faecal-occult-blood screening for colorectal cancer","volume":"348","author":"J D Hardcastle","year":"1996","journal-title":"Lancet"},{"key":"ref133","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/S0140-6736(96)03430-7","article-title":"Randomised study of screening for colorectal cancer with faecal-occult-blood test","volume":"348","author":"O Kronborg","year":"1996","journal-title":"Lancet"},{"key":"ref134","first-page":"CD001216","article-title":"Screening for colorectal cancer using the faecal occult blood test, Hemoccult","author":"P Hewitson","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"ref135","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1001\/archinte.1997.00440300064005","article-title":"Screening for colorectal cancer A comparison of 3 fecal occult blood tests","volume":"157","author":"B Levin","year":"1997","journal-title":"Arch Intern Med"},{"key":"ref136","first-page":"1125","article-title":"[Positive family history of colorectal cancer--use of a questionnaire]","volume":"47","author":"A Katalinic","year":"2009","journal-title":"Z Gastroenterol"},{"issue":"02","key":"ref137","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1001\/jamaoncol.2020.6252","article-title":"Comparison of Universal Genetic Testing vs Guideline-Directed Targeted Testing for Patients With Hereditary Cancer Syndrome","volume":"7","author":"N Samadder","year":"2021","journal-title":"JAMA Oncol"},{"issue":"24","key":"ref138","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1200\/JCO.21.02764","article-title":"Point\/Counterpoint: Is It Time for Universal Germline Genetic Testing for All GI Cancers?","volume":"40","author":"H Hampel","year":"2022","journal-title":"J Clin Oncol"},{"issue":"04","key":"ref139","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1053\/j.gastro.2017.11.004","article-title":"Germline Genetic Features of Young Individuals With Colorectal Cancer","volume":"154","author":"E Stoffel","year":"2018","journal-title":"Gastroenterology"},{"issue":"08","key":"ref140","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1002\/ijc.33117","article-title":"Evaluation of yield and experiences of age-related molecular investigation for heritable and nonheritable causes of mismatch repair deficient colorectal cancer to identify Lynch syndrome","volume":"147","author":"J Vos","year":"2020","journal-title":"Int J Cancer"},{"issue":"10","key":"ref141","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1002\/ijc.33273","article-title":"Age-dependent performance of BRAF mutation testing in Lynch syndrome diagnostics","volume":"147","author":"H Bl\u00e4ker","year":"2020","journal-title":"Int J Cancer"},{"issue":"03","key":"ref143","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.cgh.2022.12.006","article-title":"Delphi Initiative for Early-Onset Colorectal Cancer (DIRECt) International Management Guidelines","volume":"21","author":"G Cavestro","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref144","doi-asserted-by":"crossref","first-page":"e2100516","DOI":"10.1200\/PO.21.00516","article-title":"Universal Germline Genetic Testing for Hereditary Cancer Syndromes in Patients With Solid Tumor Cancer","volume":"6","author":"E Esplin","year":"2022","journal-title":"JCO Precis Oncol"},{"issue":"03","key":"ref145","doi-asserted-by":"crossref","first-page":"e508","DOI":"10.1016\/j.cgh.2021.04.013","article-title":"Germline Cancer Susceptibility Gene Testing in Unselected Patients With Colorectal Adenocarcinoma: A Multicenter Prospective Study","volume":"20","author":"P Uson","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"12","key":"ref146","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1093\/jnci\/djab124","article-title":"A Comprehensive Comparison of Early-Onset and Average-Onset Colorectal Cancers","volume":"113","author":"A Cercek","year":"2021","journal-title":"J Natl Cancer Inst"},{"issue":"05","key":"ref147","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1053\/j.gastro.2020.12.009","article-title":"A High Percentage of Early-age Onset Colorectal Cancer Is Potentially Preventable","volume":"160","author":"P Stanich","year":"2021","journal-title":"Gastroenterology"},{"issue":"05","key":"ref148","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/mgg3.317","article-title":"Targeted sequencing of 36 known or putative colorectal cancer susceptibility genes","volume":"5","author":"M DeRycke","year":"2017","journal-title":"Mol Genet Genomic Med"},{"key":"ref149","doi-asserted-by":"publisher","DOI":"10.1200\/PO.20.00525","article-title":"Prospective Statewide Study of Universal Screening for Hereditary Colorectal Cancer: The Ohio Colorectal Cancer Prevention Initiative","volume":"5","author":"R Pearlman","year":"2021","journal-title":"JCO Precis Oncol"},{"issue":"07","key":"ref150","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1038\/s41436-018-0373-1","article-title":"Determining the clinical validity of hereditary colorectal cancer and polyposis susceptibility genes using the Clinical Genome Resource Clinical Validity Framework","volume":"21","author":"B Seifert","year":"2019","journal-title":"Genet Med"},{"issue":"06","key":"ref151","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1136\/jmedgenet-2017-105188","article-title":"Consensus for genes to be included on cancer panel tests offered by UK genetics services: guidelines of the UK Cancer Genetics Group","volume":"55","author":"A Taylor","year":"2018","journal-title":"J Med Genet"},{"issue":"01","key":"ref152","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00432-022-04397-0","article-title":"Risk of cancer in individuals with Lynch-like syndrome and their families: a systematic review","volume":"149","author":"P Nugroho","year":"2023","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"key":"ref153","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s10689-009-9294-0","article-title":"The challenge of developmentally appropriate care: predictive genetic testing in young people for familial adenomatous polyposis","volume":"9","author":"R E Duncan","year":"2010","journal-title":"Fam Cancer"},{"key":"ref154","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/pon.1357","article-title":"Psychosocial issues in genetic testing for familial adenomatous polyposis: a review of the literature","volume":"17","author":"K F Douma","year":"2008","journal-title":"Psychooncology"},{"key":"ref155","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/pon.1570","article-title":"Psychological distress and use of psychosocial support in familial adenomatous polyposis","volume":"19","author":"K F Douma","year":"2010","journal-title":"Psychooncology"},{"key":"ref156","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00001574-199401000-00004","article-title":"Epidemiology and etiology of sporadic colorectal adenocarcinoma","volume":"10","author":"W Karnes","year":"1994","journal-title":"Current opinion in Gastroenterology"},{"key":"ref157","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/S0140-6736(10)61543-7","article-title":"Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials","volume":"376","author":"P M Rothwell","year":"2010","journal-title":"Lancet"},{"key":"ref158","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa021633","article-title":"A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer","volume":"348","author":"R S Sandler","year":"2003","journal-title":"N Engl J Med"},{"key":"ref159","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S1052-5157(18)30323-4","article-title":"Screening of patients with a positive family history of colorectal cancer","volume":"7","author":"R W Burt","year":"1997","journal-title":"Gastrointest Endosc Clin N Am"},{"key":"ref160","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/S0140-6736(20)30366-4","article-title":"Cancer prevention with aspirin in hereditary colorectal cancer (Lynch syndrome), 10-year follow-up and registry-based 20-year data in the CAPP2 study: a double-blind, randomised, placebo-controlled trial","volume":"395","author":"J Burn","year":"2020","journal-title":"Lancet"},{"issue":"01","key":"ref161","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s12885-021-09143-2","article-title":"Polygenic risk prediction models for colorectal cancer: a systematic review","volume":"22","author":"M Sassano","year":"2022","journal-title":"BMC Cancer"},{"key":"ref162","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/jnci\/95.10.717","article-title":"Neoplastic and antineoplastic effects of beta-carotene on colorectal adenoma recurrence: results of a randomized trial","volume":"95","author":"J A Baron","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"ref163","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00001574-199401000-00004","article-title":"Epidemiology and etiology of sporadic colorectal adenocarcinoma","volume":"10","author":"W Karnes","year":"1994","journal-title":"Current opinion in Gastroenterology"},{"key":"ref164","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/S0140-6736(10)61543-7","article-title":"Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials","volume":"376","author":"P M Rothwell","year":"2010","journal-title":"Lancet"},{"key":"ref165","doi-asserted-by":"crossref","first-page":"101909","DOI":"10.1016\/j.eclinm.2023.101909","article-title":"Mortality by age, gene and gender in carriers of pathogenic mismatch repair gene variants receiving surveillance for early cancer diagnosis and treatment: a report from the prospective Lynch syndrome database","volume":"58","author":"M Dominguez-Valentin","year":"2023","journal-title":"EClinicalMedicine"},{"issue":"05","key":"ref166","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.gim.2022.01.014","article-title":"Worldwide prevalence of Lynch syndrome in patients with colorectal cancer: Systematic review and meta-analysis","volume":"24","author":"N Abu-Ghazaleh","year":"2022","journal-title":"Genet Med"},{"issue":"05","key":"ref167","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1053\/j.gastro.2018.07.030","article-title":"No Difference in Colorectal Cancer Incidence or Stage at Detection by Colonoscopy Among 3 Countries With Different Lynch Syndrome Surveillance Policies","volume":"155","author":"C Engel","year":"2018","journal-title":"Gastroenterology"},{"issue":"07","key":"ref168","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1053\/j.gastro.2010.02.053","article-title":"One to 2-year surveillance intervals reduce risk of colorectal cancer in families with Lynch syndrome","volume":"138","author":"H Vasen","year":"2010","journal-title":"Gastroenterology"},{"issue":"22","key":"ref169","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1001\/jama.2011.743","article-title":"Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome","volume":"305","author":"V Bonadona","year":"2011","journal-title":"JAMA"},{"issue":"07","key":"ref170","first-page":"1306","article-title":"Cancer risk and survival in","volume":"67","author":"P M\u00f8ller","year":"2018","journal-title":"Gut"},{"issue":"12","key":"ref171","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1001\/jama.296.12.1507","article-title":"Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review","volume":"296","author":"N Lindor","year":"2006","journal-title":"JAMA"},{"issue":"03","key":"ref172","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.cgh.2020.11.002","article-title":"Quality of Colonoscopy Is Associated With Adenoma Detection and Postcolonoscopy Colorectal Cancer Prevention in Lynch Syndrome","volume":"20","author":"A S\u00e1nchez","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"01","key":"ref173","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13053-022-00241-1","article-title":"Colorectal cancer incidences in Lynch syndrome: a comparison of results from the prospective lynch syndrome database and the international mismatch repair consortium","volume":"20","author":"P M\u00f8ller","year":"2022","journal-title":"Hered Cancer Clin Pract"},{"issue":"06","key":"ref174","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1136\/gutjnl-2017-314057corr1","article-title":"Correction: Cancer risk and survival in path _MMR carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database","volume":"69","year":"2020","journal-title":"Gut"},{"issue":"01","key":"ref175","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/ijc.31300","article-title":"Three molecular pathways model colorectal carcinogenesis in Lynch syndrome","volume":"143","author":"A Ahadova","year":"2018","journal-title":"Int J Cancer"},{"issue":"01","key":"ref176","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1053\/j.gastro.2023.03.007","article-title":"A \u201eTwo-in-One Hit\u201c Model of Shortcut Carcinogenesis in MLH1 Lynch Syndrome Carriers","volume":"165","author":"A Ahadova","year":"2023","journal-title":"Gastroenterology"},{"issue":"03","key":"ref177","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1136\/gutjnl-2015-309675","article-title":"Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database","volume":"66","author":"P M\u00f8ller","year":"2017","journal-title":"Gut"},{"issue":"04","key":"ref178","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1200\/JCO.2014.55.8536","article-title":"Short-term risk of colorectal cancer in individuals with lynch syndrome: a meta-analysis","volume":"33","author":"M Jenkins","year":"2015","journal-title":"J Clin Oncol"},{"issue":"09","key":"ref179","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S1542-3565(05)00403-9","article-title":"Chromoendoscopic colonoscopy for detecting preneoplastic lesions in hereditary nonpolyposis colorectal cancer syndrome","volume":"3","author":"T Lecomte","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref180","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1055\/s-0028-1119628","article-title":"Chromocolonoscopy detects more adenomas than white light colonoscopy or narrow band imaging colonoscopy in hereditary nonpolyposis colorectal cancer screening","volume":"41","author":"R Huneburg","year":"2009","journal-title":"Endoscopy"},{"issue":"04","key":"ref181","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1053\/j.gastro.2019.09.003","article-title":"White-Light Endoscopy Is Adequate for Lynch Syndrome Surveillance in a Randomized and Noninferiority Study","volume":"158","author":"L Rivero-S\u00e1nchez","year":"2020","journal-title":"Gastroenterology"},{"issue":"04","key":"ref182","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.gie.2019.04.227","article-title":"Effect of chromoendoscopy in the proximal colon on colorectal neoplasia detection in Lynch syndrome: a\u00a0multicenter randomized controlled trial","volume":"90","author":"J Haanstra","year":"2019","journal-title":"Gastrointest Endosc"},{"issue":"04","key":"ref183","doi-asserted-by":"crossref","first-page":"825","DOI":"10.14309\/ajg.0000000000001138","article-title":"Dye-Based Chromoendoscopy in Patients With Lynch Syndrome: An Individual Patient Data Meta-Analysis of Randomized Trials","volume":"116","author":"B Houwen","year":"2021","journal-title":"Am J Gastroenterol"},{"issue":"01","key":"ref184","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/ueg2.12354","article-title":"Real-time use of artificial intelligence (CADEYE) in colorectal cancer surveillance of patients with Lynch syndrome-A randomized controlled pilot trial (CADLY)","volume":"11","author":"R H\u00fcneburg","year":"2023","journal-title":"United European Gastroenterol J"},{"issue":"09","key":"ref185","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/S2468-1253(24)00187-0","article-title":"An artificial intelligence-assisted system versus white light endoscopy alone for adenoma detection in individuals with Lynch syndrome (TIMELY): an international, multicentre, randomised controlled trial","volume":"9","author":"O Ortiz","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"04","key":"ref186","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.cgh.2019.07.012","article-title":"Clinical Factors Associated With Gastric Cancer in Individuals With Lynch Syndrome","volume":"18","author":"J Kim","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"35","key":"ref187","doi-asserted-by":"crossref","first-page":"4409","DOI":"10.1200\/JCO.2012.43.2278","article-title":"Risks of less common cancers in proven mutation carriers with lynch syndrome","volume":"30","author":"C Engel","year":"2012","journal-title":"J Clin Oncol"},{"issue":"29","key":"ref188","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1200\/JCO.2018.78.4777","article-title":"Cancer Risks for PMS2-Associated Lynch Syndrome","volume":"36","author":"S Ten Broeke","year":"2018","journal-title":"J Clin Oncol"},{"issue":"12","key":"ref189","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1002\/ijc.33753","article-title":"Early detection of duodenal cancer by upper gastrointestinal-endoscopy in Lynch syndrome","volume":"149","author":"D Vangala","year":"2021","journal-title":"Int J Cancer"},{"issue":"01","key":"ref190","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/ijc.33294","article-title":"Value of upper gastrointestinal endoscopy for gastric cancer surveillance in patients with Lynch syndrome","volume":"148","author":"S Ladigan-Badura","year":"2021","journal-title":"Int J Cancer"},{"issue":"08","key":"ref191","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1055\/a-2066-2051","article-title":"Endometrial Cancer Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry Number 032\/034-OL, September 2022) Part 1 with Recommendations on the Epidemiology, Screening, Diagnosis and Hereditary Factors of Endometrial Cancer, Geriatric Assessment and Supply Structures","volume":"83","author":"G Emons","year":"2023","journal-title":"Geburtshilfe Frauenheilkd"},{"issue":"10","key":"ref192","first-page":"1724","article-title":"[Not Available]","volume":"62","author":"T Seufferlein","year":"2024","journal-title":"Z Gastroenterol"},{"issue":"07","key":"ref193","first-page":"783","article-title":"[Correction: AWMF-Registernummer: 032-010OL \u2013 Leitlinie (Kurzversion)]","volume":"63","author":"T Seufferlein","year":"2025","journal-title":"Z Gastroenterol"},{"key":"ref194","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/S0140-6736(11)61049-0","article-title":"Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial","volume":"378","author":"J Burn","year":"2011","journal-title":"Lancet"},{"issue":"09","key":"ref195","doi-asserted-by":"crossref","first-page":"djv170","DOI":"10.1093\/jnci\/djv170","article-title":"Aspirin, Ibuprofen, and the Risk of Colorectal Cancer in Lynch Syndrome","volume":"107","author":"D Ait Ouakrim","year":"2015","journal-title":"J Natl Cancer Inst"},{"issue":"05","key":"ref196","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.surg.2022.06.013","article-title":"Survival outcomes associated with Lynch syndrome colorectal cancer and metachronous rate after subtotal\/total versus segmental colectomy: Meta-analysis","volume":"172","author":"J Toh","year":"2022","journal-title":"Surgery"},{"key":"ref197","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/jnci\/djk092","article-title":"Lymph node evaluation and survival after curative resection of colon cancer: systematic review","volume":"99","author":"G J Chang","year":"2007","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"ref198","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1200\/JCO.2003.05.062","article-title":"Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089","volume":"21","author":"T E Le Voyer","year":"2003","journal-title":"J Clin Oncol"},{"issue":"12","key":"ref199","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/S2468-1253(23)00228-5","article-title":"Metachronous colorectal cancer risk according to Lynch syndrome pathogenic variant after extensive versus partial colectomy in the Netherlands: a retrospective cohort study","volume":"8","author":"E Eikenboom","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"25","key":"ref200","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1056\/NEJMoa2201445","article-title":"PD-1 Blockade in Mismatch Repair-Deficient, Locally Advanced Rectal Cancer","volume":"386","author":"A Cercek","year":"2022","journal-title":"N Engl J Med"},{"key":"ref201","doi-asserted-by":"crossref","first-page":"57","DOI":"10.4065\/75.1.57","article-title":"Care of patients and their families with familial adenomatous polyposis","volume":"75","author":"J E King","year":"2000","journal-title":"Mayo Clin Proc"},{"key":"ref202","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s10350-004-6322-x","article-title":"Teenagers with familial adenomatous polyposis: what is their risk for colorectal cancer?","volume":"45","author":"J M Church","year":"2002","journal-title":"Dis Colon Rectum"},{"issue":"03","key":"ref203","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1136\/gutjnl-2019-319915","article-title":"Guidelines for the management of hereditary colorectal cancer from the British Society of Gastroenterology (BSG)\/Association of Coloproctology of Great Britain and Ireland (ACPGBI)\/United Kingdom Cancer Genetics Group (UKCGG)","volume":"69","author":"K Monahan","year":"2020","journal-title":"Gut"},{"issue":"01","key":"ref204","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jpedsurg.2013.09.033","article-title":"The natural history of familial adenomatous polyposis syndrome: a 24 year review of a single center experience in screening, diagnosis, and outcomes","volume":"49","author":"R Kennedy","year":"2014","journal-title":"J Pediatr Surg"},{"issue":"01","key":"ref205","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.gie.2015.12.029","article-title":"A proposed staging system and stage-specific interventions for familial adenomatous polyposis","volume":"84","author":"P Lynch","year":"2016","journal-title":"Gastrointest Endosc"},{"issue":"01","key":"ref206","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s00384-023-04370-4","article-title":"Incidental cancer in colectomy specimens from patients with familial adenomatous polyposis: single centre experience and literature review","volume":"38","author":"U Uylas","year":"2023","journal-title":"Int J Colorectal Dis"},{"issue":"08","key":"ref207","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1097\/DCR.0000000000001967","article-title":"Incidence and Management of Rectal Cuff and Anal Transitional Zone Neoplasia in Patients With Familial Adenomatous Polyposis","volume":"64","author":"C Lee","year":"2021","journal-title":"Dis Colon Rectum"},{"issue":"02","key":"ref208","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/DCR.0000000000002839","article-title":"Correlation Between the Severity of Adhesions and Desmoid Disease in Patients With Familial Adenomatous Polyposis: A Prospective Cohort Study","volume":"67","author":"E Faul","year":"2024","journal-title":"Dis Colon Rectum"},{"issue":"07","key":"ref209","doi-asserted-by":"crossref","first-page":"E1014","DOI":"10.1055\/a-1467-6257","article-title":"Prophylactic colectomy and rectal preservation in FAP: systematic endoscopic follow-up and adenoma destruction changes natural history of polyposis","volume":"9","author":"A Pasquer","year":"2021","journal-title":"Endosc Int Open"},{"issue":"06","key":"ref210","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1053\/gast.2000.20180","article-title":"Ileorectal anastomosis is appropriate for a subset of patients with familial adenomatous polyposis","volume":"119","author":"C B\u00fclow","year":"2000","journal-title":"Gastroenterology"},{"issue":"01","key":"ref211","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.asjsur.2021.06.034","article-title":"Risk of extracolonic malignancies and metachronous rectal cancer after colectomy and ileorectal anastomosis in familial adenomatous polyposis","volume":"45","author":"K Sasaki","year":"2022","journal-title":"Asian J Surg"},{"issue":"02","key":"ref212","first-page":"art1","article-title":"Subsequent Adenomas of Ileal Pouch and Anorectal Segment after Prophylactic Surgery for Familial Adenomatous Polyposis","volume":"3","author":"A M\u02bcKoma","year":"2013","journal-title":"World J Colorectal Surg"},{"issue":"10","key":"ref213","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1007\/s00464-013-2980-x","article-title":"Prevalence and risk factors for adenomas in the ileal pouch and the afferent loop after restorative proctocolectomy for patients with familial adenomatous polyposis","volume":"27","author":"E Pommaret","year":"2013","journal-title":"Surg Endosc"},{"issue":"04","key":"ref214","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00384-007-0422-8","article-title":"Occurrence of adenomas in the pouch and small intestine of FAP patients after proctocolectomy with ileoanal pouch construction","volume":"23","author":"A Schulz","year":"2008","journal-title":"Int J Colorectal Dis"},{"key":"ref215","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000003273","article-title":"Risk of Cancer and Reoperation After Ileorectal Anastomosis and Ileal Pouch-Anal Anastomosis in Familial Adenomatous Polyposis","author":"H Bouchiba","year":"2024","journal-title":"Am J Gastroenterol"},{"issue":"09","key":"ref216","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1007\/BF02234779","article-title":"Predicting polyposis severity by proctoscopy: how reliable is it?","volume":"44","author":"J Church","year":"2001","journal-title":"Dis Colon Rectum"},{"issue":"01","key":"ref217","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s00384-024-04608-9","article-title":"Long-term prognosis after stapled and hand-sewn ileal pouch-anal anastomoses for familial adenomatous polyposis: a multicenter retrospective study","volume":"39","author":"K Tatsuta","year":"2024","journal-title":"Int J Colorectal Dis"},{"issue":"05","key":"ref218","doi-asserted-by":"crossref","first-page":"E691","DOI":"10.1055\/a-0849-9465","article-title":"Long-term outcomes of metachronous neoplasms in the ileal pouch and rectum after surgical treatment in patients with familial adenomatous polyposis","volume":"7","author":"M Tajika","year":"2019","journal-title":"Endosc Int Open"},{"issue":"04","key":"ref219","doi-asserted-by":"crossref","first-page":"617","DOI":"10.14309\/ajg.0000000000002688","article-title":"The Spigelman Staging System and the Risk of Duodenal and Papillary Cancer in Familial Adenomatous Polyposis: A Systematic Review and Meta-Analysis","volume":"119","author":"A Mannucci","year":"2024","journal-title":"Am J Gastroenterol"},{"issue":"09","key":"ref220","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1111\/jgh.16281","article-title":"Intensive endoscopic resection strategy for multiple duodenal polyposis associated with familial adenomatous polyposis","volume":"38","author":"K Iwata","year":"2023","journal-title":"J Gastroenterol Hepatol"},{"issue":"06","key":"ref221","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1055\/a-1983-5963","article-title":"Efficacy and safety of intensive downstaging polypectomy (IDP) for multiple duodenal adenomas in patients with familial adenomatous polyposis: a prospective cohort study","volume":"55","author":"Y Takeuchi","year":"2023","journal-title":"Endoscopy"},{"issue":"03","key":"ref222","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.gie.2021.09.036","article-title":"Natural history of ampullary adenomas in familial adenomatous polyposis: a long-term follow-up study","volume":"95","author":"A Singh","year":"2022","journal-title":"Gastrointest Endosc"},{"issue":"06","key":"ref223","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.cgh.2009.02.028","article-title":"Features of duodenal cancer in patients with familial adenomatous polyposis","volume":"7","author":"A Latchford","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"05","key":"ref224","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1136\/gut.50.5.636","article-title":"Duodenal cancer in patients with familial adenomatous polyposis (FAP): results of a 10 year prospective study","volume":"50","author":"C Groves","year":"2002","journal-title":"Gut"},{"issue":"06","key":"ref225","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1097\/SLA.0000000000000734","article-title":"Progression and Management of Duodenal Neoplasia in Familial Adenomatous Polyposis: A Cohort Study","volume":"261","author":"P Serrano","year":"2015","journal-title":"Ann Surg"},{"issue":"11","key":"ref226","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1097\/DCR.0000000000000903","article-title":"Surveillance of Duodenal Polyposis in Familial Adenomatous Polyposis: Should the Spigelman Score Be Modified?","volume":"60","author":"I Sourrouille","year":"2017","journal-title":"Dis Colon Rectum"},{"issue":"06","key":"ref227","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1055\/s-0029-1214719","article-title":"Surveillance and treatment of duodenal adenomatosis in familial adenomatous polyposis","volume":"41","author":"A Lepist\u00f6","year":"2009","journal-title":"Endoscopy"},{"issue":"08","key":"ref228","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1111\/j.1463-1318.2011.02844.x","article-title":"Duodenal surveillance improves the prognosis after duodenal cancer in familial adenomatous polyposis","volume":"14","author":"S B\u00fclow","year":"2012","journal-title":"Colorectal Dis"},{"issue":"01","key":"ref229","doi-asserted-by":"crossref","first-page":"46","DOI":"10.5009\/gnl.2011.5.1.46","article-title":"Prevalence of gastric and duodenal polyps and risk factors for duodenal neoplasm in korean patients with familial adenomatous polyposis","volume":"5","author":"S Park","year":"2011","journal-title":"Gut Liver"},{"issue":"03","key":"ref230","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s10689-011-9433-2","article-title":"Progression of duodenal adenomatosis in familial adenomatous polyposis: due to ageing of subjects and advances in technology","volume":"10","author":"E Mathus-Vliegen","year":"2011","journal-title":"Fam Cancer"},{"issue":"S 02","key":"ref231","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/den.12255","article-title":"Duodenal adenomatosis in Japanese patients with familial adenomatous polyposis","volume":"26","author":"Y Maehata","year":"2014","journal-title":"Dig Endosc"},{"issue":"02","key":"ref232","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.gie.2020.02.040","article-title":"Management of ampullary adenomas in familial adenomatous polyposis syndrome: 16 years of experience from a tertiary cancer center","volume":"92","author":"P Angsuwatcharakon","year":"2020","journal-title":"Gastrointest Endosc"},{"issue":"04","key":"ref233","doi-asserted-by":"crossref","first-page":"734","DOI":"10.21037\/jgo.2019.03.06","article-title":"Upper gastrointestinal neoplasia in familial adenomatous polyposis: prevalence, endoscopic features and management","volume":"10","author":"F Campos","year":"2019","journal-title":"J Gastrointest Oncol"},{"issue":"05","key":"ref234","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/MCG.0000000000000555","article-title":"Characteristics and Clinical Outcomes of Duodenal Neoplasia in Japanese Patients With Familial Adenomatous Polyposis","volume":"51","author":"T Yachida","year":"2017","journal-title":"J Clin Gastroenterol"},{"issue":"02","key":"ref235","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.gie.2020.05.065","article-title":"Endoscopic management of duodenal adenomas in patients with familial adenomatous polyposis","volume":"93","author":"V Roos","year":"2021","journal-title":"Gastrointest Endosc"},{"issue":"09","key":"ref236","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1245\/s10434-012-2221-x","article-title":"Severe duodenal involvement in familial adenomatous polyposis treated by pylorus-preserving pancreaticoduodenectomy","volume":"19","author":"F Cailli\u00e9","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"05","key":"ref237","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1477-2574.2011.00292.x","article-title":"Pancreaticoduodenectomy for advanced duodenal and ampullary adenomatosis in familial adenomatous polyposis","volume":"13","author":"J Skipworth","year":"2011","journal-title":"HPB (Oxford)"},{"issue":"01","key":"ref238","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00423-017-1625-2","article-title":"Postoperative outcome and quality of life after surgery for FAP-associated duodenal adenomatosis","volume":"403","author":"P Ganschow","year":"2018","journal-title":"Langenbecks Arch Surg"},{"key":"ref239","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/bjs.7374","article-title":"Surgical management of the duodenal manifestations of familial adenomatous polyposis","volume":"98","author":"Y Parc","year":"2011","journal-title":"Br J Surg"},{"issue":"02","key":"ref240","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.cgh.2007.11.018","article-title":"Fundic gland polyp dysplasia is common in familial adenomatous polyposis","volume":"6","author":"L Bianchi","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"03","key":"ref241","doi-asserted-by":"crossref","first-page":"E137","DOI":"10.1055\/s-0042-119809","article-title":"Clinical outcomes of gastric polyps and neoplasms in patients with familial adenomatous polyposis","volume":"5","author":"K Nakamura","year":"2017","journal-title":"Endosc Int Open"},{"issue":"08","key":"ref242","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.14309\/ajg.0000000000001833","article-title":"Novel Endoscopic Polypectomy Surveillance Technique for Fundic Gland Polyps in Familial Adenomatous Polyposis Can Improve Early Detection of Dysplasia and Gastric Cancer","volume":"117","author":"K Wang","year":"2022","journal-title":"Am J Gastroenterol"},{"issue":"03","key":"ref243","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1136\/gut.28.3.306","article-title":"Gastric and duodenal polyps in familial adenomatous polyposis: a prospective study of the nature and prevalence of upper gastrointestinal polyps","volume":"28","author":"R Sarre","year":"1987","journal-title":"Gut"},{"issue":"03","key":"ref244","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s10689-017-9966-0","article-title":"Gastric tumours in FAP","volume":"16","author":"S Walton","year":"2017","journal-title":"Fam Cancer"},{"issue":"03","key":"ref245","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/PAS.0000000000000146","article-title":"Upper GI tract lesions in familial adenomatous polyposis (FAP): enrichment of pyloric gland adenomas and other gastric and duodenal neoplasms","volume":"38","author":"L Wood","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"08","key":"ref246","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1055\/a-1265-2716","article-title":"Gastric adenomas and their management in familial adenomatous polyposis","volume":"53","author":"I Martin","year":"2021","journal-title":"Endoscopy"},{"issue":"03","key":"ref247","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00535-023-02074-8","article-title":"Risk of gastric adenoma and adenocarcinoma in patients with familial adenomatous polyposis in Japan: a nationwide multicenter study","volume":"59","author":"K Sasaki","year":"2024","journal-title":"J Gastroenterol"},{"issue":"04","key":"ref248","doi-asserted-by":"crossref","first-page":"381","DOI":"10.5230\/jgc.2022.22.e30","article-title":"Endoscopic Findings and Treatment of Gastric Neoplasms in Familial Adenomatous Polyposis","volume":"22","author":"C Sato","year":"2022","journal-title":"J Gastric Cancer"},{"issue":"01","key":"ref249","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.gie.2022.09.002","article-title":"Incidence and natural history of gastric high-grade dysplasia in patients with familial adenomatous polyposis syndrome","volume":"97","author":"M DelSignore","year":"2023","journal-title":"Gastrointest Endosc"},{"issue":"03","key":"ref250","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1007\/s10620-011-1917-2","article-title":"Endoscopic management of duodenal adenomas in familial adenomatous polyposis--a single-center experience","volume":"57","author":"S Jaganmohan","year":"2012","journal-title":"Dig Dis Sci"},{"issue":"05","key":"ref251","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.gie.2014.03.012","article-title":"Endoscopic treatment of severe duodenal polyposis as an alternative to surgery for patients with familial adenomatous polyposis","volume":"80","author":"D Moussata","year":"2014","journal-title":"Gastrointest Endosc"},{"issue":"08","key":"ref252","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1055\/a-2029-2935","article-title":"Endoscopic papillectomy for ampullary lesions in patients with familial adenomatous polyposis compared with sporadic lesions: a propensity score-matched cohort","volume":"55","author":"K Vu Trung","year":"2023","journal-title":"Endoscopy"},{"issue":"04","key":"ref253","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.surg.2019.05.060","article-title":"Comparison of pancreas-sparing duodenectomy (PSD) and pancreatoduodenectomy (PD) for the management of duodenal polyposis syndromes","volume":"166","author":"R Walsh","year":"2019","journal-title":"Surgery"},{"issue":"11","key":"ref254","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1002\/bjs.6308","article-title":"Pancreas-preserving total duodenectomy versus standard pancreatoduodenectomy for patients with familial adenomatous polyposis and polyps in the duodenum","volume":"95","author":"S Castro","year":"2008","journal-title":"Br J Surg"},{"issue":"06","key":"ref255","doi-asserted-by":"crossref","first-page":"e1071","DOI":"10.1097\/SLA.0000000000003740","article-title":"The Prevalence and Significance of Jejunal and Duodenal Bulb Polyposis After Duodenectomy in Familial Adenomatous Polyposis: Retrospective Cohort Study","volume":"274","author":"J Yoon","year":"2021","journal-title":"Ann Surg"},{"issue":"05","key":"ref256","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1007\/s11605-020-04621-7","article-title":"Long-Term Outcomes of Pancreas-Sparing Duodenectomy for Duodenal Polyposis in Familial Adenomatous Polyposis Syndrome","volume":"25","author":"R Naples","year":"2021","journal-title":"J Gastrointest Surg"},{"issue":"01","key":"ref257","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s10689-015-9844-6","article-title":"Surveillance using capsule endoscopy is safe in post-colectomy patients with familial adenomatous polyposis: a prospective Japanese study","volume":"15","author":"M Matsumoto","year":"2016","journal-title":"Fam Cancer"},{"issue":"11","key":"ref258","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1016\/j.cgh.2024.06.018","article-title":"Development of Desmoid Tumors After Ileorectal Anastomosis Versus Ileal Pouch-Anal Anastomosis in Familial Adenomatous Polyposis","volume":"22","author":"A Aelvoet","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref259","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.cgh.2006.10.019","article-title":"Prevalence of thyroid cancer in familial adenomatous polyposis syndrome and the role of screening ultrasound examinations","volume":"5","author":"M Herraiz","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"01","key":"ref260","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1136\/jmedgenet-2017-104545","article-title":"Extracolonic cancer risk in Dutch patients with APC (adenomatous polyposis coli)-associated polyposis","volume":"55","author":"Z Ghorbanoghli","year":"2018","journal-title":"J Med Genet"},{"issue":"01","key":"ref261","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s10689-018-0085-3","article-title":"Prevalence of thyroid diseases in familial adenomatous polyposis: a systematic review and meta-analysis","volume":"18","author":"J Chenbhanich","year":"2019","journal-title":"Fam Cancer"},{"issue":"05","key":"ref262","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.amjsurg.2014.03.012","article-title":"Results of a prospective thyroid ultrasound screening program in adenomatous polyposis patients","volume":"208","author":"E Steinhagen","year":"2014","journal-title":"Am J Surg"},{"issue":"01","key":"ref263","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s00595-018-1710-3","article-title":"Prevalence of and risk factors for thyroid carcinoma in patients with familial adenomatous polyposis: results of a multicenter study in Japan and a systematic review","volume":"49","author":"H Sada","year":"2019","journal-title":"Surg Today"},{"issue":"07","key":"ref264","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.14309\/ajg.0000000000001747","article-title":"Thyroid Nodules in Children With Familial Adenomatous Polyposis","volume":"117","author":"J Smith","year":"2022","journal-title":"Am J Gastroenterol"},{"issue":"04","key":"ref265","first-page":"304","article-title":"The prevalence of thyroid cancer and benign thyroid disease in patients with familial adenomatous polyposis may be higher than previously recognized","volume":"11","author":"E Steinhagen","year":"2012","journal-title":"Clin Colorectal Cancer"},{"issue":"01","key":"ref266","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s10689-018-0097-z","article-title":"Outcome of thyroid ultrasound screening in FAP patients with a normal baseline exam","volume":"18","author":"M Monachese","year":"2019","journal-title":"Fam Cancer"},{"issue":"06","key":"ref267","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1053\/j.gastro.2019.11.310","article-title":"Update on the World Health Organization Criteria for Diagnosis of Serrated Polyposis Syndrome","volume":"158","author":"E Dekker","year":"2020","journal-title":"Gastroenterology"},{"key":"ref268","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.mam.2019.03.001","article-title":"Update on genetic predisposition to colorectal cancer and polyposis","volume":"69","author":"L Valle","year":"2019","journal-title":"Mol Aspects Med"},{"issue":"09","key":"ref269","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1055\/a-0965-0605","article-title":"Endoscopic management of polyposis syndromes: European Society of Gastrointestinal Endoscopy (ESGE) Guideline","volume":"51","author":"M Leerdam","year":"2019","journal-title":"Endoscopy"},{"issue":"09","key":"ref270","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.14309\/ajg.0000000000000339","article-title":"Low Incidence of Advanced Neoplasia in Serrated Polyposis Syndrome After (Sub)total Colectomy: Results of a 5-Year International Prospective Cohort Study","volume":"114","author":"A Bleijenberg","year":"2019","journal-title":"Am J Gastroenterol"},{"issue":"01","key":"ref271","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1136\/gutjnl-2018-318134","article-title":"Personalised surveillance for serrated polyposis syndrome: results from a prospective 5-year international cohort study","volume":"69","author":"A Bleijenberg","year":"2020","journal-title":"Gut"},{"issue":"05","key":"ref272","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/MCG.0000000000000103","article-title":"Yield of screening colonoscopy in first-degree relatives of patients with serrated polyposis syndrome","volume":"49","author":"Y Hazewinkel","year":"2015","journal-title":"J Clin Gastroenterol"},{"key":"ref273","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1136\/gut.2009.198499","article-title":"Peutz-Jeghers syndrome: a systematic review and recommendations for management","volume":"59","author":"A D Beggs","year":"2010","journal-title":"Gut"},{"key":"ref274","first-page":"163","article-title":"The differential diagnosis and surveillance of hereditary gastrointestinal polyposis syndromes","volume":"107","author":"S Aretz","year":"2010","journal-title":"Dtsch Arztebl Int"},{"key":"ref275","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1053\/j.gastro.2010.01.054","article-title":"Hereditary and familial colon cancer","volume":"138","author":"K W Jasperson","year":"2010","journal-title":"Gastroenterology"},{"key":"ref276","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1016\/S0959-8049(03)00420-9","article-title":"Familial relative risk of colorectal cancer: a population-based study","volume":"39","author":"N Andrieu","year":"2003","journal-title":"Eur J Cancer"},{"key":"ref277","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1111\/j.1572-0241.2001.04677.x","article-title":"A systematic review and meta-analysis of familial colorectal cancer risk","volume":"96","author":"L E Johns","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"ref278","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1056\/NEJM200007133430201","article-title":"Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland","volume":"343","author":"P Lichtenstein","year":"2000","journal-title":"N Engl J Med"},{"key":"ref279","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1053\/gast.2003.50044","article-title":"Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence","volume":"124","author":"S Winawer","year":"2003","journal-title":"Gastroenterology"},{"key":"ref280","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/ijc.2910410407","article-title":"Family history of colorectal cancer as a risk factor for benign and malignant tumours of the large bowel A case-control study","volume":"41","author":"L Bonelli","year":"1988","journal-title":"Int J Cancer"},{"key":"ref281","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1056\/NEJM199412223312501","article-title":"A prospective study of family history and the risk of colorectal cancer","volume":"331","author":"C Fuchs","year":"1994","journal-title":"N Engl J Med"},{"issue":"09","key":"ref282","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1007\/BF02054690","article-title":"Clustering of colorectal cancer in families of probands under 40 years of age","volume":"39","author":"J Guillem","year":"1996","journal-title":"Dis Colon Rectum"},{"issue":"06","key":"ref283","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/BF02050530","article-title":"Colonoscopic screening for neoplasms in asymptomatic first-degree relatives of colon cancer patients A controlled, prospective study","volume":"35","author":"J Guillem","year":"1992","journal-title":"Dis Colon Rectum"},{"issue":"01","key":"ref284","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/BF01671173","article-title":"The role of heredity in the etiology of large bowel cancer: data from the Melbourne Colorectal Cancer Study","volume":"13","author":"G Kune","year":"1989","journal-title":"World J Surg"},{"key":"ref285","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/1097-0142(19870715)60:2<248::AID-CNCR2820600223>3.0.CO;2-G","article-title":"Family history of colorectal cancer as a marker of potential malignancy within a screening programm","volume":"60","author":"P Rozen","year":"1987","journal-title":"Cancer"},{"key":"ref286","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/ijc.2910470207","article-title":"Cancer incidence among parents of patients with colorectal cancer","volume":"47","author":"J Sondergaard","year":"1991","journal-title":"Int J Cancer"},{"key":"ref287","doi-asserted-by":"crossref","first-page":"785","DOI":"10.7326\/0003-4819-118-10-199305150-00005","article-title":"Cancer risk in relatives of patients with common colorectal cancer","volume":"118","author":"D St John","year":"1993","journal-title":"Ann Int Med"},{"key":"ref288","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ejca.2005.09.023","article-title":"Relative and absolute risk of colorectal cancer for individuals with a family history: a meta-analysis","volume":"42","author":"A S Butterworth","year":"2006","journal-title":"Eur J Cancer"},{"issue":"03","key":"ref289","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1136\/jmedgenet-2015-103468","article-title":"Low-level APC mutational mosaicism is the underlying cause in a substantial fraction of unexplained colorectal adenomatous polyposis cases","volume":"53","author":"I Spier","year":"2016","journal-title":"J Med Genet"},{"key":"ref290","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1016\/S0959-8049(03)00420-9","article-title":"Familial relative risk of colorectal cancer: a population-based study","volume":"39","author":"N Andrieu","year":"2003","journal-title":"Eur J Cancer"},{"key":"ref291","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/ijc.2910410407","article-title":"Family history of colorectal cancer as a risk factor for benign and malignant tumours of the large bowel A case-control study","volume":"41","author":"L Bonelli","year":"1988","journal-title":"Int J Cancer"},{"key":"ref292","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ejca.2005.09.023","article-title":"Relative and absolute risk of colorectal cancer for individuals with a family history: a meta-analysis","volume":"42","author":"A S Butterworth","year":"2006","journal-title":"Eur J Cancer"},{"key":"ref293","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1056\/NEJM199412223312501","article-title":"A prospective study of family history and the risk of colorectal cancer","volume":"331","author":"C Fuchs","year":"1994","journal-title":"N Engl J Med"},{"key":"ref294","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1007\/BF02054690","article-title":"Clustering of colorectal cancer in families of probands under 40 years of age","volume":"39","author":"J Guillem","year":"1996","journal-title":"Dis Colon Rectum"},{"key":"ref295","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/BF02050530","article-title":"Colonoscopic screening for neoplasms in asymptomatic first-degree relatives of colon cancer patients A controlled, prospective study","volume":"35","author":"J Guillem","year":"1992","journal-title":"Dis Colon Rectum"},{"key":"ref296","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1111\/j.1572-0241.2001.04677.x","article-title":"A systematic review and meta-analysis of familial colorectal cancer risk","volume":"96","author":"L E Johns","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"ref297","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/BF01671173","article-title":"The role of heredity in the etiology of large bowel cancer: data from the Melbourne Colorectal Cancer Study","volume":"13","author":"G Kune","year":"1989","journal-title":"World J Surg"},{"key":"ref298","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1056\/NEJM200007133430201","article-title":"Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland","volume":"343","author":"P Lichtenstein","year":"2000","journal-title":"N Engl J Med"},{"key":"ref299","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/1097-0142(19870715)60:2<248::AID-CNCR2820600223>3.0.CO;2-G","article-title":"Family history of colorectal cancer as a marker of potential malignancy within a screening programm","volume":"60","author":"P Rozen","year":"1987","journal-title":"Cancer"},{"key":"ref300","first-page":"879","article-title":"Family history and colorectal cancer: predictors of risk","volume":"14","author":"M L Slattery","year":"2003","journal-title":"Cancer Causes Control"},{"key":"ref301","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/ijc.2910470207","article-title":"Cancer incidence among parents of patients with colorectal cancer","volume":"47","author":"J Sondergaard","year":"1991","journal-title":"Int J Cancer"},{"key":"ref302","doi-asserted-by":"crossref","first-page":"785","DOI":"10.7326\/0003-4819-118-10-199305150-00005","article-title":"Cancer risk in relatives of patients with common colorectal cancer","volume":"118","author":"D St John","year":"1993","journal-title":"Ann Int Med"},{"key":"ref303","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1053\/gast.2003.50044","article-title":"Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence","volume":"124","author":"S Winawer","year":"2003","journal-title":"Gastroenterology"},{"key":"ref304","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/BF02054437","article-title":"Hereditary susceptibility to colorectal cancer Relatives of early onset cases are particularly at risk","volume":"39","author":"N R Hall","year":"1996","journal-title":"Dis Colon Rectum"},{"issue":"11","key":"ref305","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.6004\/jnccn.2021.7004","article-title":"Importance of Family History of Colorectal Carcinoma In Situ Versus Invasive Colorectal Cancer: A Nationwide Cohort Study","volume":"19","author":"Y Tian","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"issue":"01","key":"ref306","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1053\/j.gastro.2020.03.063","article-title":"Calculating the Starting Age for Screening in Relatives of Patients With Colorectal Cancer Based on Data From Large Nationwide Data Sets","volume":"159","author":"Y Tian","year":"2020","journal-title":"Gastroenterology"},{"key":"ref307","doi-asserted-by":"crossref","first-page":"900","DOI":"10.7326\/0003-4819-128-11-199806010-00006","article-title":"Family history of colorectal adenomatous polyps and increased risk for colorectal cancer","volume":"128","author":"H Ahsan","year":"1998","journal-title":"Ann Intern Med"},{"key":"ref308","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1136\/gut.52.5.747","article-title":"Does a family history of cancer increase the risk of occurrence, growth, and recurrence of colorectal adenomas?","volume":"52","author":"K Almendingen","year":"2003","journal-title":"Gut"},{"key":"ref309","first-page":"789","article-title":"Risk and surveillance of individuals with colorectal polyps WHO Collaborating Centre for the Prevention of Colorectal Cancer","volume":"68","author":"S Winawer","year":"1990","journal-title":"Bull World Health Organ"},{"key":"ref310","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2024.12.030","article-title":"Risk of Colorectal Cancer Associated With Frequency of Colorectal Polyp Diagnosis in Relatives","author":"Y Hu","year":"2025","journal-title":"Gastroenterology"},{"key":"ref311","first-page":"879","article-title":"Family history and colorectal cancer: predictors of risk","volume":"14","author":"M L Slattery","year":"2003","journal-title":"Cancer Causes Control"},{"key":"ref312","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1053\/gast.2003.50044","article-title":"Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence","volume":"124","author":"S Winawer","year":"2003","journal-title":"Gastroenterology"},{"key":"ref313","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/BF02054437","article-title":"Hereditary susceptibility to colorectal cancer Relatives of early onset cases are particularly at risk","volume":"39","author":"N R Hall","year":"1996","journal-title":"Dis Colon Rectum"},{"key":"ref314","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/gut.42.1.71","article-title":"Endoscopic screening of relatives of patients with colorectal cancer","volume":"42","author":"L Hunt","year":"1998","journal-title":"Gut"},{"issue":"46","key":"ref315","first-page":"786","article-title":"Colorectal Cancer Screening for Persons With a Positive Family History\u2014Evaluation of the FARKOR Program for the Secondary Prevention of Colorectal Cancer in Persons Aged 25 to 50","volume":"120","author":"A Crispin","year":"2023","journal-title":"Dtsch Arztebl Int"},{"issue":"02","key":"ref316","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1056\/NEJM199601113340204","article-title":"Risk of colorectal cancer in the families of patients with adenomatous polyps National Polyp Study Workgroup","volume":"334","author":"S Winawer","year":"1996","journal-title":"N Engl J Med"},{"key":"ref317","doi-asserted-by":"crossref","first-page":"900","DOI":"10.7326\/0003-4819-128-11-199806010-00006","article-title":"Family history of colorectal adenomatous polyps and increased risk for colorectal cancer","volume":"128","author":"H Ahsan","year":"1998","journal-title":"Ann Intern Med"},{"key":"ref318","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1016\/S0959-8049(00)00293-8","article-title":"Family history of colorectal adenomatous polyps as a risk factor for colorectal cancer","volume":"36","author":"H Nakama","year":"2000","journal-title":"Eur J Cancer"},{"key":"ref319","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1136\/gut.52.5.747","article-title":"Does a family history of cancer increase the risk of occurrence, growth, and recurrence of colorectal adenomas?","volume":"52","author":"K Almendingen","year":"2003","journal-title":"Gut"},{"issue":"03","key":"ref320","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1053\/j.gastro.2017.12.012","article-title":"Cystic Fibrosis Colorectal Cancer Screening Consensus Recommendations","volume":"154","author":"D Hadjiliadis","year":"2018","journal-title":"Gastroenterology"},{"key":"ref321","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/S0140-6736(89)90840-4","article-title":"Upper gastrointestinal cancer in patients with familial adenomatous polyposis","volume":"2","author":"A D Spigelman","year":"1989","journal-title":"Lancet"},{"key":"ref322","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1148\/radiol.2233010928","article-title":"Colorectal cancer: role of CT colonography in preoperative evaluation after incomplete colonoscopy","volume":"223","author":"E Neri","year":"2002","journal-title":"Radiology"},{"key":"ref323","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1056\/NEJMoa1309086","article-title":"Adenoma detection rate and risk of colorectal cancer and death","volume":"370","author":"D A Corley","year":"2014","journal-title":"N Engl J Med"},{"key":"ref324","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1056\/NEJMoa0907667","article-title":"Quality indicators for colonoscopy and the risk of interval cancer","volume":"362","author":"M F Kaminski","year":"2010","journal-title":"N Engl J Med"},{"issue":"07","key":"ref325","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1055\/a-2304-3219","article-title":"Colorectal polypectomy and endoscopic mucosal resection: European Society of Gastrointestinal Endoscopy (ESGE) Guideline \u2013 Update 2024","volume":"56","author":"M Ferlitsch","year":"2024","journal-title":"Endoscopy"},{"issue":"14","key":"ref326","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1056\/NEJMoa1309086","article-title":"Adenoma detection rate and risk of colorectal cancer and death","volume":"370","author":"D Corley","year":"2014","journal-title":"N Engl J Med"},{"issue":"04","key":"ref327","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1055\/s-0043-103411","article-title":"Performance measures for lower gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative","volume":"49","author":"M Kaminski","year":"2017","journal-title":"Endoscopy"},{"issue":"02","key":"ref328","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1055\/s-0032-1326186","article-title":"Bowel preparation for colonoscopy: European Society of Gastrointestinal Endoscopy (ESGE) guideline","volume":"45","author":"C Hassan","year":"2013","journal-title":"Endoscopy"},{"issue":"03","key":"ref329","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/S0016-5107(04)02776-2","article-title":"Impact of colonic cleansing on quality and diagnostic yield of colonoscopy: the European Panel of Appropriateness of Gastrointestinal Endoscopy European multicenter study","volume":"61","author":"F Froehlich","year":"2005","journal-title":"Gastrointest Endosc"},{"issue":"03","key":"ref330","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.amjsurg.2021.11.032","article-title":"Does time of day matter for colonoscopy quality? A review of over 13,000 screening colonoscopies in a colorectal surgery unit","volume":"223","author":"I Sapci","year":"2022","journal-title":"Am J Surg"},{"issue":"06","key":"ref331","doi-asserted-by":"crossref","first-page":"E629","DOI":"10.1055\/s-0034-1392783","article-title":"Meticulous cecal image documentation at colonoscopy is associated with improved polyp detection","volume":"3","author":"M Thoufeeq","year":"2015","journal-title":"Endosc Int Open"},{"issue":"05","key":"ref332","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1586\/17474124.2015.1001744","article-title":"Terminal ileal intubation and biopsy in routine colonoscopy practice","volume":"9","author":"L Neilson","year":"2015","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"ref333","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1056\/NEJMoa055498","article-title":"Colonoscopic withdrawal times and adenoma detection during screening colonoscopy","volume":"355","author":"R L Barclay","year":"2006","journal-title":"N Engl J Med"},{"key":"ref334","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.cgh.2008.04.018","article-title":"Effect of a time-dependent colonoscopic withdrawal protocol on adenoma detection during screening colonoscopy","volume":"6","author":"R L Barclay","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref335","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/ajg.2013.442","article-title":"Serrated and adenomatous polyp detection increases with longer withdrawal time: results from the New Hampshire Colonoscopy Registry","volume":"109","author":"L Butterly","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"ref336","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1053\/j.gastro.2008.08.024","article-title":"Effect of institution-wide policy of colonoscopy withdrawal time > or = 7 minutes on polyp detection","volume":"135","author":"M S Sawhney","year":"2008","journal-title":"Gastroenterology"},{"issue":"01","key":"ref337","first-page":"20","article-title":"Longer mean colonoscopy withdrawal time is associated with increased adenoma detection: evidence from the Bowel Cancer Screening Programme in England","volume":"45","author":"T Lee","year":"2013","journal-title":"Endoscopy"},{"key":"ref338","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1053\/j.gastro.2005.05.012","article-title":"Colorectal cancer in patients under close colonoscopic surveillance","volume":"129","author":"D J Robertson","year":"2005","journal-title":"Gastroenterology"},{"key":"ref339","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0016-5107(04)02765-8","article-title":"Analysis of colorectal cancer occurrence during surveillance colonoscopy in the dietary Polyp Prevention Trial","volume":"61","author":"A Pabby","year":"2005","journal-title":"Gastrointest Endosc"},{"key":"ref340","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1053\/j.gastro.2006.10.022","article-title":"Microsatellite instability in interval colon cancers","volume":"131","author":"M S Sawhney","year":"2006","journal-title":"Gastroenterology"},{"key":"ref341","doi-asserted-by":"crossref","first-page":"22","DOI":"10.7326\/0003-4819-154-1-201101040-00004","article-title":"Protection from colorectal cancer after colonoscopy: a population-based, case-control study","volume":"154","author":"H Brenner","year":"2011","journal-title":"Ann Intern Med"},{"key":"ref342","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1067\/j.cpradiol.2009.08.002","article-title":"An overview of the method, application, and various findings of computed tomographic colonography in patients after incomplete colonoscopy","volume":"39","author":"K Javeri","year":"2010","journal-title":"Curr Probl Diagn Radiol"},{"key":"ref343","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1148\/radiol.2442060837","article-title":"CT colonography in 546 patients with incomplete colonoscopy","volume":"244","author":"L Copel","year":"2007","journal-title":"Radiology"},{"key":"ref344","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/BF02258293","article-title":"Role of virtual computed tomographic colonography in patients with colorectal cancers and obstructing colorectal lesions","volume":"43","author":"M M Morrin","year":"2000","journal-title":"Dis Colon Rectum"},{"key":"ref345","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1055\/s-2005-870309","article-title":"Incomplete conventional colonoscopy: magnetic resonance colonography in the evaluation of the proximal colon","volume":"37","author":"D Hartmann","year":"2005","journal-title":"Endoscopy"},{"key":"ref346","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1148\/radiol.2342032001","article-title":"MR colonography in patients with incomplete conventional colonoscopy","volume":"234","author":"W Ajaj","year":"2005","journal-title":"Radiology"},{"issue":"12","key":"ref347","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1055\/a-1258-4819","article-title":"Imaging alternatives to colonoscopy: CT colonography and colon capsule European Society of Gastrointestinal Endoscopy (ESGE) and European Society of Gastrointestinal and Abdominal Radiology (ESGAR) Guideline \u2013 Update 2020","volume":"52","author":"C Spada","year":"2020","journal-title":"Endoscopy"},{"key":"ref348","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.cgh.2016.04.038","article-title":"Accuracy of First- and Second-Generation Colon Capsules in Endoscopic Detection of Colorectal Polyps: A Systematic Review and Meta-analysis","volume":"14","author":"C Spada","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref349","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1053\/j.gastro.2015.01.025","article-title":"Accuracy of capsule colonoscopy in detecting colorectal polyps in a screening population","volume":"148","author":"D K Rex","year":"2015","journal-title":"Gastroenterology"},{"issue":"03","key":"ref350","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1053\/j.gastro.2017.05.047","article-title":"Risk Stratification for Covert Invasive Cancer Among Patients Referred for Colonic Endoscopic Mucosal Resection: A Large Multicenter Cohort","volume":"153","author":"N Burgess","year":"2017","journal-title":"Gastroenterology"},{"issue":"07","key":"ref351","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.cgh.2020.07.024","article-title":"Risk of Covert Submucosal Cancer in Patients With Granular Mixed Laterally Spreading Tumors","volume":"19","author":"F D\u02bcAmico","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"07","key":"ref352","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1053\/j.gastro.2011.02.062","article-title":"Endoscopic mucosal resection outcomes and prediction of submucosal cancer from advanced colonic mucosal neoplasia","volume":"140","author":"A Moss","year":"2011","journal-title":"Gastroenterology"},{"issue":"03","key":"ref353","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1055\/s-0043-121144","article-title":"Endoscopic subtypes of colorectal laterally spreading tumors (LSTs) and the risk of submucosal invasion: a meta-analysis","volume":"50","author":"R Bogie","year":"2018","journal-title":"Endoscopy"},{"issue":"03","key":"ref354","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1443-1661.2010.00983.x","article-title":"Diagnostic accuracy of pit pattern and vascular pattern analyses in colorectal lesions","volume":"22","author":"Y Wada","year":"2010","journal-title":"Dig Endosc"},{"issue":"01","key":"ref355","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0016-5107(96)70222-5","article-title":"Diagnosis of colorectal tumorous lesions by magnifying endoscopy","volume":"44","author":"S Kudo","year":"1996","journal-title":"Gastrointest Endosc"},{"issue":"04","key":"ref356","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.gie.2013.04.185","article-title":"Endoscopic prediction of deep submucosal invasive carcinoma: validation of the narrow-band imaging international colorectal endoscopic (NICE) classification","volume":"78","author":"N Hayashi","year":"2013","journal-title":"Gastrointest Endosc"},{"issue":"05","key":"ref357","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/den.12644","article-title":"Narrow-band imaging (NBI) magnifying endoscopic classification of colorectal tumors proposed by the Japan NBI Expert Team","volume":"28","author":"Y Sano","year":"2016","journal-title":"Dig Endosc"},{"issue":"40","key":"ref358","doi-asserted-by":"crossref","first-page":"6279","DOI":"10.3748\/wjg.v26.i40.6279","article-title":"Diagnostic efficacy of the Japan Narrow-band-imaging Expert Team and Pit pattern classifications for colorectal lesions: A meta-analysis","volume":"26","author":"Y Zhang","year":"2020","journal-title":"World J Gastroenterol"},{"key":"ref359","doi-asserted-by":"publisher","DOI":"10.1111\/den.14682","article-title":"First report from the International Evaluation of Endoscopic classification Japan NBI Expert Team: International multicenter web trial","author":"Y Saito","year":"2023","journal-title":"Dig Endosc"},{"issue":"08","key":"ref360","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.14309\/ajg.0000000000001799","article-title":"Randomized Controlled Trial Investigating Cold Snare and Forceps Polypectomy Among Small POLYPs in Rates of Complete Resection: The TINYPOLYP Trial","volume":"117","author":"M Wei","year":"2022","journal-title":"Am J Gastroenterol"},{"issue":"03","key":"ref361","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.gie.2015.08.053","article-title":"A prospective randomized comparative study of cold forceps polypectomy by using narrow-band imaging endoscopy versus cold snare polypectomy in patients with diminutive colorectal polyps","volume":"83","author":"S Park","year":"2016","journal-title":"Gastrointest Endosc"},{"issue":"01","key":"ref362","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1055\/a-1327-8357","article-title":"Efficacy and safety of cold versus hot snare polypectomy for small (5-9\u200amm) colorectal polyps: a multicenter randomized controlled trial","volume":"54","author":"M Benito Sanz","year":"2022","journal-title":"Endoscopy"},{"issue":"11","key":"ref363","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1136\/gutjnl-2017-314215","article-title":"A comparison of the resection rate for cold and hot snare polypectomy for 4-9\u200amm colorectal polyps: a multicentre randomised controlled trial (CRESCENT study)","volume":"67","author":"T Kawamura","year":"2018","journal-title":"Gut"},{"issue":"01","key":"ref364","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/jgh.14464","article-title":"Effectiveness and safety of cold versus hot snare polypectomy: A meta-analysis","volume":"34","author":"J Qu","year":"2019","journal-title":"J Gastroenterol Hepatol"},{"issue":"05","key":"ref365","doi-asserted-by":"crossref","first-page":"E708","DOI":"10.1055\/a-0808-3680","article-title":"Hot snare vs cold snare polypectomy for endoscopic removal of 4\u200a-\u200a10\u200amm colorectal polyps during colonoscopy: a systematic review and meta-analysis of randomized controlled studies","volume":"7","author":"R Jegadeesan","year":"2019","journal-title":"Endosc Int Open"},{"issue":"05","key":"ref366","first-page":"e38713","article-title":"A Comparative Analysis of the Efficacy and Safety of Hot Snare Polypectomy and Cold Snare Polypectomy for Removing Small Colorectal Polyps: A Systematic Review and Meta-Analysis","volume":"15","author":"K Winston","year":"2023","journal-title":"Cureus"},{"issue":"07","key":"ref367","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1055\/a-2029-9539","article-title":"Effectiveness and safety of cold snare polypectomy and cold endoscopic mucosal resection for nonpedunculated colorectal polyps of 10-19\u200amm: a multicenter observational cohort study","volume":"55","author":"D Mangira","year":"2023","journal-title":"Endoscopy"},{"issue":"10","key":"ref368","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1055\/a-1978-3277","article-title":"Incomplete resection of colorectal polyps of 4-20\u200amm in size when using a cold snare, and its associated factors","volume":"55","author":"D Renteln","year":"2023","journal-title":"Endoscopy"},{"issue":"01","key":"ref369","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1136\/gutjnl-2013-305516","article-title":"Long-term adenoma recurrence following wide-field endoscopic mucosal resection (WF-EMR) for advanced colonic mucosal neoplasia is infrequent: results and risk factors in 1000 cases from the Australian Colonic EMR (ACE) study","volume":"64","author":"A Moss","year":"2015","journal-title":"Gut"},{"issue":"03","key":"ref370","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1053\/j.gastro.2018.10.003","article-title":"Thermal Ablation of Mucosal Defect Margins Reduces Adenoma Recurrence After Colonic Endoscopic Mucosal Resection","volume":"156","author":"A Klein","year":"2019","journal-title":"Gastroenterology"},{"issue":"04","key":"ref371","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1053\/j.gastro.2024.05.013","article-title":"Cold Versus Hot Snare Endoscopic Resection of Large Nonpedunculated Colorectal Polyps: Randomized Controlled German CHRONICLE Trial","volume":"167","author":"I Steinbr\u00fcck","year":"2024","journal-title":"Gastroenterology"},{"issue":"11","key":"ref372","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1136\/gutjnl-2024-332807","article-title":"Cold versus hot snare endoscopic mucosal resection for large (\u226515\u200amm) flat non-pedunculated colorectal polyps: a randomised controlled trial","volume":"73","author":"T O\u02bcSullivan","year":"2024","journal-title":"Gut"},{"issue":"05","key":"ref373","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1053\/j.gastro.2021.07.044","article-title":"Underwater vs Conventional Endoscopic Mucosal Resection of Large Sessile or Flat Colorectal Polyps: A Prospective Randomized Controlled Trial","volume":"161","author":"S Nagl","year":"2021","journal-title":"Gastroenterology"},{"key":"ref374","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0299931","article-title":"Underwater versus conventional endoscopic mucosal resection for \u2265 10mm sessile or flat colorectal polyps: A systematic review and meta-analysis","author":"X WY Wang","year":"2024","journal-title":"PLoS One"},{"issue":"25","key":"ref375","first-page":"3925","article-title":"Endoscopic submucosal dissection","volume":"27","author":"X Lim","year":"2021","journal-title":"World J Gastroenterol"},{"issue":"12","key":"ref376","first-page":"941","article-title":"Endoscopic mucosal resection versus endoscopic submucosal dissection for colorectal laterally spreading tumors: a meta-analysis","volume":"112","author":"H Zhao","year":"2020","journal-title":"Rev Esp Enferm Dig"},{"issue":"02","key":"ref377","doi-asserted-by":"crossref","first-page":"E239","DOI":"10.1055\/a-0732-487","article-title":"Management of colorectal laterally spreading tumors: a systematic review and meta-analysis","volume":"7","author":"P Russo","year":"2019","journal-title":"Endosc Int Open"},{"key":"ref378","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.critrevonc.2016.06.008","article-title":"Endoscopic mucosal resection and endoscopic submucosal dissection for colorectal lesions: A systematic review","volume":"104","author":"A De Ceglie","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"issue":"11","key":"ref379","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1136\/gutjnl-2017-313823","article-title":"Wide-field endoscopic mucosal resection versus endoscopic submucosal dissection for laterally spreading colorectal lesions: a cost-effectiveness analysis","volume":"67","author":"F Bahin","year":"2018","journal-title":"Gut"},{"issue":"06","key":"ref380","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.gie.2018.12.025","article-title":"Endoscopic full-thickness resection for early colorectal cancer","volume":"89","author":"A Kuellmer","year":"2019","journal-title":"Gastrointest Endosc"},{"issue":"05","key":"ref381","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1055\/a-1637-9051","article-title":"Endoscopic full-thickness resection of T1 colorectal cancers: a retrospective analysis from a multicenter Dutch eFTR registry","volume":"54","author":"L Zwager","year":"2022","journal-title":"Endoscopy"},{"issue":"10","key":"ref382","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1055\/a-1266-1855","article-title":"Hybrid endoscopic submucosal dissection (ESD) compared with conventional ESD for colorectal lesions: a systematic review and meta-analysis","volume":"53","author":"T McCarty","year":"2021","journal-title":"Endoscopy"},{"issue":"09","key":"ref383","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1111\/jgh.15494","article-title":"Underwater endoscopic mucosal resection versus endoscopic submucosal dissection for 20-30\u200amm colorectal polyps","volume":"36","author":"T Inoue","year":"2021","journal-title":"J Gastroenterol Hepatol"},{"key":"ref384","first-page":"222","article-title":"Endoscopic submucosal dissection for early rectal neoplasia: experience from a European center","volume":"49","author":"A Probst","year":"2017","journal-title":"Endoscopy"},{"issue":"04","key":"ref385","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1136\/gutjnl-2019-319785","article-title":"Endoscopic mucosal resection is effective for laterally spreading lesions at the anorectal junction","volume":"69","author":"N Shahidi","year":"2020","journal-title":"Gut"},{"issue":"11","key":"ref386","doi-asserted-by":"crossref","first-page":"E1355","DOI":"10.1055\/a-0749-8735","article-title":"Endoscopic submucosal dissection for rectal neoplasia extending to the dentate line: European experience","volume":"6","author":"A Probst","year":"2018","journal-title":"Endosc Int Open"},{"issue":"08","key":"ref387","doi-asserted-by":"crossref","first-page":"4485","DOI":"10.1007\/s00464-024-10994-6","article-title":"Endoscopic submucosal dissection versus endoscopic mucosal resection for the treatment of rectal lesions involving the dentate line","volume":"38","author":"K Kouladouros","year":"2024","journal-title":"Surg Endosc"},{"issue":"04","key":"ref388","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1007\/s00464-019-06945-1","article-title":"Endoscopic submucosal dissection (ESD) versus transanal endoscopic microsurgery (TEM) for treatment of rectal tumors: a comparative systematic review and meta-analysis","volume":"34","author":"T McCarty","year":"2020","journal-title":"Surg Endosc"},{"issue":"09","key":"ref389","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.14309\/ajg.0000000000001374","article-title":"Postoperative Hospital Outcomes of Elective Surgery for Nonmalignant Colorectal Polyps: Does the Burden Justify the Indication?","volume":"116","author":"A Kruger","year":"2021","journal-title":"Am J Gastroenterol"},{"issue":"05","key":"ref390","doi-asserted-by":"crossref","first-page":"E706","DOI":"10.1055\/a-1380-3017","article-title":"Overutilization of surgical resection for benign colorectal polyps: analysis from a tertiary care center","volume":"9","author":"R Saade","year":"2021","journal-title":"Endosc Int Open"},{"issue":"02","key":"ref391","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.gie.2012.02.060","article-title":"Outcomes of EMR of defiant colorectal lesions directed to an endoscopy referral center","volume":"76","author":"A Buchner","year":"2012","journal-title":"Gastrointest Endosc"},{"issue":"02","key":"ref392","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00384-021-04049-8","article-title":"Prior endoscopic resection does not affect the outcome of secondary surgery for T1 colorectal cancer, a systematic review and meta-analysis","volume":"37","author":"J Nian","year":"2022","journal-title":"Int J Colorectal Dis"},{"issue":"02","key":"ref393","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/his.13975","article-title":"The 2019 WHO classification of tumours of the digestive system","volume":"76","author":"I Nagtegaal","year":"2020","journal-title":"Histopathology"},{"issue":"03","key":"ref394","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/his.12055","article-title":"The serrated pathway to colorectal carcinoma: current concepts and challenges","volume":"62","author":"M Bettington","year":"2013","journal-title":"Histopathology"},{"issue":"03","key":"ref395","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.cgh.2018.04.015","article-title":"The Association Between Mutations in BRAF and Colorectal Cancer-Specific Survival Depends on Microsatellite Status and Tumor Stage","volume":"17","author":"H Bl\u00e4ker","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"01","key":"ref396","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1053\/j.gastro.2014.09.038","article-title":"Association between molecular subtypes of colorectal cancer and patient survival","volume":"148","author":"A Phipps","year":"2015","journal-title":"Gastroenterology"},{"issue":"01","key":"ref397","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1136\/gutjnl-2015-310456","article-title":"Clinicopathological and molecular features of sessile serrated adenomas with dysplasia or carcinoma","volume":"66","author":"M Bettington","year":"2017","journal-title":"Gut"},{"issue":"04","key":"ref398","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/ajg.2015.49","article-title":"Serrated polyps and the risk of synchronous colorectal advanced neoplasia: a systematic review and meta-analysis","volume":"110","author":"Q Gao","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"ref399","first-page":"289","article-title":"[Standardized and structured histopathological evaluation of colorectal polyps: a practical checklist against the background of the new WHO classification]","volume":"32","author":"G B Baretton","year":"2011","journal-title":"Pathologe"},{"issue":"06","key":"ref400","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.gie.2023.02.027","article-title":"Long-term outcomes of local resection versus surgical resection for high-risk T1 colorectal cancer: a systematic review and meta-analysis","volume":"97","author":"Y Chen","year":"2023","journal-title":"Gastrointest Endosc"},{"issue":"S 02","key":"ref401","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/den.12089","article-title":"Risk analysis of submucosal invasive rectal carcinomas for lymph node metastasis to expand indication criteria for endoscopic resection","volume":"25","author":"S Oka","year":"2013","journal-title":"Dig Endosc"},{"issue":"11","key":"ref402","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1007\/s00384-022-04269-6","article-title":"Lymph node metastasis in T1 colorectal cancer with the only high-risk histology of submucosal invasion depth\u200a\u2265\u200a1000 \u03bcm","volume":"37","author":"Y Yamaoka","year":"2022","journal-title":"Int J Colorectal Dis"},{"issue":"01","key":"ref403","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1053\/j.gastro.2022.04.010","article-title":"Deep Submucosal Invasion Is Not an Independent Risk Factor for Lymph Node Metastasis in T1 Colorectal Cancer: A Meta-Analysis","volume":"163","author":"L Zwager","year":"2022","journal-title":"Gastroenterology"},{"issue":"03","key":"ref404","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.gie.2023.09.027","article-title":"Impact of surgery after endoscopically resected high-risk T1 colorectal cancer: results of an emulated target trial","volume":"99","author":"F Corre","year":"2024","journal-title":"Gastrointest Endosc"},{"issue":"01","key":"ref405","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1136\/gutjnl-2016-312093","article-title":"Outcomes following polypectomy for malignant colorectal polyps are similar to those following surgery in the general population","volume":"68","author":"A Lopez","year":"2019","journal-title":"Gut"},{"issue":"04","key":"ref406","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s11605-020-04580-z","article-title":"Lymph Node Positivity in T1\u200a\/\u200aT2 Rectal Cancer: a Word of Caution in an Era of Increased Incidence and Changing Biology for Rectal Cancer","volume":"25","author":"A Fields","year":"2021","journal-title":"J Gastrointest Surg"},{"issue":"06","key":"ref407","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/modpathol.2015.36","article-title":"A three-tier classification system based on the depth of submucosal invasion and budding\/sprouting can improve the treatment strategy for T1 colorectal cancer: a retrospective multicenter study","volume":"28","author":"H Kawachi","year":"2015","journal-title":"Mod Pathol"},{"issue":"02","key":"ref408","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/SLA.0000000000006092","article-title":"How Does Omitting Additional Surgery After Local Excision Affect the Prognostic Outcome of Patients With High-risk T1 Colorectal Cancer?","volume":"279","author":"A Ouchi","year":"2024","journal-title":"Ann Surg"},{"issue":"06","key":"ref409","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1055\/s-0031-1291665","article-title":"Predictors for lymph node metastasis in T1 colorectal cancer","volume":"44","author":"J Suh","year":"2012","journal-title":"Endoscopy"},{"issue":"13","key":"ref410","doi-asserted-by":"crossref","first-page":"3511","DOI":"10.3390\/cancers15133511","article-title":"Dilemmas in the Clinical Management of pT1 Colorectal Cancer","volume":"15","author":"D Zaffalon","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"05","key":"ref411","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/his.14601","article-title":"Diagnostic variability in the histopathological assessment of advanced colorectal adenomas and early colorectal cancer in a screening population","volume":"80","author":"L Smits","year":"2022","journal-title":"Histopathology"},{"issue":"08","key":"ref412","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1007\/s00464-013-2835-5","article-title":"Pathologic predictive factors for lymph node metastasis in submucosal invasive (T1) colorectal cancer: a systematic review and meta-analysis","volume":"27","author":"S Mou","year":"2013","journal-title":"Surg Endosc"},{"issue":"10","key":"ref413","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1097\/PAS.0000000000001920","article-title":"A Novel Combined Tumor Budding-Poorly Differentiated Clusters Grading System Predicts Recurrence and Survival in Stage I-III Colorectal Cancer","volume":"46","author":"S Shivji","year":"2022","journal-title":"Am J Surg Pathol"},{"issue":"04","key":"ref414","first-page":"289","article-title":"[Standardized and structured histopathological evaluation of colorectal polyps: a practical checklist against the background of the new WHO classification]","volume":"32","author":"G Baretton","year":"2011","journal-title":"Pathologe"},{"key":"ref415","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/codi.12129","article-title":"Systematic review and meta-analysis of histopathological factors influencing the risk of lymph node metastasis in early colorectal cancer","volume":"15","author":"C Beaton","year":"2013","journal-title":"Colorectal Dis"},{"key":"ref416","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1055\/s-0033-1344238","article-title":"Predicting lymph node metastasis in pT1 colorectal cancer: a systematic review of risk factors providing rationale for therapy decisions","volume":"45","author":"S L Bosch","year":"2013","journal-title":"Endoscopy"},{"key":"ref417","doi-asserted-by":"crossref","first-page":"398","DOI":"10.3346\/jkms.2015.30.4.398","article-title":"Meta-analysis of predictive clinicopathologic factors for lymph node metastasis in patients with early colorectal carcinoma","volume":"30","author":"J Y Choi","year":"2015","journal-title":"J Korean Med Sci"},{"issue":"04","key":"ref418","doi-asserted-by":"crossref","first-page":"398","DOI":"10.3346\/jkms.2015.30.4.398","article-title":"Meta-analysis of predictive clinicopathologic factors for lymph node metastasis in patients with early colorectal carcinoma","volume":"30","author":"J Choi","year":"2015","journal-title":"J Korean Med Sci"},{"issue":"10","key":"ref419","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.14309\/ajg.0000000000002715","article-title":"Treatment Decision for Locally Resected T1 Colorectal Carcinoma-Verification of the Japanese Guideline Criteria for Additional Surgery Based on Long-Term Clinical Outcomes","volume":"119","author":"S Oka","year":"2024","journal-title":"Am J Gastroenterol"},{"issue":"06","key":"ref420","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S1470-2045(17)30187-0","article-title":"Adenoma surveillance and colorectal cancer incidence: a retrospective, multicentre, cohort study","volume":"18","author":"W Atkin","year":"2017","journal-title":"Lancet Oncol"},{"key":"ref421","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1136\/gutjnl-2011-300295","article-title":"Long-term risk of colorectal cancer after adenoma removal: a population-based cohort study","volume":"61","author":"V Cottet","year":"2012","journal-title":"Gut"},{"issue":"04","key":"ref422","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1053\/j.gastro.2019.09.039","article-title":"Long-term Risk of Colorectal Cancer and Related Death After Adenoma Removal in a Large, Community-based Population","volume":"158","author":"J Lee","year":"2020","journal-title":"Gastroenterology"},{"issue":"04","key":"ref423","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1053\/j.gastro.2019.09.011","article-title":"Colorectal Cancer Incidence and Mortality After Removal of Adenomas During Screening Colonoscopies","volume":"158","author":"P Wieszczy","year":"2020","journal-title":"Gastroenterology"},{"issue":"04","key":"ref424","doi-asserted-by":"crossref","first-page":"588","DOI":"10.14309\/ajg.0000000000001682","article-title":"Risk of Metachronous Colorectal Advanced Neoplasia and Cancer in Patients With 3-4 Nonadvanced Adenomas at Index Colonoscopy: A Systematic Review and Meta-Analysis","volume":"117","author":"S Park","year":"2022","journal-title":"Am J Gastroenterol"},{"issue":"11","key":"ref425","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1080\/17474124.2022.2147925","article-title":"Incidence of colorectal cancer at different screening intervals after index colonoscopy and post-polypectomy: a meta-analysis of 811,181 participants","volume":"16","author":"Y Zhang","year":"2022","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"10","key":"ref426","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1055\/a-1795-4673","article-title":"Post-polypectomy surveillance interval and advanced neoplasia detection rates: a multicenter, retrospective cohort study","volume":"54","author":"A Cross","year":"2022","journal-title":"Endoscopy"},{"key":"ref427","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1056\/NEJM199304013281301","article-title":"Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps The National Polyp Study Workgroup","volume":"328","author":"S J Winawer","year":"1993","journal-title":"N Engl J Med"},{"issue":"03","key":"ref428","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.gie.2020.01.014","article-title":"Recommendations for Follow-Up After Colonoscopy and Polypectomy: A Consensus Update by the US Multi-Society Task Force on Colorectal Cancer","volume":"91","author":"S Gupta","year":"2020","journal-title":"Gastrointest Endosc"},{"issue":"08","key":"ref429","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1055\/a-1185-3109","article-title":"Post-polypectomy colonoscopy surveillance: European Society of Gastrointestinal Endoscopy (ESGE) Guideline \u2013 Update 2020","volume":"52","author":"C Hassan","year":"2020","journal-title":"Endoscopy"},{"issue":"06","key":"ref430","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.gie.2023.01.021","article-title":"Polyp characteristics at screening colonoscopy and post-colonoscopy colorectal cancer mortality: a retrospective cohort study","volume":"97","author":"J Zessner-Spitzenberg","year":"2023","journal-title":"Gastrointest Endosc"},{"issue":"03","key":"ref431","doi-asserted-by":"crossref","first-page":"zrad034","DOI":"10.1093\/bjsopen\/zrad034","article-title":"Risk stratification for the detection of metachronous polyps after bowel screening polypectomy: clinical outcomes from the Integrated Technologies for Improved Polyp Surveillance (INCISE) study cohort","volume":"7","author":"M Johnstone","year":"2023","journal-title":"BJS Open"},{"issue":"04","key":"ref432","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1053\/j.gastro.2019.06.039","article-title":"Long-term Risk of Colorectal Cancer After Removal of Conventional Adenomas and Serrated Polyps","volume":"158","author":"X He","year":"2020","journal-title":"Gastroenterology"},{"key":"ref433","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2023.07.020","article-title":"Impact of Clinical and Endoscopic Features on the Development of Metachronous Colorectal Advanced Serrated Lesions","author":"C Rouphael","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"01","key":"ref434","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1053\/j.gastro.2017.09.011","article-title":"Risk of Metachronous High-Risk Adenomas and Large Serrated Polyps in Individuals With Serrated Polyps on Index Colonoscopy: Data From the New Hampshire Colonoscopy Registry","volume":"154","author":"J Anderson","year":"2018","journal-title":"Gastroenterology"},{"issue":"02","key":"ref435","doi-asserted-by":"crossref","first-page":"e298","DOI":"10.1016\/j.cgh.2020.11.032","article-title":"Risk and Time Pattern of Recurrences After Local Endoscopic Resection of T1 Colorectal Cancer: A Meta-analysis","volume":"20","author":"H Dang","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"04","key":"ref436","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1007\/s00464-017-5876-3","article-title":"En bloc endoscopic mucosal resection is equally effective for sessile serrated polyps and conventional adenomas","volume":"32","author":"A Agarwal","year":"2018","journal-title":"Surg Endosc"},{"key":"ref437","doi-asserted-by":"crossref","first-page":"7243515","DOI":"10.1155\/2019\/7243515","article-title":"Investigation of the Local Recurrence Rate after Colorectal Endoscopic Mucosal Resection: Is Incomplete Polyp Resection Really a Clinically Important Problem? Analysis of the Rationale for the \u201eResect and Discard\u201c Strategy","volume":"2019","author":"J Arimoto","year":"2019","journal-title":"Can J Gastroenterol Hepatol"},{"key":"ref438","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1055\/s-2003-42622","article-title":"Long-term follow-up of large flat colorectal tumors resected endoscopically","volume":"35","author":"S Higaki","year":"2003","journal-title":"Endoscopy"},{"key":"ref439","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1055\/s-2003-37254","article-title":"Argon plasma coagulation after piecemeal polypectomy of sessile colorectal adenomas: long-term follow-up study","volume":"35","author":"J Regula","year":"2003","journal-title":"Endoscopy"},{"key":"ref440","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1055\/s-2003-41535","article-title":"Long-term results of endoscopic removal of large colorectal adenomas","volume":"35","author":"U Seitz","year":"2003","journal-title":"Endoscopy"},{"key":"ref441","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1463-1318.2005.00813.x","article-title":"A prospective analysis of extended endoscopic mucosal resection for large rectal villous adenomas: an alternative technique to transanal endoscopic microsurgery","volume":"7","author":"D P Hurlstone","year":"2005","journal-title":"Colorectal Dis"},{"key":"ref442","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1007\/s10620-006-9617-z","article-title":"Endoscopic removal of large sessile colorectal adenomas: is it safe and effective?","volume":"52","author":"J Boix","year":"2007","journal-title":"Dig Dis Sci"},{"issue":"12","key":"ref443","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1016\/j.cgh.2023.03.034","article-title":"Root-cause Analysis of 762 Danish Post-colonoscopy Colorectal Cancer Patients","volume":"21","author":"F Troelsen","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref444","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1136\/gutjnl-2013-305516","article-title":"Long-term adenoma recurrence following wide-field endoscopic mucosal resection (WF-EMR) for advanced colonic mucosal neoplasia is infrequent: results and risk factors in 1000 cases from the Australian Colonic EMR (ACE) study","volume":"64","author":"A Moss","year":"2015","journal-title":"Gut"},{"issue":"05","key":"ref445","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1136\/gutjnl-2014-308481","article-title":"Efficacy and safety of endoscopic resection of large colorectal polyps: a systematic review and meta-analysis","volume":"65","author":"C Hassan","year":"2016","journal-title":"Gut"},{"issue":"03","key":"ref446","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.gie.2022.10.036","article-title":"Impact of margin ablation after EMR of large nonpedunculated colonic polyps in routine clinical practice","volume":"97","author":"Arisha M Abu","year":"2023","journal-title":"Gastrointest Endosc"},{"issue":"05","key":"ref447","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.gie.2022.06.018","article-title":"EMR combined with hybrid argon plasma coagulation to prevent recurrence of large nonpedunculated colorectal polyps (with videos)","volume":"96","author":"L Motchum","year":"2022","journal-title":"Gastrointest Endosc"},{"issue":"03","key":"ref448","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1053\/j.gastro.2020.05.018","article-title":"Rates of Incomplete Resection of 1- to 20-mm Colorectal Polyps: A Systematic Review and Meta-Analysis","volume":"159","author":"R Djinbachian","year":"2020","journal-title":"Gastroenterology"},{"key":"ref449","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s10620-014-3334-9","article-title":"Probability of high-risk colorectal neoplasm recurrence based on the results of two previous colonoscopies","volume":"60","author":"H W Park","year":"2015","journal-title":"Dig Dis Sci"},{"issue":"05","key":"ref450","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/1751-2980.12869","article-title":"Association of second surveillance colonoscopy findings with index and first surveillance colonoscopy results","volume":"21","author":"Y Okagawa","year":"2020","journal-title":"J Dig Dis"},{"issue":"03","key":"ref451","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1136\/gutjnl-2017-315242","article-title":"Calcium and vitamin D supplementation and increased risk of serrated polyps: results from a randomised clinical trial","volume":"68","author":"S Crockett","year":"2019","journal-title":"Gut"},{"key":"ref452","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1440-1746.1991.tb00867.x","article-title":"Clinicopathological staging for colorectal cancer: an International Documentation System (IDS) and an International Comprehensive Anatomical Terminology (ICAT)","volume":"6","author":"L P Fielding","year":"1991","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"ref453","first-page":"405","article-title":"International standardization and documentation of the treatment of rectal cancer. Rectal cancer surgery","author":"O Soreide","year":"1997","journal-title":"Optimisation \u2013 standardization \u2013 documentation"},{"key":"ref456","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/jnci\/93.8.583","article-title":"Guidelines 2000 for colon and rectal cancer surgery","volume":"93","author":"H Nelson","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"ref457","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1002\/1097-0142(19840315)53:6<1354::AID-CNCR2820530623>3.0.CO;2-J","article-title":"Patterns of pelvic recurrence following definitive resections of rectal cancer","volume":"53","author":"S J Pilipshen","year":"1984","journal-title":"Cancer"},{"key":"ref458","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/sj.bjc.6602947","article-title":"MRI directed multidisciplinary team preoperative treatment strategy: the way to eliminate positive circumferential margins?","volume":"94","author":"S Burton","year":"2006","journal-title":"Br J Cancer"},{"key":"ref459","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/j.1463-1318.2008.01648.x","article-title":"Differences in multidisciplinary team assessment and treatment between patients with stage IV colon and rectal cancer","volume":"11","author":"J Segelman","year":"2009","journal-title":"Colorectal Dis"},{"key":"ref460","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1463-1318.2008.01580.x","article-title":"Improving patient survival with the colorectal cancer multi-disciplinary team","volume":"11","author":"E MacDermid","year":"2009","journal-title":"Colorectal Dis"},{"key":"ref461","first-page":"163","article-title":"Effect of preoperative colonoscopy on the incidence of synchronous and metachronous neoplasms","volume":"156","author":"P Barillari","year":"1990","journal-title":"Acta Chir Scand"},{"key":"ref462","first-page":"283","article-title":"[Endoscopic monitoring after excision of colorectal cancer]","volume":"134","author":"J Faivre","year":"1997","journal-title":"J\u00a0Chir (Paris)"},{"key":"ref463","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/BF02236556","article-title":"Synchronous and \u201cearly\u201d metachronous colorectal adenocarcinoma: analysis of prognosis and current trends","volume":"43","author":"H S Chen","year":"2000","journal-title":"Dis Colon Rectum"},{"key":"ref464","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/jmri.22010","article-title":"Performance of imaging modalities in diagnosis of liver metastases from colorectal cancer: a systematic review and meta-analysis","volume":"31","author":"I Floriani","year":"2010","journal-title":"J Magn Reson Imaging"},{"issue":"S 04","key":"ref465","doi-asserted-by":"crossref","first-page":"iv22","DOI":"10.1093\/annonc\/mdx224","article-title":"Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"28","author":"R Glynne-Jones","year":"2017","journal-title":"Ann Oncol"},{"issue":"05","key":"ref466","doi-asserted-by":"crossref","first-page":"S208","DOI":"10.1016\/j.jacr.2022.02.012","article-title":"ACR Appropriateness Criteria Staging of Colorectal Cancer: 2021 Update","volume":"19","author":"E Korngold","year":"2022","journal-title":"J Am Coll Radiol"},{"key":"ref467","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1148\/radiol.10100729","article-title":"Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and\/or FDG PET\/CT: a meta-analysis of prospective studies including patients who have not previously undergone treatment","volume":"257","author":"M C Niekel","year":"2010","journal-title":"Radiology"},{"issue":"01","key":"ref468","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1038\/s41598-020-58855-1","article-title":"Diagnostic performance of magnetic resonance imaging for colorectal liver metastasis: A systematic review and meta-analysis","volume":"10","author":"Y Mao","year":"2020","journal-title":"Sci Rep"},{"issue":"05","key":"ref469","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1002\/jmri.25852","article-title":"Diagnostic performance of CT, gadoxetate disodium-enhanced MRI, and PET\/CT for the diagnosis of colorectal liver metastasis: Systematic review and meta-analysis","volume":"47","author":"S Choi","year":"2018","journal-title":"J Magn Reson Imaging"},{"issue":"01","key":"ref470","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.annonc.2022.10.003","article-title":"Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"34","author":"A Cervantes","year":"2023","journal-title":"Ann Oncol"},{"issue":"05","key":"ref471","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1055\/s-2008-1027806","article-title":"Contrast-enhanced ultrasound for the characterization of focal liver lesions--diagnostic accuracy in clinical practice (DEGUM multicenter trial)","volume":"29","author":"D Strobel","year":"2008","journal-title":"Ultraschall in Med"},{"issue":"06","key":"ref472","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1055\/s-0041-107833","article-title":"Benefit of Contrast-Enhanced Ultrasound (CEUS) in the Follow-Up Care of Patients with Colon Cancer: A Prospective Multicenter Study","volume":"36","author":"T Bernatik","year":"2015","journal-title":"Ultraschall in Med"},{"issue":"02","key":"ref473","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.jhep.2020.09.036","article-title":"Contrast-enhanced ultrasound can guide the therapeutic strategy by improving the detection of colorectal liver metastases","volume":"74","author":"M Sawatzki","year":"2021","journal-title":"J Hepatol"},{"key":"ref474","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.crad.2010.01.024","article-title":"Diagnostic precision of CT in local staging of colon cancers: a meta-analysis","volume":"65","author":"S Dighe","year":"2010","journal-title":"Clin Radiol"},{"key":"ref475","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1148\/radiology.206.3.9494497","article-title":"Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: correlation with histopathologic and CT findings","volume":"206","author":"H Abdel-Nabi","year":"1998","journal-title":"Radiology"},{"key":"ref476","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1463-1318.2008.01643.x","article-title":"Comparison of preoperative whole-body positron emission tomography with MDCT in patients with primary colorectal cancer","volume":"11","author":"T Akiyoshi","year":"2009","journal-title":"Colorectal Dis"},{"key":"ref477","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1136\/gut.2005.076273","article-title":"Positron emission tomography scanning is not superior to whole body multidetector helical computed tomography in the preoperative staging of colorectal cancer","volume":"55","author":"H Furukawa","year":"2006","journal-title":"Gut"},{"key":"ref478","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/bjs.6866","article-title":"Comparison of magnetic resonance imaging-fluorodeoxy- glucose positron emission tomography fusion with pathological staging in rectal cancer","volume":"97","author":"M H Kam","year":"2010","journal-title":"Br J Surg"},{"key":"ref479","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1007\/s00261-007-9202-8","article-title":"Whole-body PET\/CT-colonography: a possible new concept for colorectal cancer staging","volume":"32","author":"S Kinner","year":"2007","journal-title":"Abdom Imaging"},{"key":"ref480","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s00259-006-0274-4","article-title":"Fluorine-18 fluorodeoxyglucose PET in the preoperative staging of colorectal cancer","volume":"34","author":"J M Llamas-Elvira","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref481","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/jmri.21638","article-title":"Comparison of diffusion-weighted MRI and 2-[fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) for detecting primary colorectal cancer and regional lymph node metastases","volume":"29","author":"K Ono","year":"2009","journal-title":"J Magn Reson Imaging"},{"key":"ref482","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1007\/s00259-007-0455-9","article-title":"Non-enhanced CT versus contrast-enhanced CT in integrated PET\/CT studies for nodal staging of rectal cancer","volume":"34","author":"U Tateishi","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref483","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1001\/jama.296.21.2590","article-title":"Diagnostic accuracy of colorectal cancer staging with whole-body PET\/CT colonography","volume":"296","author":"P Veit-Haibach","year":"2006","journal-title":"JAMA"},{"key":"ref484","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.ijrobp.2007.08.043","article-title":"FDG-PET\/CT imaging for staging and target volume delineation in preoperative conformal radiotherapy of rectal cancer","volume":"70","author":"M C Bassi","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref485","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1007\/s10350-008-9244-1","article-title":"The impact of 18-fluorodeoxyglucose positron emission tomography-computed tomography on the staging and management of primary rectal cancer","volume":"51","author":"K Davey","year":"2008","journal-title":"Dis Colon Rectum"},{"key":"ref486","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1245\/ASO.2006.04.042","article-title":"Improved staging with pretreatment positron emission tomography\/computed tomography in low rectal cancer","volume":"13","author":"S L Gearhart","year":"2006","journal-title":"Ann Surg Oncol"},{"key":"ref487","first-page":"1784","article-title":"Routine (18)F-FDG PET preoperative staging of colorectal cancer: comparison with conventional staging and its impact on treatment decision making","volume":"44","author":"I Kantorova","year":"2003","journal-title":"J Nucl Med"},{"key":"ref488","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1007\/s10350-008-9236-1","article-title":"PET\/CT colonography for the preoperative evaluation of the colon proximal to the obstructive colorectal cancer","volume":"51","author":"K Nagata","year":"2008","journal-title":"Dis Colon Rectum"},{"key":"ref489","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.ejso.2006.05.019","article-title":"Efficacy of PET\/CT in the accurate evaluation of primary colorectal carcinoma","volume":"32","author":"I J Park","year":"2006","journal-title":"Eur J Surg Oncol"},{"key":"ref490","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s00066-009-1962-3","article-title":"Impact of (18)F-FDG-PET\/CT on staging and irradiation of patients with locally advanced rectal cancer","volume":"185","author":"B Paskeviciute","year":"2009","journal-title":"Strahlenther Onkol"},{"key":"ref491","doi-asserted-by":"crossref","first-page":"102151","DOI":"10.1016\/j.suronc.2024.102151","article-title":"Diagnostic accuracy and treatment benefit of PET\/CT in staging of colorectal cancer compared to conventional imaging","volume":"57","author":"R Engel","year":"2024","journal-title":"Surg Oncol"},{"issue":"01","key":"ref492","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13550-021-00831-5","article-title":"The metabolic parameters based on volume in PET\/CT are associated with clinicopathological N stage of colorectal cancer and can predict prognosis","volume":"11","author":"H Kido","year":"2021","journal-title":"EJNMMI Res"},{"issue":"07","key":"ref493","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.2967\/jnumed.121.262426","article-title":"Correlation of 68Ga-FAPi-46 PET Biodistribution with FAP Expression by Immunohistochemistry in Patients with Solid Cancers: Interim Analysis of a Prospective Translational Exploratory Study","volume":"63","author":"C Mona","year":"2022","journal-title":"J Nucl Med"},{"issue":"10","key":"ref494","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.2967\/jnumed.124.267581","article-title":"Predicting Pathologic Complete Response in Locally Advanced Rectal Cancer with [","volume":"65","author":"X Zhang","year":"2024","journal-title":"J Nucl Med"},{"key":"ref495","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1002\/(SICI)1097-0142(20000401)88:7<1739::AID-CNCR30>3.0.CO;2-T","article-title":"American Joint Committee on Cancer Prognostic Factors Consensus Conference: Colorectal Working Group","volume":"88","author":"C Compton","year":"2000","journal-title":"Cancer"},{"key":"ref496","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.5858\/2000-124-1016-UPFTEO","article-title":"Updated protocol for the examination of specimens from patients with carcinomas of the colon and rectum, excluding carcinoid tumors, lymphomas, sarcomas, and tumors of the vermiform appendix: a basis for checklists Cancer Committee","volume":"124","author":"C C Compton","year":"2000","journal-title":"Arch Pathol Lab Med"},{"issue":"18","key":"ref498","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1001\/jama.2014.3740","article-title":"Effect of PET before liver resection on surgical management for colorectal adenocarcinoma metastases: a randomized clinical trial","volume":"311","author":"C Moulton","year":"2014","journal-title":"JAMA"},{"key":"ref499","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1097\/SLA.0b013e31821110c9","article-title":"Positron emission tomography\/computed tomographic scans compared to computed tomographic scans for detecting colorectal liver metastases: a systematic review","volume":"253","author":"S Patel","year":"2011","journal-title":"Ann Surg"},{"key":"ref500","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1001\/archsurg.2010.41","article-title":"Effectiveness of positron emission tomography for predicting chemotherapy response in colorectal cancer liver metastases","volume":"145","author":"E S Glazer","year":"2010","journal-title":"Arch Surg"},{"key":"ref501","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00384-010-1065-8","article-title":"Neoadjuvant chemotherapy affects staging of colorectal liver metastasis--a comparison of PET, CT and intraoperative ultrasound","volume":"26","author":"J Spatz","year":"2011","journal-title":"Int J Colorectal Dis"},{"key":"ref502","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.2967\/jnumed.109.063040","article-title":"Improved selection of patients for hepatic surgery of colorectal liver metastases with (18)F-FDG PET: a randomized study","volume":"50","author":"T J Ruers","year":"2009","journal-title":"J Nucl Med"},{"key":"ref503","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1445-2197.2009.04889.x","article-title":"Resection of liver metastases from colorectal cancer: does preoperative chemotherapy affect the accuracy of PET in preoperative planning?","volume":"79","author":"S Adie","year":"2009","journal-title":"ANZ J Surg"},{"key":"ref504","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1007\/s11605-006-0032-8","article-title":"The role and limitations of 18-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) scan and computerized tomography (CT) in restaging patients with hepatic colorectal metastases following neoadjuvant chemotherapy: comparison with operative and pathological findings","volume":"11","author":"N Lubezky","year":"2007","journal-title":"J Gastrointest Surg"},{"key":"ref505","first-page":"138","article-title":"Tumor markers in staging and prognosis of colorectal carcinoma","volume":"55","author":"M Levy","year":"2008","journal-title":"Neoplasma"},{"key":"ref506","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.ygyno.2006.12.035","article-title":"Metastatic colorectal adenocarcinoma involving the ovary with elevated serum CA125: a potential diagnostic pitfall","volume":"105","author":"M R Lewis","year":"2007","journal-title":"Gynecol Oncol"},{"key":"ref507","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jss.2004.08.013","article-title":"Is it reasonable to add preoperative serum level of CEA and CA19-9 to staging for colorectal cancer?","volume":"124","author":"C C Chen","year":"2005","journal-title":"J Surg Res"},{"issue":"01","key":"ref508","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3233\/TUB-200069","article-title":"CA125: A superior prognostic biomarker for colorectal cancer compared to CEA, CA19-9 or CA242","volume":"43","author":"K Bj\u00f6rkman","year":"2021","journal-title":"Tumour Biol"},{"issue":"16","key":"ref509","doi-asserted-by":"crossref","first-page":"3757","DOI":"10.7150\/jca.31660","article-title":"The difference in prognosis of stage II and III colorectal cancer based on preoperative serum tumor markers","volume":"10","author":"W You","year":"2019","journal-title":"J Cancer"},{"issue":"01","key":"ref510","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12916-023-02773-2","article-title":"Prediction models of colorectal cancer prognosis incorporating perioperative longitudinal serum tumor markers: a retrospective longitudinal cohort study","volume":"21","author":"C Li","year":"2023","journal-title":"BMC Med"},{"issue":"01","key":"ref511","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1186\/s12885-022-10051-2","article-title":"Preoperative serum CA19-9 should be routinely measured in the colorectal patients with preoperative normal serum CEA: a multicenter retrospective cohort study","volume":"22","author":"Z Li","year":"2022","journal-title":"BMC Cancer"},{"issue":"08","key":"ref512","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1245\/s10434-020-08256-5","article-title":"Clinical Significance of Preoperative Serum Carcinoembryonic Antigen Within the Normal Range in Colorectal Cancer Patients Undergoing Curative Resection","volume":"27","author":"S Beom","year":"2020","journal-title":"Ann Surg Oncol"},{"issue":"01","key":"ref513","doi-asserted-by":"crossref","first-page":"22830","DOI":"10.1038\/s41598-023-49832-5","article-title":"Prognostic value of normal levels of preoperative tumor markers in colorectal cancer","volume":"13","author":"G Ren","year":"2023","journal-title":"Sci Rep"},{"issue":"02","key":"ref514","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/DCR.0000000000000906","article-title":"Comparisons of Rigid Proctoscopy, Flexible Colonoscopy, and Digital Rectal Examination for Determining the Localization of Rectal Cancers","volume":"61","author":"A Tanaka","year":"2018","journal-title":"Dis Colon Rectum"},{"issue":"01","key":"ref515","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1177\/2050640617707090","article-title":"Comparison of MRI and colonoscopy in determining tumor height in rectal cancer","volume":"6","author":"L Jacobs","year":"2018","journal-title":"United European Gastroenterol J"},{"key":"ref516","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s003840100309","article-title":"The prognostic inhomogeneity in pT3 rectal carcinomas","volume":"16","author":"S Merkel","year":"2001","journal-title":"Int J Colorectal Dis"},{"key":"ref517","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1200\/JCO.2007.12.7027","article-title":"What is the role for the circumferential margin in the modern treatment of rectal cancer?","volume":"26","author":"I D Nagtegaal","year":"2008","journal-title":"J Clin Oncol"},{"issue":"12","key":"ref518","doi-asserted-by":"crossref","first-page":"8827","DOI":"10.1007\/s00330-021-07981-z","article-title":"The prognostic value of MRI-detected extramural vascular invasion (mrEMVI) for rectal cancer patients treated with neoadjuvant therapy: a meta-analysis","volume":"31","author":"S Chen","year":"2021","journal-title":"Eur Radiol"},{"issue":"02","key":"ref519","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ijrobp.2021.05.136","article-title":"Prognostic Importance of MRI-Detected Extramural Venous Invasion in Rectal Cancer: A Literature Review and Systematic Meta-Analysis","volume":"111","author":"J Tan","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref520","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1148\/radiol.2323031368","article-title":"Rectal cancer: local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging--a meta-analysis","volume":"232","author":"S Bipat","year":"2004","journal-title":"Radiology"},{"key":"ref521","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00261-009-9591-y","article-title":"MDCT with multiplanar reconstruction in the preoperative local staging of rectal tumor","volume":"36","author":"A Ahmetoglu","year":"2011","journal-title":"Abdom Imaging"},{"key":"ref522","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1007\/s00330-005-0084-2","article-title":"Preoperative staging of rectal cancer: accuracy of 3-Tesla magnetic resonance imaging","volume":"16","author":"C K Kim","year":"2006","journal-title":"Eur Radiol"},{"key":"ref523","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.ejso.2007.05.001","article-title":"A prospective comparison study for predicting circumferential resection margin between preoperative MRI and whole mount sections in mid-rectal cancer: significance of different scan planes","volume":"34","author":"Y W Kim","year":"2008","journal-title":"Eur J Surg Oncol"},{"key":"ref524","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1007\/s00268-009-0126-z","article-title":"Factors related to preoperative assessment of the circumferential resection margin and the extent of mesorectal invasion by magnetic resonance imaging in rectal cancer: a prospective comparison study","volume":"33","author":"Y W Kim","year":"2009","journal-title":"World J Surg"},{"key":"ref525","first-page":"4097","article-title":"MRI diagnosis of mesorectal lymph node metastasis in patients with rectal carcinoma what is the optimal criterion?","volume":"24","author":"H Matsuoka","year":"2004","journal-title":"Anticancer Res"},{"key":"ref526","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1007\/DCR.0b013e318194f923","article-title":"Multislice CT as a primary screening tool for the prediction of an involved mesorectal fascia and distant metastases in primary rectal cancer: a multicenter study","volume":"52","author":"S V Wolberink","year":"2009","journal-title":"Dis Colon Rectum"},{"key":"ref527","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1463-1318.2006.01126.x","article-title":"Magnetic resonance colonography vs computed tomography colonography for the diagnosis of colorectal cancer: an indirect comparison","volume":"9","author":"S Purkayastha","year":"2007","journal-title":"Colorectal Dis"},{"key":"ref528","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1245\/s10434-009-0337-4","article-title":"Accuracy of endoscopic ultrasound to diagnose nodal invasion by rectal cancers: a meta-analysis and systematic review","volume":"16","author":"S R Puli","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"ref529","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.gassur.2005.08.016","article-title":"Contrast-enhanced intraoperative ultrasonography during hepatectomies for colorectal cancer liver metastases","volume":"9","author":"G Torzilli","year":"2005","journal-title":"J Gastrointest Surg"},{"key":"ref530","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1007\/BF02052218","article-title":"Intraoperative spillage of tumor cells in surgery for rectal cancer","volume":"33","author":"H Zirngibl","year":"1990","journal-title":"Dis Colon Rectum"},{"key":"ref531","first-page":"445","article-title":"Incidence and pathology of carcinoma of the colon and rectum","author":"J Goligher","year":"1984","journal-title":"Surgery of the anus, rectum and colon"},{"key":"ref532","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/BF02048026","article-title":"Rationale for extent of lymph node dissection for right colon cancer","volume":"38","author":"S Toyota","year":"1995","journal-title":"Dis Colon Rectum"},{"key":"ref533","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1463-1318.2009.01924.x","article-title":"Distribution of the first metastatic lymph node in colon cancer and its clinical significance","volume":"12","author":"K Y Tan","year":"2010","journal-title":"Colorectal Dis"},{"key":"ref534","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1245\/s10434-010-1270-2","article-title":"Significance of lymph node retrieval from the terminal ileum for patients with cecal and ascending colonic cancers","volume":"18","author":"Y T Lan","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"ref536","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/bjs.5327","article-title":"Survival benefit of high ligation of the inferior mesenteric artery in sigmoid colon or rectal cancer surgery","volume":"93","author":"Y Kanemitsu","year":"2006","journal-title":"Br J Surg"},{"key":"ref537","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s00384-010-0904-y","article-title":"Carcinoma obstruction of the proximal colon cancer and long-term prognosis--obstruction is a predictor of worse outcome in TNM stage II tumor","volume":"25","author":"C C Chin","year":"2010","journal-title":"Int J Colorectal Dis"},{"issue":"08","key":"ref538","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/j.ejso.2022.04.019","article-title":"Incidence of lymph node recurrence after primary surgery for non-metastatic colon cancer: A systematic review","volume":"48","author":"M Struys","year":"2022","journal-title":"Eur J Surg Oncol"},{"issue":"03","key":"ref539","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/ans.18741","article-title":"Complete mesocolic excision for colon cancer: current status and controversies","volume":"94","author":"K Brown","year":"2024","journal-title":"ANZ J Surg"},{"issue":"10","key":"ref540","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/s10151-021-02471-2","article-title":"Right hemicolectomy with complete mesocolic excision is safe, leads to an increased lymph node yield and to increased survival: results of a systematic review and meta-analysis","volume":"25","author":"G Anania","year":"2021","journal-title":"Tech Coloproctol"},{"issue":"13","key":"ref541","doi-asserted-by":"crossref","first-page":"8823","DOI":"10.1245\/s10434-021-10186-9","article-title":"Complete Mesocolic Excision and D3 Lymphadenectomy versus Conventional Colectomy for Colon Cancer: A Systematic Review and Meta-Analysis","volume":"28","author":"T D\u00edaz-Vico","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"ref542","doi-asserted-by":"crossref","first-page":"101755","DOI":"10.1016\/j.suronc.2022.101755","article-title":"Complete mesocolic excision with central venous ligation\/D3 lymphadenectomy for colon cancer \u2013 A comprehensive review of the evidence","volume":"42","author":"I Seow-En","year":"2022","journal-title":"Surg Oncol"},{"issue":"02","key":"ref543","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1007\/s00464-022-09548-5","article-title":"Definition and reporting of lymphadenectomy and complete mesocolic excision for radical right colectomy: a systematic review","volume":"37","author":"G Sica","year":"2023","journal-title":"Surg Endosc"},{"issue":"05","key":"ref544","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/bjs.11387","article-title":"Short-term outcomes of a multicentre randomized clinical trial comparing D2 versus D3 lymph node dissection for colonic cancer (COLD trial)","volume":"107","author":"A Karachun","year":"2020","journal-title":"Br J Surg"},{"issue":"03","key":"ref545","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1470-2045(20)30685-9","article-title":"Short-term outcomes of complete mesocolic excision versus D2 dissection in patients undergoing laparoscopic colectomy for right colon cancer (RELARC): a randomised, controlled, phase 3, superiority trial","volume":"22","author":"L Xu","year":"2021","journal-title":"Lancet Oncol"},{"key":"ref547","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4174\/jkss.2011.81.1.25","article-title":"Comparative analysis of radiofrequency ablation and surgical resection for colorectal liver metastases","volume":"81","author":"K H Kim","year":"2011","journal-title":"J Korean Surg Soc"},{"key":"ref548","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1245\/s10434-007-9478-5","article-title":"Radiofrequency ablation versus resection for resectable colorectal liver metastases: time for a randomized trial?","volume":"15","author":"S Mulier","year":"2008","journal-title":"Ann Surg Oncol"},{"issue":"05","key":"ref549","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1007\/s00464-022-09815-5","article-title":"Surgical approach to microwave and radiofrequency liver ablation for hepatocellular carcinoma and colorectal liver metastases less than 5 cm: a systematic review and meta-analysis","volume":"37","author":"M Abdalla","year":"2023","journal-title":"Surg Endosc"},{"key":"ref550","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/bjs.1800691019","article-title":"The mesorectum in rectal cancer surgery \u2013 the clue to pelvic recurrence?","volume":"69","author":"R J Heald","year":"1982","journal-title":"Br J Surg"},{"key":"ref551","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1046\/j.1365-2168.1999.01216.x","article-title":"Local recurrence after curative excision of the rectum for cancer without adjuvant therapy: role of total anatomical dissection","volume":"86","author":"E L Bokey","year":"1999","journal-title":"Br J Surg"},{"key":"ref553","first-page":"495","article-title":"Male and female sexual and urinary function after total mesorectal excision with autonomic nerve preservation for carcinoma of the rectum","volume":"182","author":"K Havenga","year":"1996","journal-title":"J Am Coll Surg"},{"key":"ref554","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s002689900296","article-title":"Abdominoperineal resection via total mesorectal excision and autonomic nerve preservation for low rectal cancer","volume":"21","author":"W E Enker","year":"1997","journal-title":"World J Surg"},{"key":"ref555","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S1470-2045(09)70224-4","article-title":"Extended lymphadenectomy versus conventional surgery for rectal cancer: a meta-analysis","volume":"10","author":"P Georgiou","year":"2009","journal-title":"Lancet Oncol"},{"key":"ref556","first-page":"57","article-title":"Lymph node dissection in rectal carcinoma: TME and what else?","volume":"32","author":"J Gohl","year":"2009","journal-title":"Onkologie"},{"key":"ref557","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.soc.2006.10.007","article-title":"Total mesorectal excision and pelvic node dissection for rectal cancer: an appraisal","volume":"16","author":"M M Mortenson","year":"2007","journal-title":"Surg Oncol Clin N Am"},{"key":"ref558","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/3-540-27449-9_6","article-title":"Is the lateral lymph node compartment relevant?","volume":"165","author":"M Koch","year":"2005","journal-title":"Recent Results Cancer Res"},{"key":"ref560","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2190\/EUFN-RV1K-Y3TR-FK0L","article-title":"Psychosocial interventions for depression, anxiety, and quality of life in cancer survivors: meta-analyses","volume":"36","author":"R L Osborn","year":"2006","journal-title":"Int J Psychiatry Med"},{"key":"ref561","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0738-3991(02)00149-0","article-title":"Effects of psychosocial interventions on quality of life in adult cancer patients: meta analysis of 37 published controlled outcome studies","volume":"50","author":"B Rehse","year":"2003","journal-title":"Patient Educ Couns"},{"key":"ref562","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/sj.bjc.6602103","article-title":"Psychosocial interventions for patients with advanced cancer \u2013 a systematic review of the literature","volume":"91","author":"R J Uitterhoeve","year":"2004","journal-title":"Br J Cancer"},{"key":"ref563","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/sj.bjc.6602949","article-title":"The effectiveness of treatment for depression\/depressive symptoms in adults with cancer: a systematic review","volume":"94","author":"S Williams","year":"2006","journal-title":"Br J Cancer"},{"key":"ref564","doi-asserted-by":"crossref","first-page":"3992","DOI":"10.1200\/JCO.2002.03.083","article-title":"Effectiveness of adjuvant fluorouracil in clinical practice: a population-based cohort study of elderly patients with stage III colon cancer","volume":"20","author":"T J Iwashyna","year":"2002","journal-title":"J Clin Oncol"},{"key":"ref565","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1007\/BF02050080","article-title":"Simple technique for high ligation of the inferior mesenteric artery and vein","volume":"34","author":"H Abcarian","year":"1991","journal-title":"Dis Colon Rectum"},{"key":"ref566","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1007\/s00384-009-0761-8","article-title":"Level of arterial ligation in total mesorectal excision (TME): an anatomical study","volume":"24","author":"M Buunen","year":"2009","journal-title":"Int J Colorectal Dis"},{"key":"ref567","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/00000658-198412000-00010","article-title":"Survival after high or low ligation of the inferior mesenteric artery during curative surgery for rectal cancer","volume":"200","author":"M E Pezim","year":"1984","journal-title":"Ann Surg"},{"key":"ref568","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/bjs.1800770607","article-title":"High versus low ligation of the inferior mesenteric artery in rectal cancer","volume":"77","author":"P Surtees","year":"1990","journal-title":"Br J Surg"},{"key":"ref569","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1007\/BF02055167","article-title":"Effect of high and intermediate ligation on survival and recurrence rates following curative resection of colorectal cancer","volume":"40","author":"C A Slanetz","year":"1997","journal-title":"Dis Colon Rectum"},{"key":"ref570","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1007\/s10350-008-9328-y","article-title":"Level of arterial ligation in rectal cancer surgery: low tie preferred over high tie A review","volume":"51","author":"M M Lange","year":"2008","journal-title":"Dis Colon Rectum"},{"key":"ref571","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1097\/00000658-199806000-00003","article-title":"Surgical treatment of adenocarcinoma of the rectum","volume":"227","author":"S Zaheer","year":"1998","journal-title":"Ann Surg"},{"key":"ref572","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1007\/BF02237427","article-title":"Selective total mesorectal excision for rectal cancer","volume":"43","author":"A F Leong","year":"2000","journal-title":"Dis Colon Rectum"},{"key":"ref573","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1007\/BF02066981","article-title":"Results of radical surgery for rectal cancer","volume":"16","author":"R J Heald","year":"1992","journal-title":"World J Surg"},{"key":"ref574","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3109\/07853899709113698","article-title":"Total mesorectal excision--the new golden standard of surgery for rectal cancer","volume":"29","author":"W E Enker","year":"1997","journal-title":"Ann Med"},{"issue":"01","key":"ref575","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12957-023-02977-z","article-title":"Comparison of complications and bowel function among different reconstruction techniques after low anterior resection for rectal cancer: a systematic review and network meta-analysis","volume":"21","author":"H Liu","year":"2023","journal-title":"World J Surg Oncol"},{"issue":"03","key":"ref576","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/bjs\/znac400","article-title":"Reconstructive techniques following low anterior resection for carcinoma of the rectum: meta-analysis","volume":"110","author":"A Mathew","year":"2023","journal-title":"Br J Surg"},{"issue":"04","key":"ref577","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s00384-022-04130-w","article-title":"Comparison of the colonic J-pouch versus straight (end-to-end) anastomosis following low anterior resection: a systematic review and meta-analysis","volume":"37","author":"S Zaman","year":"2022","journal-title":"Int J Colorectal Dis"},{"issue":"07","key":"ref578","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/bjs.9782","article-title":"Meta-analysis of reconstruction techniques after low anterior resection for rectal cancer","volume":"102","author":"F H\u00fcttner","year":"2015","journal-title":"Br J Surg"},{"key":"ref579","first-page":"294","article-title":"[Neoadjuvant radiochemotherapy for rectal cancer]","volume":"80","author":"W Hohenberger","year":"2009","journal-title":"Chirurg"},{"issue":"S 02","key":"ref580","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1463-1318.2010.02321.x","article-title":"Controversial aspects of rectal cancer surgery following preoperative chemoradiation","volume":"12","author":"D Y Artioukh","year":"2010","journal-title":"Colorectal Dis"},{"issue":"35","key":"ref581","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.1200\/JCO.2011.37.7176","article-title":"Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer","volume":"29","author":"M Maas","year":"2011","journal-title":"J Clin Oncol"},{"key":"ref582","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1186\/s12885-015-1632-z","article-title":"Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management","volume":"15","author":"J Smith","year":"2015","journal-title":"BMC Cancer"},{"issue":"12","key":"ref583","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/s41571-021-00538-5","article-title":"International consensus recommendations on key outcome measures for organ preservation after (chemo)radiotherapy in patients with rectal cancer","volume":"18","author":"E Fokas","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"issue":"06","key":"ref584","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1097\/DCR.0000000000003209","article-title":"An International Expert-Based Consensus on the Definition of a Clinical Near-Complete Response After Neoadjuvant (Chemo)radiotherapy for Rectal Cancer","volume":"67","author":"P Custers","year":"2024","journal-title":"Dis Colon Rectum"},{"issue":"01","key":"ref585","doi-asserted-by":"crossref","first-page":"e2350903","DOI":"10.1001\/jamanetworkopen.2023.50903","article-title":"Organ Preservation and Survival by Clinical Response Grade in Patients With Rectal Cancer Treated With Total Neoadjuvant Therapy: A Secondary Analysis of the OPRA Randomized Clinical Trial","volume":"7","author":"H Thompson","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"52","key":"ref586","doi-asserted-by":"crossref","first-page":"e9150","DOI":"10.1097\/MD.0000000000009150","article-title":"Standard versus extralevator abdominoperineal excision and oncologic outcomes for patients with distal rectal cancer: A meta-analysis","volume":"96","author":"Y Zhang","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"02","key":"ref587","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00384-013-1793-7","article-title":"Comparison of short- and long-term outcomes after extralevator abdominoperineal excision and standard abdominoperineal excision for rectal cancer: a systematic review and meta-analysis","volume":"29","author":"H Yu","year":"2014","journal-title":"Int J Colorectal Dis"},{"issue":"02","key":"ref588","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/codi.13436","article-title":"Extralevator with vs nonextralevator abdominoperineal excision for rectal cancer: the RELAPe randomized controlled trial","volume":"19","author":"F Bianco","year":"2017","journal-title":"Colorectal Dis"},{"issue":"07","key":"ref589","doi-asserted-by":"crossref","first-page":"O253","DOI":"10.1111\/codi.13726","article-title":"A pilot randomized study comparing extralevator with conventional abdominoperineal excision for low rectal cancer after neoadjuvant chemoradiation","volume":"19","author":"R Seshadri","year":"2017","journal-title":"Colorectal Dis"},{"issue":"03","key":"ref590","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.amjsurg.2012.05.001","article-title":"Randomized clinical trial of conventional versus cylindrical abdominoperineal resection for locally advanced lower rectal cancer","volume":"204","author":"J Han","year":"2012","journal-title":"Am J Surg"},{"issue":"12","key":"ref591","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1007\/s10151-023-02868-1","article-title":"A comparison of surgical techniques for perineal wound closure following perineal excision: a systematic review and network meta-analysis","volume":"27","author":"C Riva","year":"2023","journal-title":"Tech Coloproctol"},{"key":"ref592","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/j.1463-1318.2008.01743.x","article-title":"Myocutaneous flap reconstruction of the pelvis after abdominoperineal excision","volume":"11","author":"P J Nisar","year":"2009","journal-title":"Colorectal Dis"},{"issue":"11","key":"ref593","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1007\/s11605-022-05427-5","article-title":"When Is a Diverting Stoma Indicated after Low Anterior Resection? A Meta-analysis of Randomized Trials and Meta-Regression of the Risk Factors of Leakage and Complications in Non-Diverted Patients","volume":"26","author":"S Emile","year":"2022","journal-title":"J Gastrointest Surg"},{"key":"ref594","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/DCR.0b013e3181fd2948","article-title":"What is the risk for a permanent stoma after low anterior resection of the rectum for cancer? A six-year follow-up of a multicenter trial","volume":"54","author":"R Lindgren","year":"2011","journal-title":"Dis Colon Rectum"},{"issue":"08","key":"ref595","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1111\/codi.16118","article-title":"The effect of preoperative stoma site marking on risk of stoma-related complications in patients with intestinal ostomy \u2013 A systematic review and meta-analysis","volume":"24","author":"P Ambe","year":"2022","journal-title":"Colorectal Dis"},{"issue":"03","key":"ref596","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1503\/cjs.022320","article-title":"Preoperative stoma site marking for fecal diversions (ileostomy and colostomy): position statement of the Canadian Society of Colon and Rectal Surgeons and Nurses Specialized in Wound, Ostomy and Continence Canada","volume":"65","author":"T Zwiep","year":"2022","journal-title":"Can J Surg"},{"key":"ref598","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/BF02258389","article-title":"Does preoperative stoma marking and education by the enterostomal therapist affect outcome?","volume":"40","author":"E M Bass","year":"1997","journal-title":"Dis Colon Rectum"},{"key":"ref599","doi-asserted-by":"crossref","first-page":"e88","DOI":"10.1111\/j.1463-1318.2009.01942.x","article-title":"Preoperative stoma siting and education by stomatherapists of colorectal cancer patients: a descriptive study in twelve Spanish colorectal surgical units","volume":"12","author":"M Millan","year":"2010","journal-title":"Colorectal Dis"},{"key":"ref600","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1007\/s10350-004-0897-0","article-title":"Preoperative intensive, community-based vs traditional stoma education: a randomized, controlled trial","volume":"48","author":"S Chaudhri","year":"2005","journal-title":"Dis Colon Rectum"},{"key":"ref602","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/BF02054683","article-title":"Surgical cure for early rectal carcinomas (T1) Transanal endoscopic microsurgery vs anterior resection","volume":"39","author":"G Winde","year":"1996","journal-title":"Dis Colon Rectum"},{"key":"ref603","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/BF02234796","article-title":"Local excision of rectal cancer: what is the evidence?","volume":"44","author":"S Sengupta","year":"2001","journal-title":"Dis Colon Rectum"},{"key":"ref604","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s00104-003-0745-0","article-title":"Lokale Therapieprinzipien beim Rektumkarzinom","volume":"74","author":"K E Matzel","year":"2003","journal-title":"Chirurg"},{"key":"ref605","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1001\/archsurg.142.7.649","article-title":"Oncological outcome of local vs radical resection of low-risk pT1 rectal cancer","volume":"142","author":"H Ptok","year":"2007","journal-title":"Arch Surg"},{"key":"ref606","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1097\/01.sla.0000252590.95116.4f","article-title":"Is the increasing rate of local excision for stage I rectal cancer in the United States justified? a nationwide cohort study from the National Cancer Database","volume":"245","author":"Y N You","year":"2007","journal-title":"Ann Surg"},{"issue":"11","key":"ref607","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1002\/1097-0142(19940601)73:11<2716::AID-CNCR2820731111>3.0.CO;2-9","article-title":"Selection factors for local excision or abdominoperineal resection of early stage rectal cancer","volume":"73","author":"C Willett","year":"1994","journal-title":"Cancer"},{"issue":"10","key":"ref608","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.6004\/jnccn.2022.0051","article-title":"Rectal Cancer, Version 22022, NCCN Clinical Practice Guidelines in Oncology","volume":"20","author":"A Benson","year":"2022","journal-title":"J Natl Compr Canc Netw"},{"issue":"07","key":"ref609","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/bjs\/znab168","article-title":"Histopathological risk factors for lymph node metastases in T1 colorectal cancer: meta-analysis","volume":"108","author":"A Ebbeh\u00f8j","year":"2021","journal-title":"Br J Surg"},{"issue":"09","key":"ref610","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1097\/DCR.0000000000002164","article-title":"Classic and Novel Histopathologic Risk Factors for Lymph Node Metastasis in T1 Colorectal Cancer: A Systematic Review and Meta-analysis","volume":"64","author":"M Dykstra","year":"2021","journal-title":"Dis Colon Rectum"},{"key":"ref611","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/bjs.6456","article-title":"A predictive model for local recurrence after transanal endoscopic microsurgery for rectal cancer","volume":"96","author":"S P Bach","year":"2009","journal-title":"Br J Surg"},{"key":"ref612","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s10350-004-0900-9","article-title":"Immediate radical resection after local excision of rectal cancer: an oncologic compromise?","volume":"48","author":"D Hahnloser","year":"2005","journal-title":"Dis Colon Rectum"},{"key":"ref613","first-page":"CD003145","article-title":"Short term benefits for laparoscopic colorectal resection","author":"W Schwenk","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"ref614","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.ejso.2007.11.004","article-title":"Laparoscopic versus open colorectal resection for cancer: a meta-analysis of results of randomized controlled trials on recurrence","volume":"34","author":"Y Liang","year":"2008","journal-title":"Eur J Surg Oncol"},{"key":"ref615","first-page":"CD003432","article-title":"Long-term results of laparoscopic colorectal cancer resection","author":"E Kuhry","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"ref616","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1016\/S0140-6736(05)66545-2","article-title":"Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial","volume":"365","author":"P J Guillou","year":"2005","journal-title":"Lancet"},{"key":"ref617","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1002\/bjs.7160","article-title":"Five-year follow-up of the Medical Research Council CLASICC trial of laparoscopically assisted versus open surgery for colorectal cancer","volume":"97","author":"D G Jayne","year":"2010","journal-title":"Br J Surg"},{"issue":"09","key":"ref618","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1111\/ans.17972","article-title":"Laparoscopic versus open surgery for elderly patients with colorectal cancer: a systematic review and meta-analysis of matched studies","volume":"92","author":"W Luo","year":"2022","journal-title":"ANZ J Surg"},{"issue":"05","key":"ref619","doi-asserted-by":"crossref","first-page":"e2210861","DOI":"10.1001\/jamanetworkopen.2022.10861","article-title":"Comparison of Survival Among Adults With Rectal Cancer Who Have Undergone Laparoscopic vs Open Surgery: A Meta-analysis","volume":"5","author":"M Kong","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"10","key":"ref620","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1097\/DCR.0000000000002535","article-title":"Patient-Related Functional Outcomes After Robotic-Assisted Rectal Surgery Compared With a Laparoscopic Approach: A Systematic Review and Meta-analysis","volume":"65","author":"J Flynn","year":"2022","journal-title":"Dis Colon Rectum"},{"issue":"05","key":"ref621","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1007\/s00268-023-06936-3","article-title":"Multidimensional Quality of Life After Robotic Versus Laparoscopic Surgery for Rectal Cancer: A Systematic Review and Meta-Analysis","volume":"47","author":"R Martins","year":"2023","journal-title":"World J Surg"},{"issue":"03","key":"ref622","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/ans.18075","article-title":"Operative and oncological outcomes after robotic rectal resection compared with laparoscopy: a systematic review and meta-analysis","volume":"93","author":"J Flynn","year":"2023","journal-title":"ANZ J Surg"},{"key":"ref623","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1245\/s10434-009-0487-4","article-title":"A systematic review and meta-analysis of cytoreductive surgery with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal origin","volume":"16","author":"C Cao","year":"2009","journal-title":"Ann Surg Oncol"},{"issue":"03","key":"ref624","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/PPO.0b013e3181a58d67","article-title":"Management of peritoneal carcinomatosis from colorectal cancer: current state of practice","volume":"15","author":"E Cotte","year":"2009","journal-title":"Cancer J"},{"issue":"05","key":"ref625","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1200\/JCO.2008.19.7160","article-title":"Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin","volume":"27","author":"D Elias","year":"2009","journal-title":"J Clin Oncol"},{"key":"ref626","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1200\/JCO.2003.04.187","article-title":"Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer","volume":"21","author":"V J Verwaal","year":"2003","journal-title":"J Clin Oncol"},{"key":"ref627","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1046\/j.1365-2168.2002.02148.x","article-title":"Systematic review of the efficacy and safety of colorectal stents","volume":"89","author":"U P Khot","year":"2002","journal-title":"Br J Surg"},{"issue":"01","key":"ref628","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/jso.26868","article-title":"Timing of resection of synchronous colorectal liver metastasis: A systematic review and meta-analysis","volume":"126","author":"J Gumiero","year":"2022","journal-title":"J\u00a0Surg Oncol"},{"issue":"01","key":"ref629","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1186\/s40001-022-00937-z","article-title":"Safety and long-term prognosis of simultaneous versus staged resection in synchronous colorectal cancer with liver metastasis: a systematic review and meta-analysis","volume":"27","author":"S Wang","year":"2022","journal-title":"Eur J Med Res"},{"issue":"08","key":"ref630","first-page":"e1617","article-title":"Simultaneous versus staged major hepatectomy (\u22653 liver segments) for outcomes of synchronous colorectal liver metastases: A systematic review and meta-analysis","volume":"5","author":"J Liu","year":"2022","journal-title":"Cancer Rep (Hoboken)"},{"key":"ref631","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s00268-009-0366-y","article-title":"Meta-analysis of survival of patients with stage IV colorectal cancer managed with surgical resection versus chemotherapy alone","volume":"34","author":"A P Stillwell","year":"2010","journal-title":"World J Surg"},{"key":"ref632","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1200\/JCO.2008.20.9817","article-title":"Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatment","volume":"27","author":"G A Poultsides","year":"2009","journal-title":"J Clin Oncol"},{"key":"ref633","doi-asserted-by":"crossref","first-page":"16516","DOI":"10.1038\/srep16516","article-title":"Primary Tumor Resection Is Associated with Improved Survival in Stage IV Colorectal Cancer: An Instrumental Variable Analysis","volume":"5","author":"H Xu","year":"2015","journal-title":"Sci Rep"},{"issue":"02","key":"ref634","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ejca.2014.10.023","article-title":"Is primary tumour resection associated with survival improvement in patients with colorectal cancer and unresectable synchronous metastases? A pooled analysis of individual data from four randomised trials","volume":"51","author":"M Faron","year":"2015","journal-title":"Eur J Cancer"},{"issue":"05","key":"ref635","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1177\/0003134820919729","article-title":"Is Primary Tumor Excision and Specific Metastases Sites Resection Associated With Improved Survival in Stage \u2163 Colorectal Cancer? Results From SEER Database Analysis","volume":"86","author":"C Yi","year":"2020","journal-title":"Am Surg"},{"issue":"10","key":"ref636","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1200\/JCO.20.02447","article-title":"Primary Tumor Resection Plus Chemotherapy Versus Chemotherapy Alone for Colorectal Cancer Patients With Asymptomatic, Synchronous Unresectable Metastases (JCOG1007; iPACS): A Randomized Clinical Trial","volume":"39","author":"Y Kanemitsu","year":"2021","journal-title":"J Clin Oncol"},{"key":"ref637","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.1200\/JCO.2023.41.16_suppl.3517","article-title":"Upfront palliative resection of primary tumor versus no resection in patients with synchronous metastatic colorectal cancer: The randomized phase 3 CAIRO4 study of the Dutch Colorectal Cancer Group (DCCG)","volume":"41","author":"M Koopman","year":"2023","journal-title":"Journal of Clinical Oncology"},{"key":"ref638","first-page":"JCO2301540","article-title":"Primary Tumor Resection Before Systemic Therapy in Patients With Colon Cancer and Unresectable Metastases: Combined Results of the SYNCHRONOUS and CCRe-IV Trials","author":"N Rahbari","year":"2024","journal-title":"J Clin Oncol"},{"key":"ref639","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.prp.2008.03.002","article-title":"Familial adenomatous polyposis and the small bowel: a loco-regional review and current management strategies","volume":"204","author":"O C Will","year":"2008","journal-title":"Pathol Res Pract"},{"key":"ref640","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s003840050072","article-title":"Pathological features of rectal cancer after preoperative radiochemotherapy","volume":"12","author":"O Dworak","year":"1997","journal-title":"Int J Colorectal Dis"},{"issue":"08","key":"ref641","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1002\/ijc.29221","article-title":"Lymph node count and prognosis in colorectal cancer: the influence of examination quality","volume":"136","author":"H Bl\u00e4ker","year":"2015","journal-title":"Int J Cancer"},{"key":"ref642","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/00000658-200204000-00002","article-title":"Prognostic evaluation of stage B colon cancer patients is improved by an adequate lymphadenectomy: results of a secondary analysis of a large scale adjuvant trial","volume":"235","author":"M Prandi","year":"2002","journal-title":"Ann Surg"},{"key":"ref643","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/ajg.2009.578","article-title":"Negative lymph node count is associated with survival of colorectal cancer patients, independent of tumoral molecular alterations and lymphocytic reaction","volume":"105","author":"S Ogino","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"ref644","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1245\/ASO.2003.03.058","article-title":"The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined","volume":"10","author":"R S Swanson","year":"2003","journal-title":"Ann Surg Oncol"},{"key":"ref645","first-page":"345","article-title":"The impact of number of lymph nodes removed on five-year survival in stage II colon and rectal cancer","volume":"102","author":"H Carloss","year":"2004","journal-title":"J Ky Med Assoc"},{"key":"ref646","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1111\/j.1572-0241.2005.00319.x","article-title":"Association between colonic screening, subject characteristics, and stage of colorectal cancer","volume":"100","author":"L Fazio","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"ref647","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1001\/jama.298.18.2149","article-title":"Hospital lymph node examination rates and survival after resection for colon cancer","volume":"298","author":"S L Wong","year":"2007","journal-title":"JAMA"},{"key":"ref648","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/SLA.0b013e318197f2c8","article-title":"Should total number of lymph nodes be used as a quality of care measure for stage III colon cancer?","volume":"249","author":"J Wang","year":"2009","journal-title":"Ann Surg"},{"key":"ref649","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/SLA.0b013e3181ffa780","article-title":"Lymph node ratio as a quality and prognostic indicator in stage III colon cancer","volume":"253","author":"S L Chen","year":"2011","journal-title":"Ann Surg"},{"key":"ref650","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1245\/s10434-010-1528-8","article-title":"Ratio of metastatic to resected lymph nodes enhances to predict survival in patients with stage III colorectal cancer","volume":"18","author":"H B Qiu","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"ref651","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/SLA.0b013e3181e61e33","article-title":"Influence of preoperative chemoradiotherapy on the number of lymph nodes retrieved in rectal cancer","volume":"252","author":"Y H Ha","year":"2010","journal-title":"Ann Surg"},{"key":"ref652","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1200\/JCO.2009.24.1448","article-title":"Complete mesocolic excision with central vascular ligation produces an oncologically superior specimen compared with standard surgery for carcinoma of the colon","volume":"28","author":"N P West","year":"2010","journal-title":"J Clin Oncol"},{"key":"ref653","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1463-1318.2009.02153.x","article-title":"Clinical significance of macroscopic completeness of mesorectal resection in rectal cancer","volume":"13","author":"J S Leite","year":"2011","journal-title":"Colorectal Dis"},{"key":"ref654","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0140-6736(09)60485-2","article-title":"Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial","volume":"373","author":"P Quirke","year":"2009","journal-title":"Lancet"},{"key":"ref655","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.1200\/JCO.2007.14.5961","article-title":"Evidence of the oncologic superiority of cylindrical abdominoperineal excision for low rectal cancer","volume":"26","author":"N P West","year":"2008","journal-title":"J Clin Oncol"},{"key":"ref656","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1007\/DCR.0b013e3181b54fbd","article-title":"The influence of circumferential resection margins on long-term outcomes following rectal cancer surgery","volume":"52","author":"H S Tilney","year":"2009","journal-title":"Dis Colon Rectum"},{"key":"ref657","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1002\/bjs.6739","article-title":"Circumferential resection margin as a prognostic factor in rectal cancer","volume":"96","author":"T E Bernstein","year":"2009","journal-title":"Br J Surg"},{"issue":"23","key":"ref658","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1056\/NEJMoa2017699","article-title":"Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer","volume":"383","author":"T Andr\u00e9","year":"2020","journal-title":"N Engl J Med"},{"issue":"02","key":"ref659","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1200\/JCO.21.01015","article-title":"First-Line Nivolumab Plus Low-Dose Ipilimumab for Microsatellite Instability-High\/Mismatch Repair-Deficient Metastatic Colorectal Cancer: The Phase II CheckMate 142 Study","volume":"40","author":"H Lenz","year":"2022","journal-title":"J Clin Oncol"},{"key":"ref660","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1056\/NEJMoa022289","article-title":"Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer","volume":"349","author":"C M Ribic","year":"2003","journal-title":"N Engl J Med"},{"issue":"20","key":"ref661","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1200\/JCO.2009.27.1825","article-title":"Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer","volume":"28","author":"D Sargent","year":"2010","journal-title":"J Clin Oncol"},{"issue":"11","key":"ref662","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1093\/jnci\/djr153","article-title":"DNA mismatch repair status and colon cancer recurrence and survival in clinical trials of 5-fluorouracil-based adjuvant therapy","volume":"103","author":"F Sinicrope","year":"2011","journal-title":"J Natl Cancer Inst"},{"issue":"S 03","key":"ref663","doi-asserted-by":"crossref","first-page":"S630","DOI":"10.1245\/s10434-015-4807-6","article-title":"Defective Mismatch Repair Status was not Associated with DFS and OS in Stage II Colon Cancer Treated with Adjuvant Chemotherapy","volume":"22","author":"J Kim","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"ref664","doi-asserted-by":"crossref","first-page":"LBA5","DOI":"10.1200\/JCO.2022.40.17_suppl.LBA5","article-title":"Single agent PD-1 blockade as curative-intent treatment in mismatch repair deficient locally advanced rectal cancer","volume":"40","author":"A Cercek","year":"2022","journal-title":"Journal of Clinical Oncology"},{"issue":"04","key":"ref665","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/s41591-020-0805-8","article-title":"Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers","volume":"26","author":"M Chalabi","year":"2020","journal-title":"Nat Med"},{"issue":"06","key":"ref666","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1001\/jamaoncol.2018.0104","article-title":"Assessment of Tumor Sequencing as a Replacement for Lynch Syndrome Screening and Current Molecular Tests for Patients With Colorectal Cancer","volume":"4","author":"H Hampel","year":"2018","journal-title":"JAMA Oncol"},{"key":"ref667","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1200\/JCO.2014.59.4812","article-title":"Fluorouracil, leucovorin, and irinotecan plus cetuximab treatment and RAS mutations in colorectal cancer","volume":"33","author":"E Van Cutsem","year":"2015","journal-title":"J Clin Oncol"},{"issue":"17","key":"ref668","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1056\/NEJMoa1908075","article-title":"Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer","volume":"381","author":"S Kopetz","year":"2019","journal-title":"N Engl J Med"},{"issue":"01","key":"ref669","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S1470-2045(21)00605-7","article-title":"Sotorasib for previously treated colorectal cancers with KRAS G12C mutation (CodeBreaK100): a prespecified analysis of a single-arm, phase 2 trial","volume":"23","author":"M Fakih","year":"2022","journal-title":"Lancet Oncol"},{"issue":"23","key":"ref670","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1056\/NEJMoa2308795","article-title":"Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12C","volume":"389","author":"M Fakih","year":"2023","journal-title":"N Engl J Med"},{"issue":"01","key":"ref671","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1056\/NEJMoa2212419","article-title":"Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS G12C","volume":"388","author":"R Yaeger","year":"2023","journal-title":"N Engl J Med"},{"key":"ref672","doi-asserted-by":"crossref","first-page":"4623","DOI":"10.1002\/cncr.26086","article-title":"Impact of BRAF mutation and microsatellite instability on the pattern of metastatic spread and prognosis in metastatic colorectal cancer","volume":"117","author":"B Tran","year":"2011","journal-title":"Cancer"},{"key":"ref673","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1200\/JCO.2011.38.0915","article-title":"Phase III trial of cetuximab with continuous or intermittent fluorouracil, leucovorin, and oxaliplatin (Nordic FLOX) versus FLOX alone in first-line treatment of metastatic colorectal cancer: the NORDIC-VII study","volume":"30","author":"K M Tveit","year":"2012","journal-title":"J Clin Oncol"},{"key":"ref674","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.ejca.2015.01.054","article-title":"Predictive role of BRAF mutations in patients with advanced colorectal cancer receiving cetuximab and panitumumab: a meta-analysis","volume":"51","author":"F Pietrantonio","year":"2015","journal-title":"Eur J Cancer"},{"key":"ref675","doi-asserted-by":"crossref","first-page":"5322","DOI":"10.1158\/1078-0432.CCR-14-0332","article-title":"Mismatch repair status and BRAF mutation status in metastatic colorectal cancer patients: a pooled analysis of the CAIRO, CAIRO2, COIN, and FOCUS studies","volume":"20","author":"S Venderbosch","year":"2014","journal-title":"Clin Cancer Res"},{"key":"ref676","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1038\/sj.onc.1208569","article-title":"BRAF-V600E is not involved in the colorectal tumorigenesis of HNPCC in patients with functional MLH1 and MSH2 genes","volume":"24","author":"E Domingo","year":"2005","journal-title":"Oncogene"},{"key":"ref677","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1093\/annonc\/mdv290","article-title":"BRAF codons 594 and 596 mutations identify a new molecular subtype of metastatic colorectal cancer at favorable prognosis","volume":"26","author":"C Cremolini","year":"2015","journal-title":"Ann Oncol"},{"key":"ref678","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1056\/NEJMoa1305275","article-title":"Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer","volume":"369","author":"J Y Douillard","year":"2013","journal-title":"N Engl J Med"},{"key":"ref679","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/annonc\/mdu378","article-title":"Extended RAS mutations and anti-EGFR monoclonal antibody survival benefit in metastatic colorectal cancer: a meta-analysis of randomized, controlled trials","volume":"26","author":"M J Sorich","year":"2015","journal-title":"Ann Oncol"},{"key":"ref680","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/S1470-2045(16)30269-8","article-title":"FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab for metastatic colorectal cancer (FIRE-3): a post-hoc analysis of tumour dynamics in the final RAS wild-type subgroup of this randomised open-label phase 3 trial","volume":"17","author":"S Stintzing","year":"2016","journal-title":"Lancet Oncol"},{"key":"ref681","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/sj.bjc.6604009","article-title":"PTEN loss of expression predicts cetuximab efficacy in metastatic colorectal cancer patients","volume":"97","author":"M Frattini","year":"2007","journal-title":"Br J Cancer"},{"key":"ref682","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.ejca.2015.04.007","article-title":"FOLFOX4 plus cetuximab treatment and RAS mutations in colorectal cancer","volume":"51","author":"C Bokemeyer","year":"2015","journal-title":"Eur J Cancer"},{"key":"ref683","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/annonc\/mdt523","article-title":"Final results from a randomized phase 3 study of FOLFIRI {+\/-} panitumumab for second-line treatment of metastatic colorectal cancer","volume":"25","author":"M Peeters","year":"2014","journal-title":"Ann Oncol"},{"key":"ref684","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1056\/NEJMoa0804385","article-title":"K-ras mutations and benefit from cetuximab in advanced colorectal cancer","volume":"359","author":"C S Karapetis","year":"2008","journal-title":"N Engl J Med"},{"issue":"12","key":"ref685","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.prp.2009.07.010","article-title":"Frequency and type of KRAS mutations in routine diagnostic analysis of metastatic colorectal cancer","volume":"205","author":"J Neumann","year":"2009","journal-title":"Pathol Res Pract"},{"issue":"07","key":"ref686","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/bjc.2017.37","article-title":"Specific mutations in KRAS codon 12 are associated with worse overall survival in patients with advanced and recurrent colorectal cancer","volume":"116","author":"R Jones","year":"2017","journal-title":"Br J Cancer"},{"issue":"16","key":"ref687","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1038\/s41388-018-0634-0","article-title":"Impact of RAS mutation subtype on clinical outcome-a cross-entity comparison of patients with advanced non-small cell lung cancer and colorectal cancer","volume":"38","author":"M Wiesweg","year":"2019","journal-title":"Oncogene"},{"issue":"02","key":"ref689","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1056\/NEJMc2030638","article-title":"Distribution of KRAS G12C Somatic Mutations across Race, Sex, and Cancer Type","volume":"384","author":"A Nassar","year":"2021","journal-title":"N Engl J Med"},{"key":"ref690","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/ijc.30089","article-title":"Impact of KRAS, BRAF, PIK3CA, TP53 status and intraindividual mutation heterogeneity on outcome after liver resection for colorectal cancer metastases","volume":"139","author":"I M Loes","year":"2016","journal-title":"Int J Cancer"},{"issue":"08","key":"ref691","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1093\/annonc\/mdw235","article-title":"ESMO consensus guidelines for the management of patients with metastatic colorectal cancer","volume":"27","author":"E Van Cutsem","year":"2016","journal-title":"Ann Oncol"},{"issue":"06","key":"ref692","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/bjc.2011.26","article-title":"KRAS mutation analysis: a comparison between primary tumours and matched liver metastases in 305 colorectal cancer patients","volume":"104","author":"N Knijn","year":"2011","journal-title":"Br J Cancer"},{"key":"ref693","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/ijc.30089","article-title":"Impact of KRAS, BRAF, PIK3CA, TP53 status and intraindividual mutation heterogeneity on outcome after liver resection for colorectal cancer metastases","volume":"139","author":"I M Loes","year":"2016","journal-title":"Int J Cancer"},{"key":"ref694","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ejca.2016.10.007","article-title":"The relevance of primary tumour location in patients with metastatic colorectal cancer: A meta-analysis of first-line clinical trials","volume":"70","author":"J Holch","year":"2017","journal-title":"Eur J Cancer"},{"key":"ref695","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1093\/annonc\/mdx175","article-title":"Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials","volume":"28","author":"D Arnold","year":"2017","journal-title":"Ann Oncol"},{"issue":"02","key":"ref696","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1001\/jamaoncol.2016.3797","article-title":"Prognostic and Predictive Relevance of Primary Tumor Location in Patients With RAS Wild-Type Metastatic Colorectal Cancer: Retrospective Analyses of the CRYSTAL and FIRE-3 Trials","volume":"3","author":"S Tejpar","year":"2017","journal-title":"JAMA Oncol"},{"issue":"03","key":"ref697","doi-asserted-by":"crossref","first-page":"dju427","DOI":"10.1093\/jnci\/dju427","article-title":"Primary tumor location as a prognostic factor in metastatic colorectal cancer","volume":"107","author":"F Loupakis","year":"2015","journal-title":"J Natl Cancer Inst"},{"issue":"15","key":"ref698","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1001\/jama.2023.4428","article-title":"Panitumumab vs Bevacizumab Added to Standard First-line Chemotherapy and Overall Survival Among Patients With RAS Wild-type, Left-Sided Metastatic Colorectal Cancer: A Randomized Clinical Trial","volume":"329","author":"J Watanabe","year":"2023","journal-title":"JAMA"},{"issue":"03","key":"ref699","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1001\/jamaoncol.2018.5080","article-title":"Rechallenge for Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer With Acquired Resistance to First-line Cetuximab and Irinotecan: A Phase 2 Single-Arm Clinical Trial","volume":"5","author":"C Cremolini","year":"2019","journal-title":"JAMA Oncol"},{"issue":"10","key":"ref700","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1001\/jamaoncol.2021.2915","article-title":"Cetuximab Rechallenge Plus Avelumab in Pretreated Patients With RAS Wild-type Metastatic Colorectal Cancer: The Phase 2 Single-Arm Clinical CAVE Trial","volume":"7","author":"E Martinelli","year":"2021","journal-title":"JAMA Oncol"},{"issue":"08","key":"ref701","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1038\/s41591-022-01886-0","article-title":"Circulating tumor DNA to guide rechallenge with panitumumab in metastatic colorectal cancer: the phase 2 CHRONOS trial","volume":"28","author":"A Sartore-Bianchi","year":"2022","journal-title":"Nat Med"},{"key":"ref702","doi-asserted-by":"crossref","first-page":"e2200688","DOI":"10.1200\/PO.22.00688","article-title":"Clinical Validation of Plasma-Based Genotyping for RAS and BRAF V600E Mutation in Metastatic Colorectal Cancer: SCRUM-Japan GOZILA Substudy","volume":"7","author":"Y Aoki","year":"2023","journal-title":"JCO Precis Oncol"},{"key":"ref703","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ejca.2021.05.010","article-title":"NeoRAS wild-type in metastatic colorectal cancer: Myth or truth? -Case series and review of the literature","volume":"153","author":"H Osumi","year":"2021","journal-title":"Eur J Cancer"},{"issue":"06","key":"ref704","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/S1470-2045(16)00150-9","article-title":"Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12\/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial","volume":"17","author":"A Sartore-Bianchi","year":"2016","journal-title":"Lancet Oncol"},{"issue":"09","key":"ref705","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/S1470-2045(21)00336-3","article-title":"Pertuzumab and trastuzumab for HER2-positive, metastatic biliary tract cancer (MyPathway): a multicentre, open-label, phase 2a, multiple basket study","volume":"22","author":"M Javle","year":"2021","journal-title":"Lancet Oncol"},{"issue":"06","key":"ref706","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S1470-2045(21)00086-3","article-title":"Trastuzumab deruxtecan (DS-8201) in patients with HER2-expressing metastatic colorectal cancer (DESTINY-CRC01): a multicentre, open-label, phase 2 trial","volume":"22","author":"S Siena","year":"2021","journal-title":"Lancet Oncol"},{"issue":"05","key":"ref707","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S1470-2045(23)00150-X","article-title":"Tucatinib plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer (MOUNTAINEER): a multicentre, open-label, phase 2 study","volume":"24","author":"J Strickler","year":"2023","journal-title":"Lancet Oncol"},{"issue":"10","key":"ref708","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1634\/theoncologist.2018-0785","article-title":"HER2 Positivity Predicts Unresponsiveness to EGFR-Targeted Treatment in Metastatic Colorectal Cancer","volume":"24","author":"A Sartore-Bianchi","year":"2019","journal-title":"Oncologist"},{"issue":"04","key":"ref709","first-page":"361","article-title":"[HER2 testing in gastric cancer: Results of a meeting of German experts]","volume":"37","author":"G Baretton","year":"2016","journal-title":"Pathologe"},{"issue":"11","key":"ref710","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1038\/modpathol.2015.98","article-title":"Assessment of a HER2 scoring system for colorectal cancer: results from a validation study","volume":"28","author":"E Valtorta","year":"2015","journal-title":"Mod Pathol"},{"key":"ref711","first-page":"1","article-title":"HER2 in Colorectal Cancer: The Long and Winding Road From Negative Predictive Factor to Positive Actionable Target","volume":"42","author":"Djaballah S Ahcene","year":"2022","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"12","key":"ref712","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djx089","article-title":"ALK, ROS1, and NTRK Rearrangements in Metastatic Colorectal Cancer","volume":"109","author":"F Pietrantonio","year":"2017","journal-title":"J Natl Cancer Inst"},{"issue":"09","key":"ref713","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1093\/annonc\/mdz204","article-title":"ESMO recommendations on the standard methods to detect NTRK fusions in daily practice and clinical research","volume":"30","author":"C Marchi\u00f2","year":"2019","journal-title":"Ann Oncol"},{"issue":"04","key":"ref714","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S1470-2045(19)30856-3","article-title":"Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1\/2 clinical trials","volume":"21","author":"D Hong","year":"2020","journal-title":"Lancet Oncol"},{"issue":"02","key":"ref715","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1470-2045(19)30691-6","article-title":"Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1-2 trials","volume":"21","author":"R Doebele","year":"2020","journal-title":"Lancet Oncol"},{"issue":"11","key":"ref716","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1097\/PAS.0000000000000911","article-title":"Pan-Trk Immunohistochemistry Is an Efficient and Reliable Screen for the Detection of NTRK Fusions","volume":"41","author":"J Hechtman","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"ref717","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1200\/JCO.2023.41.16_suppl.3507","article-title":"Phase III FIRE-4 study (AIO KRK-0114): Influence of baseline liquid biopsy results in first-line treatment efficacy of FOLFIRI\/cetuximab in patients with tissue RAS-WT mCRC","volume":"41","author":"S Stintzing","year":"2023","journal-title":"Journal of Clinical Oncology"},{"issue":"03","key":"ref718","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/s41416-022-01816-4","article-title":"Circulating tumour DNA and its clinical utility in predicting treatment response or survival in patients with metastatic colorectal cancer: a systematic review and meta-analysis","volume":"127","author":"L Callesen","year":"2022","journal-title":"Br J Cancer"},{"issue":"01","key":"ref719","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1245\/s10434-022-12641-7","article-title":"Circulating Tumor DNA, Imaging, and Carcinoembryonic Antigen: Comparison of Surveillance Strategies Among Patients Who Underwent Resection of Colorectal Cancer-A Systematic Review and Meta-analysis","volume":"30","author":"Z Dawood","year":"2023","journal-title":"Ann Surg Oncol"},{"issue":"02","key":"ref720","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/s41416-022-02017-9","article-title":"The utility of ctDNA in detecting minimal residual disease following curative surgery in colorectal cancer: a systematic review and meta-analysis","volume":"128","author":"L Faulkner","year":"2023","journal-title":"Br J Cancer"},{"issue":"346","key":"ref721","first-page":"346ra92","article-title":"Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer","volume":"8","author":"J Tie","year":"2016","journal-title":"Sci Transl Med"},{"issue":"08","key":"ref722","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1001\/jamaoncol.2019.0512","article-title":"Prognostic Potential of Circulating Tumor DNA Measurement in Postoperative Surveillance of Nonmetastatic Colorectal Cancer","volume":"5","author":"Y Wang","year":"2019","journal-title":"JAMA Oncol"},{"issue":"08","key":"ref723","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1001\/jamaoncol.2019.0528","article-title":"Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients With Stages I to III Colorectal Cancer","volume":"5","author":"T Reinert","year":"2019","journal-title":"JAMA Oncol"},{"issue":"11","key":"ref724","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1093\/annonc\/mdz390","article-title":"Targeted next-generation sequencing of circulating-tumor DNA for tracking minimal residual disease in localized colon cancer","volume":"30","author":"N Tarazona","year":"2019","journal-title":"Ann Oncol"},{"issue":"12","key":"ref725","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1001\/jamaoncol.2019.3616","article-title":"Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer","volume":"5","author":"J Tie","year":"2019","journal-title":"JAMA Oncol"},{"issue":"08","key":"ref726","first-page":"760","article-title":"Circulating Tumor DNA Guiding Adjuvant Therapy in Colon Cancer Reply","volume":"387","author":"J Tie","year":"2022","journal-title":"N Engl J Med"},{"issue":"20","key":"ref727","doi-asserted-by":"crossref","first-page":"5586","DOI":"10.1158\/1078-0432.CCR-21-0410","article-title":"Minimal Residual Disease Detection using a Plasma-only Circulating Tumor DNA Assay in Patients with Colorectal Cancer","volume":"27","author":"A Parikh","year":"2021","journal-title":"Clin Cancer Res"},{"issue":"03","key":"ref728","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1158\/1078-0432.CCR-21-2404","article-title":"Circulating Tumor DNA in Stage III Colorectal Cancer, beyond Minimal Residual Disease Detection, toward Assessment of Adjuvant Therapy Efficacy and Clinical Behavior of Recurrences","volume":"28","author":"T Henriksen","year":"2022","journal-title":"Clin Cancer Res"},{"issue":"01","key":"ref729","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41591-022-02115-4","article-title":"Molecular residual disease and efficacy of adjuvant chemotherapy in patients with colorectal cancer","volume":"29","author":"D Kotani","year":"2023","journal-title":"Nat Med"},{"issue":"7404","key":"ref730","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/nature11156","article-title":"Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer","volume":"486","author":"S Misale","year":"2012","journal-title":"Nature"},{"issue":"7404","key":"ref731","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nature11219","article-title":"The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers","volume":"486","author":"L Diaz","year":"2012","journal-title":"Nature"},{"key":"ref734","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1002\/bjs.10183","article-title":"Prognosis of patients with colonic carcinoma before, during and after implementation of complete mesocolic excision","volume":"103","author":"S Merkel","year":"2016","journal-title":"Br J Surg"},{"key":"ref735","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1001\/jama.2011.749","article-title":"Association between time to initiation of adjuvant chemotherapy and survival in colorectal cancer: a systematic review and meta-analysis","volume":"305","author":"J J Biagi","year":"2011","journal-title":"JAMA"},{"key":"ref736","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.ejca.2010.01.020","article-title":"Does delaying adjuvant chemotherapy after curative surgery for colorectal cancer impair survival? A meta-analysis","volume":"46","author":"G Des Guetz","year":"2010","journal-title":"Eur J Cancer"},{"key":"ref737","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1016\/j.ejca.2015.08.016","article-title":"Timing of adjuvant chemotherapy and its relation to survival among patients with stage III colon cancer","volume":"51","author":"A C Bos","year":"2015","journal-title":"Eur J Cancer"},{"key":"ref738","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1002\/cncr.25720","article-title":"Does delay of adjuvant chemotherapy impact survival in patients with resected stage II and III colon adenocarcinoma?","volume":"117","author":"U D Bayraktar","year":"2011","journal-title":"Cancer"},{"key":"ref739","doi-asserted-by":"crossref","first-page":"3833","DOI":"10.1002\/cncr.25954","article-title":"Association between receipt and timing of adjuvant chemotherapy and survival for patients with stage III colon cancer in Alberta, Canada","volume":"117","author":"I S Lima","year":"2011","journal-title":"Cancer"},{"key":"ref740","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/codi.13308","article-title":"Initiation of adjuvant chemotherapy within 8 weeks of elective colorectal resection improves overall survival regardless of reoperation","volume":"18","author":"S Nachiappan","year":"2016","journal-title":"Colorectal Dis"},{"issue":"01","key":"ref741","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1186\/s12885-023-10863-w","article-title":"The optimal time of starting adjuvant chemotherapy after curative surgery in patients with colorectal cancer","volume":"23","author":"Y Yang","year":"2023","journal-title":"BMC Cancer"},{"key":"ref742","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/BF02055679","article-title":"Adjuvant chemotherapy in colorectal carcinoma: results of a meta-analysis","volume":"40","author":"S Dube","year":"1997","journal-title":"Dis Colon Rectum"},{"key":"ref743","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1200\/JCO.2004.09.059","article-title":"Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?","volume":"22","author":"S Gill","year":"2004","journal-title":"J Clin Oncol"},{"key":"ref744","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1056\/NEJMoa010957","article-title":"A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients","volume":"345","author":"D J Sargent","year":"2001","journal-title":"N Engl J Med"},{"key":"ref745","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/0016-5085(94)90748-X","article-title":"Folinic acid and 5-fluorouracil as adjuvant chemotherapy in colon cancer","volume":"106","author":"G Francini","year":"1994","journal-title":"Gastroenterology"},{"issue":"01","key":"ref746","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1200\/JCO.1997.15.1.246","article-title":"Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer","volume":"15","author":"M O\u02bcConnell","year":"1997","journal-title":"J Clin Oncol"},{"key":"ref747","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0140-6736(95)90696-7","article-title":"Efficacy of adjuvant fluorouracil and folinic acid in colon cancer International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) investigators","volume":"345","year":"1995","journal-title":"Lancet"},{"key":"ref748","doi-asserted-by":"crossref","first-page":"47","DOI":"10.6004\/jnccn.2016.0006","article-title":"Use and Effectiveness of Adjuvant Chemotherapy for Stage III Colon Cancer: A Population-Based Study","volume":"14","author":"C M Booth","year":"2016","journal-title":"J Natl Compr Canc Netw"},{"key":"ref749","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1200\/JCO.2012.42.5645","article-title":"Adjuvant therapy with fluorouracil and oxaliplatin in stage II and elderly patients (between ages 70 and 75 years) with colon cancer: subgroup analyses of the Multicenter International Study of Oxaliplatin, Fluorouracil, and Leucovorin in the Adjuvant Treatment of Colon Cancer trial","volume":"30","author":"C Tournigand","year":"2012","journal-title":"J Clin Oncol"},{"key":"ref750","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1093\/annonc\/mdv003","article-title":"Impact of age and medical comorbidity on adjuvant treatment outcomes for stage III colon cancer: a pooled analysis of individual patient data from four randomized, controlled trials","volume":"26","author":"D G Haller","year":"2015","journal-title":"Ann Oncol"},{"key":"ref751","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.1200\/JCO.2015.60.9107","article-title":"Capecitabine Plus Oxaliplatin Compared With Fluorouracil\/Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer: Final Results of the NO16968 Randomized Controlled Phase III Trial","volume":"33","author":"H J Schmoll","year":"2015","journal-title":"J Clin Oncol"},{"key":"ref752","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1200\/JCO.2013.49.6638","article-title":"Impact of age on the efficacy of newer adjuvant therapies in patients with stage II\/III colon cancer: findings from the ACCENT database","volume":"31","author":"N J McCleary","year":"2013","journal-title":"J Clin Oncol"},{"key":"ref753","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1002\/cncr.10430","article-title":"Efficacy and toxicity of adjuvant chemotherapy in elderly patients with colon carcinoma: a 10-year experience of the Geisinger Medical Center","volume":"94","author":"F Fata","year":"2002","journal-title":"Cancer"},{"issue":"19","key":"ref754","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1200\/JCO.23.01326","article-title":"Oxaliplatin-Based Adjuvant Chemotherapy in Older Patients With Stage III Colon Cancer: An ACCENT\/IDEA Pooled Analysis of 12 Trials","volume":"42","author":"C Gallois","year":"2024","journal-title":"J Clin Oncol"},{"key":"ref755","first-page":"379","article-title":"Adjuvant therapy for stage II colon cancer after complete resection Provincial Gastrointestinal Disease Site Group","volume":"1","author":"A Figueredo","year":"1997","journal-title":"Cancer Prev Control"},{"key":"ref756","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1200\/JCO.1999.17.5.1356","article-title":"Efficacy of adjuvant fluorouracil and folinic acid in B2 colon cancer International Multicentre Pooled Analysis of B2 Colon Cancer Trials (IMPACT B2) Investigators","volume":"17","year":"1999","journal-title":"J Clin Oncol"},{"key":"ref757","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1200\/JCO.1999.17.5.1349","article-title":"Comparative efficacy of adjuvant chemotherapy in patients with Dukes\u02bc B versus Dukes\u02bc C colon cancer: results from four National Surgical Adjuvant Breast and Bowel Project adjuvant studies (C-01, C-02, C-03, and C-04)","volume":"17","author":"E Mamounas","year":"1999","journal-title":"J Clin Oncol"},{"key":"ref758","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1200\/JCO.2004.05.063","article-title":"American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer","volume":"22","author":"A B Benson","year":"2004","journal-title":"J Clin Oncol"},{"key":"ref759","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1016\/S0140-6736(07)61866-2","article-title":"Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study","volume":"370","author":"Collaborative G Quasar","year":"2007","journal-title":"Lancet"},{"key":"ref760","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1200\/JCO.2010.34.3426","article-title":"Adjuvant chemotherapy for stage II colon cancer with poor prognostic features","volume":"29","author":"E S O\u02bcConnor","year":"2011","journal-title":"J Clin Oncol"},{"key":"ref761","doi-asserted-by":"crossref","first-page":"4176","DOI":"10.1200\/JCO.2015.63.4238","article-title":"Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According to BRAF Mutation and Mismatch Repair Status of the MOSAIC Study","volume":"33","author":"T Andre","year":"2015","journal-title":"J Clin Oncol"},{"key":"ref762","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1200\/JCO.1995.13.12.2936","article-title":"Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II\/Dukes\u02bc B2 colon cancer","volume":"13","author":"C G Moertel","year":"1995","journal-title":"J Clin Oncol"},{"key":"ref763","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1054\/bjoc.2001.2117","article-title":"Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III","volume":"85","author":"B G Taal","year":"2001","journal-title":"Br J Cancer"},{"key":"ref764","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/(SICI)1097-0142(19980815)83:4<666::AID-CNCR6>3.0.CO;2-I","article-title":"For patients with Dukes\u02bc B (TNM Stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis","volume":"83","author":"S Caplin","year":"1998","journal-title":"Cancer"},{"key":"ref765","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1200\/JCO.2002.11.084","article-title":"Adjuvant chemotherapy use for Medicare beneficiaries with stage II colon cancer","volume":"20","author":"D Schrag","year":"2002","journal-title":"J Clin Oncol"},{"key":"ref766","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1002\/1097-0142(20010915)92:6<1435::AID-CNCR1467>3.0.CO;2-N","article-title":"High-risk groups of patients with Stage II colon carcinoma","volume":"92","author":"S Merkel","year":"2001","journal-title":"Cancer"},{"key":"ref767","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1136\/gut.51.1.65","article-title":"Identification of objective pathological prognostic determinants and models of prognosis in Dukes\u02bc B colon cancer","volume":"51","author":"V C Petersen","year":"2002","journal-title":"Gut"},{"key":"ref768","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/bjs.5345","article-title":"Population-based study of prognostic factors in stage II colonic cancer","volume":"93","author":"M Morris","year":"2006","journal-title":"Br J Surg"},{"key":"ref769","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1007\/BF02234390","article-title":"Identifying patients with T3-T4 node-negative colon cancer at high risk of recurrence","volume":"44","author":"G Burdy","year":"2001","journal-title":"Dis Colon Rectum"},{"key":"ref770","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/bjs.4780","article-title":"Emergency surgery for colonic cancer in a defined population","volume":"92","author":"P Jestin","year":"2005","journal-title":"Br J Surg"},{"key":"ref771","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/bjs.5269","article-title":"The impact of blood loss, obstruction and perforation on survival in patients undergoing curative resection for colon cancer","volume":"93","author":"C S McArdle","year":"2006","journal-title":"Br J Surg"},{"key":"ref772","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/sj.bjc.6603352","article-title":"Will Rogers revisited: prospective observational study of survival of 3592 patients with colorectal cancer according to number of nodes examined by pathologists","volume":"95","author":"S George","year":"2006","journal-title":"Br J Cancer"},{"key":"ref773","first-page":"602","article-title":"More extensive nodal dissection improves survival for stages I to III of colon cancer: a population-based study","volume":"244","author":"S L Chen","year":"2006","journal-title":"Ann Surg"},{"key":"ref774","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1200\/JCO.1997.15.1.246","article-title":"Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer","volume":"15","author":"M J O\u02bcConnell","year":"1997","journal-title":"J Clin Oncol"},{"key":"ref775","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1200\/JCO.2009.27.1825","article-title":"Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer","volume":"28","author":"D J Sargent","year":"2010","journal-title":"J Clin Oncol"},{"key":"ref776","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1136\/gut.2005.073015","article-title":"Mismatch repair status in the prediction of benefit from adjuvant fluorouracil chemotherapy in colorectal cancer","volume":"55","author":"R Jover","year":"2006","journal-title":"Gut"},{"issue":"S 03","key":"ref777","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1245\/s10434-015-4807-6","article-title":"Defective Mismatch Repair Status was not Associated with DFS and OS in Stage II Colon Cancer Treated with Adjuvant Chemotherapy","volume":"22","author":"J E Kim","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"ref778","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1056\/NEJM199002083220602","article-title":"Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma","volume":"322","author":"C G Moertel","year":"1990","journal-title":"N Engl J Med"},{"key":"ref779","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1002\/(SICI)1097-0142(20000401)88:7<1739::AID-CNCR30>3.0.CO;2-T","article-title":"American Joint Committee on Cancer Prognostic Factors Consensus Conference: Colorectal Working Group","volume":"88","author":"C Compton","year":"2000","journal-title":"Cancer"},{"key":"ref780","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/BF01613004","article-title":"Prognostic grouping: the next step in tumor classification","volume":"116","author":"P Hermanek","year":"1990","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref781","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1093\/annonc\/mdu499","article-title":"Prognosis of stage II and III colon cancer treated with adjuvant 5-fluorouracil or FOLFIRI in relation to microsatellite status: results of the PETACC-3 trial","volume":"26","author":"D Klingbiel","year":"2015","journal-title":"Ann Oncol"},{"key":"ref782","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1200\/JCO.2005.03.2433","article-title":"Immunohistochemical test for MLH1 and MSH2 expression predicts clinical outcome in stage II and III colorectal cancer patients","volume":"24","author":"G Lanza","year":"2006","journal-title":"J Clin Oncol"},{"key":"ref783","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1053\/j.gastro.2006.06.005","article-title":"Prognostic impact of microsatellite instability and DNA ploidy in human colon carcinoma patients","volume":"131","author":"F A Sinicrope","year":"2006","journal-title":"Gastroenterology"},{"key":"ref784","first-page":"104","article-title":"Microsatellite instability is a predictive marker for survival benefit from adjuvant chemotherapy in a population-based series of stage III colorectal carcinoma","volume":"1","author":"H Elsaleh","year":"2001","journal-title":"Clin Colorectal Cancer"},{"key":"ref785","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/ajco.12411","article-title":"Clinicopathological predictors of benefit from adjuvant chemotherapy for stage C colorectal cancer: Microsatellite unstable cases benefit","volume":"11","author":"M L Thomas","year":"2015","journal-title":"Asia Pac J Clin Oncol"},{"issue":"08","key":"ref786","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1200\/JCO.21.02538","article-title":"Adjuvant Therapy for Stage II Colon Cancer: ASCO Guideline Update","volume":"40","author":"N Baxter","year":"2022","journal-title":"J Clin Oncol"},{"key":"ref787","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa1506597","article-title":"CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer","volume":"374","author":"P Dalerba","year":"2016","journal-title":"N Engl J Med"},{"key":"ref788","first-page":"346ra92","article-title":"Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer","volume":"8","author":"J Tie","year":"2016","journal-title":"Sci Transl Med"},{"key":"ref789","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/ijc.29805","article-title":"Analysis of local chronic inflammatory cell infiltrate combined with systemic inflammation improves prognostication in stage II colon cancer independent of standard clinicopathologic criteria","volume":"138","author":"N Turner","year":"2016","journal-title":"Int J Cancer"},{"key":"ref790","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1056\/NEJMoa032709","article-title":"Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer","volume":"350","author":"T Andre","year":"2004","journal-title":"N Engl J Med"},{"key":"ref791","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1200\/JCO.2006.08.2974","article-title":"Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07","volume":"25","author":"J P Kuebler","year":"2007","journal-title":"J Clin Oncol"},{"key":"ref792","doi-asserted-by":"crossref","first-page":"5614","DOI":"10.1002\/cncr.27593","article-title":"Long-term neurotoxicity effects of oxaliplatin added to fluorouracil and leucovorin as adjuvant therapy for colon cancer: results from National Surgical Adjuvant Breast and Bowel Project trials C-07 and LTS-01","volume":"118","author":"K M Kidwell","year":"2012","journal-title":"Cancer"},{"key":"ref794","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/S1470-2045(14)70486-3","article-title":"Effect of adjuvant capecitabine or fluorouracil, with or without oxaliplatin, on survival outcomes in stage III colon cancer and the effect of oxaliplatin on post-relapse survival: a pooled analysis of individual patient data from four randomised controlled trials","volume":"15","author":"H J Schmoll","year":"2014","journal-title":"Lancet Oncol"},{"issue":"21","key":"ref795","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1200\/JCO.2011.41.1140","article-title":"Effect of adjuvant chemotherapy on survival of patients with stage III colon cancer diagnosed after age 75 years","volume":"30","author":"H Sanoff","year":"2012","journal-title":"J Clin Oncol"},{"key":"ref796","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1200\/JCO.2011.36.4539","article-title":"Oxaliplatin as adjuvant therapy for colon cancer: updated results of NSABP C-07 trial, including survival and subset analyses","volume":"29","author":"G Yothers","year":"2011","journal-title":"J Clin Oncol"},{"key":"ref797","doi-asserted-by":"crossref","first-page":"e000087","DOI":"10.1136\/esmoopen-2016-000087","article-title":"Efficacy and toxicity of adjuvant chemotherapy in elderly patients with colorectal cancer: the ACCORE study","volume":"1","author":"C M Lund","year":"2016","journal-title":"ESMO Open"},{"key":"ref798","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1200\/JCO.2011.41.1140","article-title":"Effect of adjuvant chemotherapy on survival of patients with stage III colon cancer diagnosed after age 75 years","volume":"30","author":"H K Sanoff","year":"2012","journal-title":"J Clin Oncol"},{"key":"ref799","first-page":"199","article-title":"Efficacy and safety of single agent or combination adjuvant chemotherapy in elderly patients with colon cancer: a Canadian cancer institute experience","volume":"13","author":"C A Kim","year":"2014","journal-title":"Clin Colorectal Cancer"},{"key":"ref800","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1056\/NEJMoa043116","article-title":"Capecitabine as adjuvant treatment for stage III colon cancer","volume":"352","author":"C Twelves","year":"2005","journal-title":"N Engl J Med"},{"key":"ref803","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.1200\/JCO.2003.10.065","article-title":"Semimonthly versus monthly regimen of fluorouracil and leucovorin administered for 24 or 36 weeks as adjuvant therapy in stage II and III colon cancer: results of a randomized trial","volume":"21","author":"T Andre","year":"2003","journal-title":"J Clin Oncol"},{"key":"ref804","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s00384-004-0657-6","article-title":"Adjuvant chemotherapy in curative resected colon carcinoma: 5-fluorouracil\/leucovorin versus high-dose 5-fluorouracil 24-h infusion\/leucovorin versus high-dose 5-fluorouracil 24-h infusion","volume":"20","author":"H T Arkenau","year":"2005","journal-title":"Int J Colorectal Dis"},{"key":"ref805","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/annonc\/mdi116","article-title":"A randomised comparison between 6 months of bolus fluorouracil\/leucovorin and 12 weeks of protracted venous infusion fluorouracil as adjuvant treatment in colorectal cancer","volume":"16","author":"I Chau","year":"2005","journal-title":"Ann Oncol"},{"key":"ref806","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1200\/JCO.2005.04.7498","article-title":"Oral uracil and tegafur plus leucovorin compared with intravenous fluorouracil and leucovorin in stage II and III carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project Protocol C-06","volume":"24","author":"B C Lembersky","year":"2006","journal-title":"J Clin Oncol"},{"key":"ref807","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1200\/JCO.2004.04.065","article-title":"Efficacy of oral adjuvant therapy after resection of colorectal cancer: 5-year results from three randomized trials","volume":"22","author":"J Sakamoto","year":"2004","journal-title":"J Clin Oncol"},{"key":"ref808","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1200\/JCO.2005.04.169","article-title":"Phase III Southwest Oncology Group 9415\/Intergroup 0153 randomized trial of fluorouracil, leucovorin, and levamisole versus fluorouracil continuous infusion and levamisole for adjuvant treatment of stage III and high-risk stage II colon cancer","volume":"23","author":"E A Poplin","year":"2005","journal-title":"J Clin Oncol"},{"key":"ref809","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1200\/JCO.1998.16.1.295","article-title":"Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer","volume":"16","author":"M J O\u02bcConnell","year":"1998","journal-title":"J Clin Oncol"},{"key":"ref810","doi-asserted-by":"crossref","first-page":"8671","DOI":"10.1200\/JCO.2004.00.5686","article-title":"Phase III study of fluorouracil, leucovorin, and levamisole in high-risk stage II and III colon cancer: final report of Intergroup 0089","volume":"23","author":"D G Haller","year":"2005","journal-title":"J Clin Oncol"},{"key":"ref811","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1200\/JCO.2008.21.6663","article-title":"Randomized phase III trial comparing biweekly infusional fluorouracil\/leucovorin alone or with irinotecan in the adjuvant treatment of stage III colon cancer: PETACC-3","volume":"27","author":"E Van Cutsem","year":"2009","journal-title":"J Clin Oncol"},{"key":"ref812","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1093\/annonc\/mdn680","article-title":"A phase III randomised trial of LV5FU2 + irinotecan versus LV5FU2 alone in adjuvant high-risk colon cancer (FNCLCC Accord02\u200a\/\u200aFFCD9802)","volume":"20","author":"M Ychou","year":"2009","journal-title":"Ann Oncol"},{"key":"ref813","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1200\/JCO.2007.11.2144","article-title":"Irinotecan fluorouracil plus leucovorin is not superior to fluorouracil plus leucovorin alone as adjuvant treatment for stage III colon cancer: results of CALGB 89803","volume":"25","author":"L B Saltz","year":"2007","journal-title":"J Clin Oncol"},{"key":"ref814","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1001\/jama.2012.385","article-title":"Effect of oxaliplatin, fluorouracil, and leucovorin with or without cetuximab on survival among patients with resected stage III colon cancer: a randomized trial","volume":"307","author":"S R Alberts","year":"2012","journal-title":"JAMA"},{"key":"ref815","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/S1470-2045(14)70227-X","article-title":"Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial","volume":"15","author":"J Taieb","year":"2014","journal-title":"Lancet Oncol"},{"key":"ref816","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1200\/JCO.2012.44.4711","article-title":"Bevacizumab in stage II\u2013III colon cancer: 5-year update of the National Surgical Adjuvant Breast and Bowel Project C-08 trial","volume":"31","author":"C J Allegra","year":"2013","journal-title":"J Clin Oncol"},{"key":"ref817","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/S1470-2045(12)70509-0","article-title":"Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial","volume":"13","author":"A Gramont","year":"2012","journal-title":"Lancet Oncol"},{"key":"ref818","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S1470-2045(16)30172-3","article-title":"Adjuvant capecitabine plus bevacizumab versus capecitabine alone in patients with colorectal cancer (QUASAR 2): an open-label, randomised phase 3 trial","volume":"17","author":"R S Kerr","year":"2016","journal-title":"Lancet Oncol"},{"key":"ref819","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1002\/cam4.745","article-title":"Compliance with adjuvant capecitabine in patients with stage II and III colon cancer: comparison of administrative versus medical record data","volume":"5","author":"A Amlani","year":"2016","journal-title":"Cancer Med"},{"issue":"13","key":"ref820","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1056\/NEJMoa1713709","article-title":"Duration of Adjuvant Chemotherapy for Stage III Colon Cancer","volume":"378","author":"A Grothey","year":"2018","journal-title":"N Engl J Med"},{"issue":"15","key":"ref821","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1200\/JCO.2017.76.0355","article-title":"Three Versus 6 Months of Oxaliplatin-Based Adjuvant Chemotherapy for Patients With Stage III Colon Cancer: Disease-Free Survival Results From a Randomized, Open-Label, International Duration Evaluation of Adjuvant (IDEA) France, Phase III Trial","volume":"36","author":"T Andr\u00e9","year":"2018","journal-title":"J Clin Oncol"},{"issue":"15","key":"ref822","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1200\/JCO.2017.76.2187","article-title":"FOLFOX or CAPOX in Stage II to III Colon Cancer: Efficacy Results of the Italian Three or Six Colon Adjuvant Trial","volume":"36","author":"A Sobrero","year":"2018","journal-title":"J Clin Oncol"},{"issue":"04","key":"ref823","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/S1470-2045(18)30093-7","article-title":"3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial","volume":"19","author":"T Iveson","year":"2018","journal-title":"Lancet Oncol"},{"key":"ref824","doi-asserted-by":"crossref","first-page":"LBA1","DOI":"10.1200\/JCO.2017.35.18_suppl.LBA1","article-title":"Prospective pooled analysis of six phase III trials investigating duration of adjuvant (adjuv) oxaliplatin-based therapy (3 vs 6 months) for patients (pts) with stage III colon cancer (CC): The IDEA (International Duration Evaluation of Adjuvant chemotherapy) collaboration","volume":"35","author":"Q Shi","journal-title":"Journal of Clinical Oncology"},{"key":"ref825","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1056\/NEJMoa1713709","article-title":"Duration of Adjuvant Chemotherapy for Stage III Colon Cancer","volume":"378","author":"A Grothey","year":"2018","journal-title":"N Engl J Med"},{"issue":"12","key":"ref826","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1016\/S1470-2045(20)30527-1","article-title":"Effect of duration of adjuvant chemotherapy for patients with stage III colon cancer (IDEA collaboration): final results from a prospective, pooled analysis of six randomised, phase 3 trials","volume":"21","author":"T Andr\u00e9","year":"2020","journal-title":"Lancet Oncol"},{"key":"ref827","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1200\/JCO.2017.76.0355","article-title":"Three Versus 6 Months of Oxaliplatin-Based Adjuvant Chemotherapy for Patients With Stage III Colon Cancer: Disease-Free Survival Results From a Randomized, Open-Label, International Duration Evaluation of Adjuvant (IDEA) France, Phase III Trial","volume":"36","author":"T Andre","year":"2018","journal-title":"J Clin Oncol"},{"key":"ref828","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1200\/JCO.2017.76.2187","article-title":"FOLFOX or CAPOX in Stage II to III Colon Cancer: Efficacy Results of the Italian Three or Six Colon Adjuvant Trial","volume":"36","author":"A Sobrero","year":"2018","journal-title":"J Clin Oncol"},{"key":"ref829","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/S1470-2045(18)30093-7","article-title":"3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial","volume":"19","author":"T J Iveson","year":"2018","journal-title":"Lancet Oncol"},{"key":"ref830","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1093\/annonc\/mdy064","article-title":"The hard road to data interpretation: 3 or 6 months of adjuvant chemotherapy for patients with stage III colon cancer?","volume":"29","author":"A Sobrero","year":"2018","journal-title":"Ann Oncol"},{"key":"ref831","doi-asserted-by":"crossref","first-page":"3605","DOI":"10.1200\/JCO.2017.35.15_suppl.3605","article-title":"Association between timing and duration of adjuvant chemotherapy and survival for colorectal cancer in korea, 2011-2014: A nationwide study based on the database of quality assessment and the health insurance","volume":"35","author":"I G Hwang","year":"2017","journal-title":"Journal of Clinical Oncology"},{"issue":"06","key":"ref832","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1111\/codi.15585","article-title":"Does neoadjuvant FOLFOX chemotherapy improve the prognosis of high-risk Stage II and III colon cancers? Three years\u02bc follow-up results of the PRODIGE 22 phase II randomized multicentre trial","volume":"23","author":"M Karoui","year":"2021","journal-title":"Colorectal Dis"},{"issue":"08","key":"ref833","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1200\/JCO.22.00046","article-title":"Preoperative Chemotherapy for Operable Colon Cancer: Mature Results of an International Randomized Controlled Trial","volume":"41","author":"D Morton","year":"2023","journal-title":"J Clin Oncol"},{"issue":"02","key":"ref834","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1177\/15533506221125323","article-title":"Robotic Approach is Associated With a Lower Conversion Rate Compared to Laparoscopic Approach for Patients Undergoing Colectomy for T4b Colon Cancer An Analysis of the National Cancer Database","volume":"30","author":"M Kamel","year":"2023","journal-title":"Surg Innov"},{"issue":"21","key":"ref835","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1056\/NEJMoa2400634","article-title":"Neoadjuvant Immunotherapy in Locally Advanced Mismatch Repair-Deficient Colon Cancer","volume":"390","author":"M Chalabi","year":"2024","journal-title":"N Engl J Med"},{"key":"ref836","doi-asserted-by":"crossref","first-page":"1044353","DOI":"10.3389\/fimmu.2023.1044353","article-title":"Meta-analysis of neoadjuvant immunotherapy for non-metastatic colorectal cancer","volume":"14","author":"L Zhou","year":"2023","journal-title":"Front Immunol"},{"issue":"09","key":"ref838","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/j.ejso.2020.01.008","article-title":"The sigmoid take-off: An anatomical imaging definition of the rectum validated on specimen analysis","volume":"46","author":"N D\u02bcSouza","year":"2020","journal-title":"Eur J Surg Oncol"},{"issue":"09","key":"ref839","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/bjs.10163","article-title":"Meta-analysis of oncological outcomes after local excision of pT1-2 rectal cancer requiring adjuvant (chemo)radiotherapy or completion surgery","volume":"103","author":"W Borstlap","year":"2016","journal-title":"Br J Surg"},{"issue":"09","key":"ref840","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1002\/bjs.11525","article-title":"Locoregional recurrences after transanal total mesorectal excision of rectal cancer during implementation","volume":"107","author":"S Oostendorp","year":"2020","journal-title":"Br J Surg"},{"key":"ref841","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/bjs.9809","article-title":"Chemoradiation therapy for rectal cancer in the distal rectum followed by organ-sparing transanal endoscopic microsurgery (CARTS study)","volume":"102","author":"M Verseveld","year":"2015","journal-title":"Br J Surg"},{"issue":"01","key":"ref842","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jamasurg.2018.3752","article-title":"Long-term Oncological and Functional Outcomes of Chemoradiotherapy Followed by Organ-Sparing Transanal Endoscopic Microsurgery for Distal Rectal Cancer: The CARTS Study","volume":"154","author":"R Stijns","year":"2019","journal-title":"JAMA Surg"},{"issue":"02","key":"ref843","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S2468-1253(20)30333-2","article-title":"Radical surgery versus organ preservation via short-course radiotherapy followed by transanal endoscopic microsurgery for early-stage rectal cancer (TREC): a randomised, open-label feasibility study","volume":"6","author":"S Bach","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref844","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1136\/bmj.38937.646400.55","article-title":"Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study","volume":"333","year":"2006","journal-title":"BMJ"},{"key":"ref845","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/SLA.0b013e31820b8d52","article-title":"Preoperative high-resolution magnetic resonance imaging can identify good prognosis stage I, II, and III rectal cancer best managed by surgery alone: a prospective, multicenter, European study","volume":"253","author":"F G Taylor","year":"2011","journal-title":"Ann Surg"},{"issue":"24","key":"ref846","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.1200\/JCO.22.02166","article-title":"Risk-Adapted Neoadjuvant Chemoradiotherapy in Rectal Cancer: Final Report of the OCUM Study","volume":"41","author":"R Ruppert","year":"2023","journal-title":"J Clin Oncol"},{"issue":"04","key":"ref847","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJMoa2303269","article-title":"Preoperative Treatment of Locally Advanced Rectal Cancer","volume":"389","author":"D Schrag","year":"2023","journal-title":"N Engl J Med"},{"issue":"21","key":"ref848","doi-asserted-by":"crossref","first-page":"3724","DOI":"10.1200\/JCO.23.00903","article-title":"Patient-Reported Outcomes During and After Treatment for Locally Advanced Rectal Cancer in the PROSPECT Trial (Alliance N1048)","volume":"41","author":"E Basch","year":"2023","journal-title":"J Clin Oncol"},{"issue":"04","key":"ref849","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/SLA.0000000000005780","article-title":"Neoadjuvant Chemotherapy With CAPOX Versus Chemoradiation for Locally Advanced Rectal Cancer With Uninvolved Mesorectal Fascia (CONVERT): Initial Results of a Phase III Trial","volume":"277","author":"W Mei","year":"2023","journal-title":"Ann Surg"},{"issue":"06","key":"ref850","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1055\/s-0043-1767702","article-title":"Application of Molecular Profiling in Colorectal Cancer Surgery","volume":"36","author":"P Ding","year":"2023","journal-title":"Clin Colon Rectal Surg"},{"key":"ref851","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0140-6736(17)31056-5","article-title":"Organ preservation for rectal cancer (GRECCAR 2): a prospective, randomised, open-label, multicentre, phase 3 trial","volume":"390","author":"E Rullier","year":"2017","journal-title":"Lancet"},{"issue":"05","key":"ref852","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S2468-1253(19)30410-8","article-title":"Organ preservation with chemoradiotherapy plus local excision for rectal cancer: 5-year results of the GRECCAR 2 randomised trial","volume":"5","author":"E Rullier","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"01","key":"ref853","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.annonc.2022.09.160","article-title":"Short-term outcomes of chemoradiotherapy and local excision versus total mesorectal excision in T2-T3ab,N0,M0 rectal cancer: a multicentre randomised, controlled, phase III trial (the TAU-TEM study)","volume":"34","author":"X Serra-Aracil","year":"2023","journal-title":"Ann Oncol"},{"issue":"01","key":"ref854","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00384-023-04558-8","article-title":"Comparing neoadjuvant therapy followed by local excision to total mesorectal excision in the treatment of early stage rectal cancer: a systematic review and meta-analysis of randomised clinical trials","volume":"38","author":"P Lynch","year":"2023","journal-title":"Int J Colorectal Dis"},{"key":"ref855","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/01.sla.0000141194.27992.32","article-title":"Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results","volume":"240","author":"A Habr-Gama","year":"2004","journal-title":"Ann Surg"},{"issue":"02","key":"ref856","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S1470-2045(15)00467-2","article-title":"Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis","volume":"17","author":"A Renehan","year":"2016","journal-title":"Lancet Oncol"},{"key":"ref857","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/S0140-6736(18)31078-X","article-title":"Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study","volume":"391","author":"M der Valk","year":"2018","journal-title":"Lancet"},{"issue":"01","key":"ref858","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1470-2045(20)30557-X","article-title":"Conditional recurrence-free survival of clinical complete responders managed by watch and wait after neoadjuvant chemoradiotherapy for rectal cancer in the International Watch & Wait Database: a retrospective, international, multicentre registry study","volume":"22","author":"L Fernandez","year":"2021","journal-title":"Lancet Oncol"},{"issue":"06","key":"ref859","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/bjs\/znad051","article-title":"Watch and wait after neoadjuvant treatment in rectal cancer: comparison of outcomes in patients with and without a complete response at first reassessment in the International Watch & Wait Database (IWWD)","volume":"110","author":"S Temmink","year":"2023","journal-title":"Br J Surg"},{"issue":"01","key":"ref860","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/DCR.0000000000002494","article-title":"The Risk of Distant Metastases in Patients With Clinical Complete Response Managed by Watch and Wait After Neoadjuvant Therapy for Rectal Cancer: The Influence of Local Regrowth in the International Watch and Wait Database","volume":"66","author":"L Fernandez","year":"2023","journal-title":"Dis Colon Rectum"},{"issue":"07","key":"ref861","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S2468-1253(17)30074-2","article-title":"A watch-and-wait approach for locally advanced rectal cancer after a clinical complete response following neoadjuvant chemoradiation: a systematic review and meta-analysis","volume":"2","author":"F Dossa","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"06","key":"ref862","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1097\/SLA.0000000000002761","article-title":"Oncological and Survival Outcomes in Watch and Wait Patients With a Clinical Complete Response After Neoadjuvant Chemoradiotherapy for Rectal Cancer: A Systematic Review and Pooled Analysis","volume":"268","author":"M Dattani","year":"2018","journal-title":"Ann Surg"},{"issue":"04","key":"ref863","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1007\/s00464-021-08932-x","article-title":"Efficacy and safety of the \u201ewatch-and-wait\u201c approach for rectal cancer with clinical complete response after neoadjuvant chemoradiotherapy: a meta-analysis","volume":"36","author":"X Zhang","year":"2022","journal-title":"Surg Endosc"},{"issue":"10","key":"ref864","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1097\/DCR.0000000000000862","article-title":"Quality of Life in Rectal Cancer Patients After Chemoradiation: Watch-and-Wait Policy Versus Standard Resection \u2013 A Matched-Controlled Study","volume":"60","author":"B Hupkens","year":"2017","journal-title":"Dis Colon Rectum"},{"issue":"05","key":"ref865","doi-asserted-by":"crossref","first-page":"e230146","DOI":"10.1001\/jamasurg.2023.0146","article-title":"Long-term Quality of Life and Functional Outcome of Patients With Rectal Cancer Following a Watch-and-Wait Approach","volume":"158","author":"P Custers","year":"2023","journal-title":"JAMA Surg"},{"issue":"08","key":"ref866","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S1470-2045(15)00120-5","article-title":"High-dose chemoradiotherapy and watchful waiting for distal rectal cancer: a prospective observational study","volume":"16","author":"A Appelt","year":"2015","journal-title":"Lancet Oncol"},{"issue":"04","key":"ref867","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S2468-1253(22)00392-2","article-title":"Neoadjuvant chemoradiotherapy with radiation dose escalation with contact x-ray brachytherapy boost or external beam radiotherapy boost for organ preservation in early cT2-cT3 rectal adenocarcinoma (OPERA): a phase 3, randomised controlled trial","volume":"8","author":"J Gerard","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"23","key":"ref868","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1200\/JCO.22.00032","article-title":"Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy","volume":"40","author":"J Garcia-Aguilar","year":"2022","journal-title":"J Clin Oncol"},{"issue":"05","key":"ref869","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1200\/JCO.23.01208","article-title":"Long-Term Results of Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy: The Randomized Phase II OPRA Trial","volume":"42","author":"F Verheij","year":"2024","journal-title":"J Clin Oncol"},{"issue":"01","key":"ref870","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1470-2045(20)30555-6","article-title":"Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial","volume":"22","author":"R Bahadoer","year":"2021","journal-title":"Lancet Oncol"},{"issue":"04","key":"ref871","doi-asserted-by":"crossref","first-page":"e766","DOI":"10.1097\/SLA.0000000000005799","article-title":"Locoregional Failure During and After Short-course Radiotherapy Followed by Chemotherapy and Surgery Compared With Long-course Chemoradiotherapy and Surgery: A 5-Year Follow-up of the RAPIDO Trial","volume":"278","author":"E Dijkstra","year":"2023","journal-title":"Ann Surg"},{"issue":"05","key":"ref872","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S1470-2045(21)00079-6","article-title":"Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial","volume":"22","author":"T Conroy","year":"2021","journal-title":"Lancet Oncol"},{"issue":"01","key":"ref873","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00384-023-04376-y","article-title":"Efficacy and safety of total neoadjuvant therapy in locally advanced rectal cancer: a meta-analysis","volume":"38","author":"K Xiong","year":"2023","journal-title":"Int J Colorectal Dis"},{"issue":"15","key":"ref874","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1200\/JCO.21.01667","article-title":"Multicenter, Randomized, Phase III Trial of Short-Term Radiotherapy Plus Chemotherapy Versus Long-Term Chemoradiotherapy in Locally Advanced Rectal Cancer (STELLAR)","volume":"40","author":"J Jin","year":"2022","journal-title":"J Clin Oncol"},{"issue":"08","key":"ref875","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1093\/annonc\/mdz186","article-title":"Long-course preoperative chemoradiation versus 5 \u00d7 5 Gy and consolidation chemotherapy for clinical T4 and fixed clinical T3 rectal cancer: long-term results of the randomized Polish II study","volume":"30","author":"B Cise\u0142","year":"2019","journal-title":"Ann Oncol"},{"issue":"10","key":"ref876","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.annonc.2024.06.019","article-title":"Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 trial","volume":"35","author":"T Conroy","year":"2024","journal-title":"Ann Oncol"},{"key":"ref877","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/01.sla.0000257358.56863.ce","article-title":"The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma","volume":"246","author":"K C Peeters","year":"2007","journal-title":"Ann Surg"},{"issue":"14","key":"ref878","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1056\/NEJM199704033361402","article-title":"Improved survival with preoperative radiotherapy in resectable rectal cancer","volume":"336","author":"B Cedermark","year":"1997","journal-title":"N Engl J Med"},{"key":"ref879","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/01.sla.0000257358.56863.ce","article-title":"The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma","volume":"246","author":"K C Peeters","year":"2007","journal-title":"Ann Surg"},{"key":"ref880","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1056\/NEJMoa040694","article-title":"Preoperative versus postoperative chemoradiotherapy for rectal cancer","volume":"351","author":"R Sauer","year":"2004","journal-title":"N Engl J Med"},{"issue":"04","key":"ref881","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJMoa2303269","article-title":"Preoperative Treatment of Locally Advanced Rectal Cancer","volume":"389","author":"D Schrag","year":"2023","journal-title":"N Engl J Med"},{"issue":"31","key":"ref882","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1200\/JCO.2012.42.9597","article-title":"Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group trial 0104","volume":"30","author":"S Ngan","year":"2012","journal-title":"J Clin Oncol"},{"key":"ref883","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.radonc.2003.12.006","article-title":"Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs conventionally fractionated radiochemotherapy","volume":"72","author":"K Bujko","year":"2004","journal-title":"Radiother Oncol"},{"key":"ref884","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/bjs.5506","article-title":"Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer","volume":"93","author":"K Bujko","year":"2006","journal-title":"Br J Surg"},{"issue":"03","key":"ref885","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.radonc.2007.07.007","article-title":"Quality of life, anorectal and sexual functions after preoperative radiotherapy for rectal cancer: report of a randomised trial","volume":"84","author":"L Pietrzak","year":"2007","journal-title":"Radiother Oncol"},{"key":"ref886","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ejca.2015.10.060","article-title":"The impact on health-related quality of life in the first 12 months: A randomised comparison of preoperative short-course radiation versus long-course chemoradiation for T3 rectal cancer (Trans-Tasman Radiation Oncology Group Trial 0104)","volume":"55","author":"S A McLachlan","year":"2016","journal-title":"Eur J Cancer"},{"key":"ref887","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/bjs.6914","article-title":"Interim analysis of the Stockholm III trial of preoperative radiotherapy regimens for rectal cancer","volume":"97","author":"D Pettersson","year":"2010","journal-title":"Br J Surg"},{"issue":"03","key":"ref888","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S1470-2045(17)30086-4","article-title":"Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): a multicentre, randomised, non-blinded, phase 3, non-inferiority trial","volume":"18","author":"J Erlandsson","year":"2017","journal-title":"Lancet Oncol"},{"issue":"11","key":"ref889","doi-asserted-by":"crossref","first-page":"djv248","DOI":"10.1093\/jnci\/djv248","article-title":"Neoadjuvant 5-FU or Capecitabine Plus Radiation With or Without Oxaliplatin in Rectal Cancer Patients: A Phase III Randomized Clinical Trial","volume":"107","author":"C Allegra","year":"2015","journal-title":"J Natl Cancer Inst"},{"issue":"07","key":"ref890","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.ctrv.2010.03.002","article-title":"Can chemotherapy concomitantly delivered with radiotherapy improve survival of patients with resectable rectal cancer? A meta-analysis of literature data","volume":"36","author":"F Fiorica","year":"2010","journal-title":"Cancer Treat Rev"},{"issue":"06","key":"ref891","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S1470-2045(12)70116-X","article-title":"Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial","volume":"13","author":"R Hofheinz","year":"2012","journal-title":"Lancet Oncol"},{"issue":"18","key":"ref892","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1200\/JCO.2013.53.7753","article-title":"Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: surgical end points from National Surgical Adjuvant Breast and Bowel Project trial R-04","volume":"32","author":"M O\u02bcConnell","year":"2014","journal-title":"J Clin Oncol"},{"issue":"01","key":"ref893","first-page":"CD006041","article-title":"Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer","author":"W Ceelen","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"ref894","doi-asserted-by":"crossref","first-page":"4620","DOI":"10.1200\/JCO.2006.06.7629","article-title":"Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203","volume":"24","author":"J P Gerard","year":"2006","journal-title":"J Clin Oncol"},{"key":"ref895","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S1470-2045(13)70599-0","article-title":"Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study","volume":"15","author":"J F Bosset","year":"2014","journal-title":"Lancet Oncol"},{"key":"ref896","first-page":"Cd006041","article-title":"Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer","volume":"1","author":"W P Ceelen","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"ref897","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.ctrv.2010.03.002","article-title":"Can chemotherapy concomitantly delivered with radiotherapy improve survival of patients with resectable rectal cancer? A meta-analysis of literature data","volume":"36","author":"F Fiorica","year":"2010","journal-title":"Cancer Treat Rev"},{"key":"ref898","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S1470-2045(12)70116-X","article-title":"Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial","volume":"13","author":"R D Hofheinz","year":"2012","journal-title":"Lancet Oncol"},{"key":"ref899","doi-asserted-by":"crossref","first-page":"4558","DOI":"10.1200\/JCO.2012.42.8771","article-title":"Clinical outcome of the ACCORD 12\/0405 PRODIGE 2 randomized trial in rectal cancer","volume":"30","author":"J P Gerard","year":"2012","journal-title":"J Clin Oncol"},{"issue":"20","key":"ref900","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1200\/JCO.2010.34.4911","article-title":"Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: pathologic results of the STAR-01 randomized phase III trial","volume":"29","author":"C Aschele","year":"2011","journal-title":"J Clin Oncol"},{"issue":"08","key":"ref901","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S1470-2045(15)00159-X","article-title":"Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO\/ARO\/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial","volume":"16","author":"C R\u00f6del","year":"2015","journal-title":"Lancet Oncol"},{"issue":"01","key":"ref902","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1200\/JCO.20.01740","article-title":"Pre- and Postoperative Capecitabine Without or With Oxaliplatin in Locally Advanced Rectal Cancer: PETACC 6 Trial by EORTC GITCG and ROG, AIO, AGITG, BGDO, and FFCD","volume":"39","author":"H Schmoll","year":"2021","journal-title":"J Clin Oncol"},{"issue":"23","key":"ref903","doi-asserted-by":"crossref","first-page":"6035","DOI":"10.3390\/cancers13236035","article-title":"Is There a Benefit of Oxaliplatin in Combination with Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer? An Updated Meta-Analysis","volume":"13","author":"G Des Guetz","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"08","key":"ref904","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1093\/annonc\/mdy205","article-title":"Impact of age on the efficacy of oxaliplatin in the preoperative chemoradiotherapy and adjuvant chemotherapy of rectal cancer: a post hoc analysis of the CAO\/ARO\/AIO-04 phase III trial","volume":"29","author":"R Hofheinz","year":"2018","journal-title":"Ann Oncol"},{"key":"ref905","doi-asserted-by":"crossref","first-page":"4074","DOI":"10.1200\/JCO.2020.38.15_suppl.4074","article-title":"Neoadjuvant chemoradiation (CRT) for locally advanced rectal cancer (LARC) with or without oxaliplatin (OX): Individual patient data (IPD) meta-analysis of three randomized controlled trials (RCTs) with subgroup analyses of age cohorts","volume":"38","author":"E Fontana","year":"2020","journal-title":"Journal of Clinical Oncology"},{"issue":"34","key":"ref906","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.1200\/JCO.19.00308","article-title":"Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO\/ARO\/AIO-12","volume":"37","author":"E Fokas","year":"2019","journal-title":"J Clin Oncol"},{"issue":"01","key":"ref907","doi-asserted-by":"crossref","first-page":"e215445","DOI":"10.1001\/jamaoncol.2021.5445","article-title":"Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer: Long-term Results of the CAO\/ARO\/AIO-12 Randomized Clinical Trial","volume":"8","author":"E Fokas","year":"2022","journal-title":"JAMA Oncol"},{"key":"ref908","doi-asserted-by":"crossref","first-page":"LBA3512","DOI":"10.1200\/JCO.2024.42.17_suppl.LBA3512","article-title":"Durable complete responses to PD-1 blockade alone in mismatch repair deficient locally advanced rectal cancer","volume":"42","author":"A Cercek","year":"2024","journal-title":"Journal of Clinical Oncology"},{"issue":"02","key":"ref909","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S1470-2045(13)70599-0","article-title":"Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study","volume":"15","author":"J Bosset","year":"2014","journal-title":"Lancet Oncol"},{"key":"ref910","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.radonc.2014.10.006","article-title":"No benefit of adjuvant Fluorouracil Leucovorin chemotherapy after neoadjuvant chemoradiotherapy in locally advanced cancer of the rectum (LARC): Long term results of a randomized trial (I-CNR-RT)","volume":"113","author":"A Sainato","year":"2014","journal-title":"Radiother Oncol"},{"key":"ref911","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1093\/annonc\/mdu147","article-title":"Chronicle: results of a randomised phase III trial in locally advanced rectal cancer after neoadjuvant chemoradiation randomising postoperative adjuvant capecitabine plus oxaliplatin (XELOX) versus control","volume":"25","author":"R Glynne-Jones","year":"2014","journal-title":"Ann Oncol"},{"key":"ref912","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1093\/annonc\/mdu560","article-title":"Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: a Dutch Colorectal Cancer Group (DCCG) randomized phase III trial","volume":"26","author":"A J Breugom","year":"2015","journal-title":"Ann Oncol"},{"issue":"07","key":"ref913","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1093\/annonc\/mdu147","article-title":"Chronicle: results of a randomised phase III trial in locally advanced rectal cancer after neoadjuvant chemoradiation randomising postoperative adjuvant capecitabine plus oxaliplatin (XELOX) versus control","volume":"25","author":"R Glynne-Jones","year":"2014","journal-title":"Ann Oncol"},{"issue":"02","key":"ref914","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S1470-2045(14)71199-4","article-title":"Adjuvant chemotherapy after preoperative (chemo)radiotherapy and surgery for patients with rectal cancer: a systematic review and meta-analysis of individual patient data","volume":"16","author":"A Breugom","year":"2015","journal-title":"Lancet Oncol"},{"issue":"33","key":"ref915","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1200\/JCO.19.00016","article-title":"Oxaliplatin-Based Adjuvant Chemotherapy for Rectal Cancer After Preoperative Chemoradiotherapy (ADORE): Long-Term Results of a Randomized Controlled Trial","volume":"37","author":"Y Hong","year":"2019","journal-title":"J Clin Oncol"},{"key":"ref916","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S1470-2045(11)70097-3","article-title":"Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial","volume":"12","author":"W Gijn","year":"2011","journal-title":"Lancet Oncol"},{"issue":"03","key":"ref917","first-page":"CD004078","article-title":"Postoperative adjuvant chemotherapy in rectal cancer operated for cure","volume":"2012","author":"S Petersen","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"ref918","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/S1470-2045(15)00286-7","article-title":"Clinical relevance of DPYD variants c1679T>G, c1236G>A\/HapB3, and c1601G>A as predictors of severe fluoropyrimidine-associated toxicity: a systematic review and meta-analysis of individual patient data","volume":"16","author":"D Meulendijks","year":"2015","journal-title":"Lancet Oncol"},{"issue":"11","key":"ref919","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1159\/000510258","article-title":"Dihydropyrimidine Dehydrogenase Testing prior to Treatment with 5-Fluorouracil, Capecitabine, and Tegafur: A Consensus Paper","volume":"43","author":"B W\u00f6rmann","year":"2020","journal-title":"Oncol Res Treat"},{"issue":"09","key":"ref920","doi-asserted-by":"crossref","first-page":"djx015","DOI":"10.1093\/jnci\/djx015","article-title":"Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial","volume":"109","author":"T Ruers","year":"2017","journal-title":"J Natl Cancer Inst"},{"issue":"08","key":"ref921","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1007\/s00270-018-1959-3","article-title":"Radiofrequency and Microwave Ablation Compared to Systemic Chemotherapy and to Partial Hepatectomy in the Treatment of Colorectal Liver Metastases: A Systematic Review and Meta-Analysis","volume":"41","author":"M Meijerink","year":"2018","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"09","key":"ref922","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S1470-2045(17)30457-6","article-title":"First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials","volume":"18","author":"H Wasan","year":"2017","journal-title":"Lancet Oncol"},{"issue":"04","key":"ref923","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s12094-023-03299-y","article-title":"Recommendations for the management of yttrium-90 radioembolization in the treatment of patients with colorectal cancer liver metastases: a multidisciplinary review","volume":"26","author":"E Gonz\u00e1lez-Flores","year":"2024","journal-title":"Clin Transl Oncol"},{"issue":"01","key":"ref924","first-page":"120","article-title":"Stereotactic Ablative Radiation Therapy for Colorectal Liver Metastases","volume":"22","author":"R McDermott","year":"2023","journal-title":"Clin Colorectal Cancer"},{"issue":"08","key":"ref925","first-page":"CD012757","article-title":"Transarterial (chemo)embolisation versus systemic chemotherapy for colorectal cancer liver metastases","volume":"8","author":"M Swierz","year":"2024","journal-title":"Cochrane Database Syst Rev"},{"issue":"03","key":"ref926","first-page":"CD007823","article-title":"Fluoropyrimidine-HAI (hepatic arterial infusion) versus systemic chemotherapy (SCT) for unresectable liver metastases from colorectal cancer","author":"S Mocellin","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"39","key":"ref928","first-page":"647","article-title":"Initial Cancer Treatment in Certified Versus Non-Certified Hospitals","volume":"120","author":"J Schmitt","year":"2023","journal-title":"Dtsch Arztebl Int"},{"issue":"02","key":"ref929","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S1470-2045(24)00660-0","article-title":"Thermal ablation versus surgical resection of small-size colorectal liver metastases (COLLISION): an international, randomised, controlled, phase 3 non-inferiority trial","volume":"26","author":"Lei S der","year":"2025","journal-title":"Lancet Oncol"},{"issue":"12","key":"ref930","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/S1470-2045(13)70447-9","article-title":"Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial","volume":"14","author":"B Nordlinger","year":"2013","journal-title":"Lancet Oncol"},{"key":"ref931","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0140-6736(08)60455-9","article-title":"Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial","volume":"371","author":"B Nordlinger","year":"2008","journal-title":"Lancet"},{"issue":"02","key":"ref932","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.surge.2014.07.005","article-title":"Neoadjuvant chemotherapy for resectable colorectal liver metastases: what is the evidence? Results of a systematic review of comparative studies","volume":"13","author":"G Nigri","year":"2015","journal-title":"Surgeon"},{"key":"ref933","first-page":"1849","article-title":"Role of systemic chemothreapy in the management of rsected or resectable colorectal liver metastases: A systematic review and meta-analysis of randomized controlled trials","volume":"27","author":"D Ciliberto","year":"2012","journal-title":"Oncology Reports"},{"key":"ref934","first-page":"94","article-title":"Systematic Review with network Meta-Analysis","author":"G Zhu","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"ref935","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0140-6736(24)02848-4","article-title":"Nivolumab plus ipilimumab versus nivolumab in microsatellite instability-high metastatic colorectal cancer (CheckMate 8HW): a randomised, open-label, phase 3 trial","volume":"405","author":"T Andr\u00e9","year":"2025","journal-title":"Lancet"},{"issue":"03","key":"ref936","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.annonc.2024.11.012","article-title":"Pembrolizumab versus chemotherapy in microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer: 5-year follow-up from the randomized phase III KEYNOTE-177 study","volume":"36","author":"T Andr\u00e9","year":"2025","journal-title":"Ann Oncol"},{"issue":"05","key":"ref937","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S1470-2045(22)00197-8","article-title":"Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study","volume":"23","author":"L Diaz","year":"2022","journal-title":"Lancet Oncol"},{"issue":"03","key":"ref938","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1200\/JCO.22.01690","article-title":"Treatment of Metastatic Colorectal Cancer: ASCO Guideline","volume":"41","author":"V Morris","year":"2023","journal-title":"J Clin Oncol"},{"issue":"24","key":"ref939","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1056\/NEJMoa2501912","article-title":"Encorafenib, Cetuximab, and mFOLFOX6 in","volume":"392","author":"E Elez","year":"2025","journal-title":"N Engl J Med"},{"issue":"21","key":"ref940","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1056\/NEJMoa2402141","article-title":"Nivolumab plus Ipilimumab in Microsatellite-Instability-High Metastatic Colorectal Cancer","volume":"391","author":"T Andre","year":"2024","journal-title":"N Engl J Med"},{"key":"ref941","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.critrevonc.2018.03.003","article-title":"The best strategy for RAS wild-type metastatic colorectal cancer patients in first-line treatment: A classic and Bayesian meta-analysis","volume":"125","author":"D Ciliberto","year":"2018","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref942","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ejca.2018.10.009","article-title":"Efficacy of bevacizumab in first-line treatment of metastatic colorectal cancer: A systematic review and meta-analysis","volume":"106","author":"A Baraniskin","year":"2019","journal-title":"Eur J Cancer"},{"issue":"27","key":"ref943","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1200\/JCO.20.00174","article-title":"Bevacizumab Plus mFOLFOX6 Versus mFOLFOX6 Alone as First-Line Treatment for","volume":"38","author":"W Tang","year":"2020","journal-title":"J Clin Oncol"},{"key":"ref944","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.1200\/JCO.2005.05.112","article-title":"Addition of bevacizumab to bolus fluorouracil and leucovorin in first-line metastatic colorectal cancer: results of a randomized phase II trial","volume":"23","author":"F F Kabbinavar","year":"2005","journal-title":"J Clin Oncol"},{"issue":"04","key":"ref945","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/annonc\/mdm516","article-title":"First-line single-agent cetuximab in patients with advanced colorectal cancer","volume":"19","author":"A Pessino","year":"2008","journal-title":"Ann Oncol"},{"issue":"08","key":"ref946","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1200\/JCO.2017.76.9901","article-title":"Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair-Deficient\/Microsatellite Instability-High Metastatic Colorectal Cancer","volume":"36","author":"M Overman","year":"2018","journal-title":"J Clin Oncol"},{"issue":"13","key":"ref947","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/S1470-2045(15)00042-X","article-title":"Maintenance strategies after first-line oxaliplatin plus fluoropyrimidine plus bevacizumab for patients with metastatic colorectal cancer (AIO 0207): a randomised, non-inferiority, open-label, phase 3 trial","volume":"16","author":"S Hegewisch-Becker","year":"2015","journal-title":"Lancet Oncol"},{"issue":"9980","key":"ref948","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/S0140-6736(14)62004-3","article-title":"Maintenance treatment with capecitabine and bevacizumab in metastatic colorectal cancer (CAIRO3): a phase 3 randomised controlled trial of the Dutch Colorectal Cancer Group","volume":"385","author":"L Simkens","year":"2015","journal-title":"Lancet"},{"issue":"01","key":"ref949","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1200\/JCO.21.01332","article-title":"Panitumumab Plus Fluorouracil and Folinic Acid Versus Fluorouracil and Folinic Acid Alone as Maintenance Therapy in","volume":"40","author":"D Modest","year":"2022","journal-title":"J Clin Oncol"},{"issue":"09","key":"ref950","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/jamaoncol.2019.1467","article-title":"Maintenance Therapy With Panitumumab Alone vs Panitumumab Plus Fluorouracil-Leucovorin in Patients With RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Trial","volume":"5","author":"F Pietrantonio","year":"2019","journal-title":"JAMA Oncol"},{"issue":"10","key":"ref951","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.3109\/0284186X.2015.1044022","article-title":"The impact of complete chemotherapy stop on the overall survival of patients with advanced colorectal cancer in first-line setting: A meta-analysis of randomized trials","volume":"54","author":"A Pereira","year":"2015","journal-title":"Acta Oncol"},{"issue":"05","key":"ref952","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1093\/annonc\/mdq580","article-title":"Intermittent versus continuous chemotherapy in advanced colorectal cancer: a randomised \u201eGISCAD\u201c trial","volume":"22","author":"R Labianca","year":"2011","journal-title":"Ann Oncol"},{"issue":"01","key":"ref953","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1470-2045(12)70477-1","article-title":"Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial","volume":"14","author":"J Bennouna","year":"2013","journal-title":"Lancet Oncol"},{"issue":"09","key":"ref954","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1093\/annonc\/mdt231","article-title":"Bevacizumab plus chemotherapy continued beyond first progression in patients with metastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 study KRAS subgroup findings","volume":"24","author":"S Kubicka","year":"2013","journal-title":"Ann Oncol"},{"issue":"28","key":"ref955","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1200\/JCO.2012.42.8201","article-title":"Addition of aflibercept to fluorouracil, leucovorin, and irinotecan improves survival in a phase III randomized trial in patients with metastatic colorectal cancer previously treated with an oxaliplatin-based regimen","volume":"30","author":"E Van Cutsem","year":"2012","journal-title":"J Clin Oncol"},{"issue":"05","key":"ref956","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S1470-2045(15)70127-0","article-title":"Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 study","volume":"16","author":"J Tabernero","year":"2015","journal-title":"Lancet Oncol"},{"key":"ref957","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1056\/NEJMoa1414325","article-title":"Randomized trial of TAS-102 for refractory metastatic colorectal cancer","volume":"372","author":"R J Mayer","year":"2015","journal-title":"N Engl J Med"},{"key":"ref958","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/S1470-2045(12)70345-5","article-title":"TAS-102 monotherapy for pretreated metastatic colorectal cancer: a double-blind, randomised, placebo-controlled phase 2 trial","volume":"13","author":"T Yoshino","year":"2012","journal-title":"Lancet Oncol"},{"issue":"18","key":"ref959","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1056\/NEJMoa2214963","article-title":"Trifluridine-Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer","volume":"388","author":"G Prager","year":"2023","journal-title":"N Engl J Med"},{"issue":"08","key":"ref960","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1056\/NEJMoa1714448","article-title":"Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children","volume":"378","author":"A Drilon","year":"2018","journal-title":"N Engl J Med"},{"issue":"07","key":"ref961","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1158\/1078-0432.CCR-21-3597","article-title":"Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Patients With NTRK Fusion-Positive Solid Tumors","volume":"28","author":"G Demetri","year":"2022","journal-title":"Clin Cancer Res"},{"key":"ref962","first-page":"793","article-title":"Second primary cancers after sporadic and familial colorectal cancer","volume":"10","author":"K Hemminki","year":"2001","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref963","first-page":"1057","article-title":"Factors influencing incidence and extension of metachronous liver metastases of colorectal adenocarcinoma A multivariate analysis","volume":"44","author":"G B Secco","year":"1997","journal-title":"Hepatogastroenterology"},{"key":"ref964","first-page":"1573","article-title":"Risk factors of local recurrence of colorectal cancer: a multivariate study","volume":"45","author":"N Pietra","year":"1998","journal-title":"Hepatogastroenterology"},{"issue":"05","key":"ref965","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1053\/j.gastro.2018.12.006","article-title":"New and Recurrent Colorectal Cancers After Resection: a Systematic Review and Meta-analysis of Endoscopic Surveillance Studies","volume":"156","author":"L Fuccio","year":"2019","journal-title":"Gastroenterology"},{"key":"ref966","first-page":"420","article-title":"[Sense and nonsense in after-care of colorectal carcinoma]","volume":"91","author":"J Scholmerich","year":"1996","journal-title":"Med Klin (Munich)"},{"issue":"09","key":"ref967","first-page":"CD002200","article-title":"Follow-up strategies for patients treated for non-metastatic colorectal cancer","volume":"9","author":"M Jeffery","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"02","key":"ref968","doi-asserted-by":"crossref","first-page":"724","DOI":"10.3390\/curroncol29020062","article-title":"An Evidence-Based Guideline for Surveillance of Patients after Curative Treatment for Colon and Rectal Cancer","volume":"29","author":"E Kennedy","year":"2022","journal-title":"Curr Oncol"},{"key":"ref969","first-page":"CD002200","article-title":"Follow-up strategies for patients treated for non-metastatic colorectal cancer","author":"G M Jeffery","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"ref970","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1136\/bmj.324.7341.813","article-title":"Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials","volume":"324","author":"A G Renehan","year":"2002","journal-title":"Bmj"},{"key":"ref971","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1001\/archsurg.1995.01430100040009","article-title":"Five-year follow-up after radical surgery for colorectal cancer Results of a prospective randomized trial","volume":"130","author":"J T Makela","year":"1995","journal-title":"Arch Surg"},{"key":"ref972","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/BF02054122","article-title":"Follow-up after curative surgery for colorectal carcinoma Randomized comparison with no follow-up","volume":"38","author":"B Ohlsson","year":"1995","journal-title":"Dis Colon Rectum"},{"key":"ref973","first-page":"666","article-title":"A prospective randomized study of follow-up after radical surgery for colorectal cancer","volume":"84","author":"B J Kjeldsen","year":"1997","journal-title":"Br J Surg"},{"key":"ref974","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/BF02239434","article-title":"Role of follow-up in management of local recurrences of colorectal cancer: a prospective, randomized study","volume":"41","author":"N Pietra","year":"1998","journal-title":"Dis Colon Rectum"},{"key":"ref975","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0016-5085(98)70626-2","article-title":"Yearly colonoscopy, liver CT, and chest radiography do not influence 5-year survival of colorectal cancer patients","volume":"114","author":"D Schoemaker","year":"1998","journal-title":"Gastroenterology"},{"key":"ref976","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1053\/ejso.2001.1250","article-title":"Efficacy and cost of risk-adapted follow-up in patients after colorectal cancer surgery: a prospective, randomized and controlled trial","volume":"28","author":"G B Secco","year":"2002","journal-title":"Eur J Surg Oncol"},{"key":"ref977","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/00000658-199402000-00009","article-title":"Follow-up of patients with colorectal cancer A meta-analysis","volume":"219","author":"D J Bruinvels","year":"1994","journal-title":"Ann Surg"},{"key":"ref978","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1007\/BF02239433","article-title":"Follow-up of colorectal cancer: a meta-analysis","volume":"41","author":"M Rosen","year":"1998","journal-title":"Dis Colon Rectum"},{"key":"ref979","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1053\/ejso.1999.0893","article-title":"Colorectal cancer follow-up: a reassessment of empirical evidence on effectiveness","volume":"26","author":"J Kievit","year":"2000","journal-title":"Eur J Surg Oncol"},{"key":"ref980","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S0959-8049(02)00061-8","article-title":"Follow-up of patients with colorectal cancer: numbers needed to test and treat","volume":"38","author":"J Kievit","year":"2002","journal-title":"Eur J Cancer"},{"key":"ref981","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.1200\/JCO.2000.18.20.3586","article-title":"2000 update of American Society of Clinical Oncology colorectal cancer surveillance guidelines","volume":"18","author":"A B Benson","year":"2000","journal-title":"J Clin Oncol"},{"key":"ref982","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1200\/JCO.1999.17.4.1312","article-title":"Recommended colorectal cancer surveillance guidelines by the American Society of Clinical Oncology","volume":"17","author":"C E Desch","year":"1999","journal-title":"J Clin Oncol"},{"key":"ref983","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S0959-8049(02)00811-0","article-title":"Clinical utility of biochemical markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines","volume":"39","author":"M J Duffy","year":"2003","journal-title":"Eur J Cancer"},{"key":"ref984","first-page":"556","article-title":"Carcinoembryonic antigen screening: pros and cons","volume":"26","author":"J S Macdonald","year":"1999","journal-title":"Semin Oncol"},{"key":"ref985","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/BF02239434","article-title":"Role of follow-up in management of local recurrences of colorectal cancer: a prospective, randomized study","volume":"41","author":"N Pietra","year":"1998","journal-title":"Dis Colon Rectum"},{"issue":"20","key":"ref986","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1001\/jama.2018.5623","article-title":"Effect of More vs Less Frequent Follow-up Testing on Overall and Colorectal Cancer-Specific Mortality in Patients With Stage II or III Colorectal Cancer: The COLOFOL Randomized Clinical Trial","volume":"319","author":"P Wille-J\u00f8rgensen","year":"2018","journal-title":"JAMA"},{"key":"ref987","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S0959-8049(02)00811-0","article-title":"Clinical utility of biochemical markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines","volume":"39","author":"M J Duffy","year":"2003","journal-title":"Eur J Cancer"},{"issue":"04","key":"ref988","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/annonc\/mdu543","article-title":"Intensive follow-up strategies improve outcomes in nonmetastatic colorectal cancer patients after curative surgery: a systematic review and meta-analysis","volume":"26","author":"S Pita-Fern\u00e1ndez","year":"2015","journal-title":"Ann Oncol"},{"issue":"22","key":"ref989","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta21220","article-title":"What carcinoembryonic antigen level should trigger further investigation during colorectal cancer follow-up? A systematic review and secondary analysis of a randomised controlled trial","volume":"21","author":"B Shinkins","year":"2017","journal-title":"Health Technol Assess"},{"key":"ref990","first-page":"CD002200","article-title":"Follow-up strategies for patients treated for non-metastatic colorectal cancer","author":"G M Jeffery","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"ref991","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0140-6736(99)06552-6","article-title":"Surveillance after colorectal cancer resection","volume":"355","author":"J M Berman","year":"2000","journal-title":"Lancet"},{"key":"ref992","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1001\/archsurg.1995.01430100040009","article-title":"Five-year follow-up after radical surgery for colorectal cancer Results of a prospective randomized trial","volume":"130","author":"J T Makela","year":"1995","journal-title":"Arch Surg"},{"key":"ref993","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1067\/msy.2001.110428","article-title":"The role of transrectal ultrasound-guided biopsy in the postoperative follow-up of patients with rectal cancer","volume":"129","author":"M Hunerbein","year":"2001","journal-title":"Surgery"},{"key":"ref994","first-page":"CD002200","article-title":"Follow-up strategies for patients treated for non-metastatic colorectal cancer","volume":"1","author":"M Jeffery","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"ref995","first-page":"79","article-title":"A simplified plan for follow-up of patients with colon and rectal cancer supported by prospective studies of laboratory and radiologic test results","volume":"102","author":"P H Sugarbaker","year":"1987","journal-title":"Surgery"},{"key":"ref996","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0016-5085(98)70626-2","article-title":"Yearly colonoscopy, liver CT, and chest radiography do not influence 5-year survival of colorectal cancer patients","volume":"114","author":"D Schoemaker","year":"1998","journal-title":"Gastroenterology"},{"key":"ref997","doi-asserted-by":"crossref","first-page":"8512","DOI":"10.1200\/JCO.2005.04.0063","article-title":"Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline","volume":"23","author":"C E Desch","year":"2005","journal-title":"J Clin Oncol"},{"key":"ref998","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1200\/JCO.2004.05.041","article-title":"The value of routine serum carcino-embryonic antigen measurement and computed tomography in the surveillance of patients after adjuvant chemotherapy for colorectal cancer","volume":"22","author":"I Chau","year":"2004","journal-title":"J Clin Oncol"},{"key":"ref999","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1053\/j.gastro.2006.03.013","article-title":"Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and the US Multi-Society Task Force on Colorectal Cancer","volume":"130","author":"D K Rex","year":"2006","journal-title":"Gastroenterology"},{"key":"ref1000","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.ejca.2008.01.007","article-title":"The lifelong risk of metachronous colorectal cancer justifies long-term colonoscopic follow-up","volume":"44","author":"A M Bouvier","year":"2008","journal-title":"Eur J Cancer"},{"key":"ref1001","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1136\/bmj.324.7341.813","article-title":"Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials","volume":"324","author":"A G Renehan","year":"2002","journal-title":"Bmj"},{"key":"ref1002","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.cgh.2006.11.027","article-title":"Outcome of follow-up colon examination among a population-based cohort of colorectal cancer patients","volume":"5","author":"S J Rulyak","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref1003","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.gie.2008.05.017","article-title":"The role of postoperative colonoscopic surveillance after radical surgery for colorectal cancer: a prospective, randomized clinical study","volume":"69","author":"T Wang","year":"2009","journal-title":"Gastrointest Endosc"},{"key":"ref1004","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.gie.2008.05.017","article-title":"The role of postoperative colonoscopic surveillance after radical surgery for colorectal cancer: a prospective, randomized clinical study","volume":"69","author":"T Wang","year":"2009","journal-title":"Gastrointest Endosc"},{"key":"ref1005","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.cgh.2006.11.027","article-title":"Outcome of follow-up colon examination among a population-based cohort of colorectal cancer patients","volume":"5","author":"S J Rulyak","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref1006","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/BF02053945","article-title":"Cumulative incidence of metachronous colorectal cancer","volume":"36","author":"R L Cali","year":"1993","journal-title":"Dis Colon Rectum"},{"key":"ref1007","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1053\/ejso.2002.1305","article-title":"Late locoregional recurrence in rectal carcinoma","volume":"28","author":"S Merkel","year":"2002","journal-title":"Eur J Surg Oncol"},{"key":"ref1008","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/BF02054122","article-title":"Follow-up after curative surgery for colorectal carcinoma Randomized comparison with no follow-up","volume":"38","author":"B Ohlsson","year":"1995","journal-title":"Dis Colon Rectum"},{"key":"ref1009","first-page":"666","article-title":"A prospective randomized study of follow-up after radical surgery for colorectal cancer","volume":"84","author":"B J Kjeldsen","year":"1997","journal-title":"Br J Surg"},{"key":"ref1010","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1053\/ejso.2001.1250","article-title":"Efficacy and cost of risk-adapted follow-up in patients after colorectal cancer surgery: a prospective, randomized and controlled trial","volume":"28","author":"G B Secco","year":"2002","journal-title":"Eur J Surg Oncol"},{"key":"ref1011","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1093\/annonc\/mdh318","article-title":"Recognition of distress and psychiatric morbidity in cancer patients: a multi-method approach","volume":"15","author":"M Keller","year":"2004","journal-title":"Ann Oncol"},{"key":"ref1012","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/sj.bjc.6601578","article-title":"Major depression in outpatients attending a regional cancer centre: screening and unmet treatment needs","volume":"90","author":"M Sharpe","year":"2004","journal-title":"Br J Cancer"},{"key":"ref1013","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1093\/annonc\/mdp515","article-title":"Prevalence of mental health conditions in cancer patients in acute care--a meta-analysis","volume":"21","author":"S Singer","year":"2010","journal-title":"Ann Oncol"},{"key":"ref1014","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1200\/JCO.2010.31.4013","article-title":"Health-related quality of life during the 10 years after diagnosis of colorectal cancer: a population-based study","volume":"29","author":"L Jansen","year":"2011","journal-title":"J Clin Oncol"},{"key":"ref1015","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1002\/cncr.23300","article-title":"Describing and predicting psychological distress after colorectal cancer","volume":"112","author":"B M Lynch","year":"2008","journal-title":"Cancer"},{"issue":"02","key":"ref1016","first-page":"1483","article-title":"Colorectal cancer survival: prevalence of psychosocial distress and unmet supportive care needs","volume":"30","author":"Y Andreu","year":"2022","journal-title":"Support Care Cancer"},{"key":"ref1017","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1002\/cncr.22980","article-title":"Psychiatric disorders in advanced cancer","volume":"110","author":"M Miovic","year":"2007","journal-title":"Cancer"},{"key":"ref1018","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1002\/(SICI)1097-0142(20000315)88:6<1294::AID-CNCR4>3.0.CO;2-M","article-title":"Quality of life in survivors of colorectal carcinoma","volume":"88","author":"S D Ramsey","year":"2000","journal-title":"Cancer"},{"key":"ref1020","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1054\/bjoc.2001.1724","article-title":"Psychiatric morbidity and its recognition by doctors in patients with cancer","volume":"84","author":"L Fallowfield","year":"2001","journal-title":"Br J Cancer"},{"key":"ref1021","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1054\/bjoc.2000.1545","article-title":"How successful are oncologists in identifying patient distress, perceived social support, and need for psychosocial counselling?","volume":"84","author":"W Sollner","year":"2001","journal-title":"Br J Cancer"},{"key":"ref1022","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1056\/NEJMoa0806347","article-title":"Capsule endoscopy versus colonoscopy for the detection of polyps and cancer","volume":"361","author":"A Van Gossum","year":"2009","journal-title":"N Engl J Med"},{"key":"ref1023","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1136\/gut.52.12.1748","article-title":"Colonoscopy surveillance of individuals at risk of familial colorectal cancer","volume":"52","author":"N Bradshaw","year":"2003","journal-title":"Gut"},{"key":"ref1024","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1111\/j.1572-0241.2008.01978.x","article-title":"Family history and age at initiation of colorectal cancer screening","volume":"103","author":"H Brenner","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"ref1025","first-page":"1052","article-title":"[Colon cancer risk in persons at familial or hereditary risk < 55 years]","volume":"47","author":"A Waldmann","year":"2009","journal-title":"Z Gastroenterol"},{"issue":"03","key":"ref1026","first-page":"130","article-title":"Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology","volume":"58","author":"B Levin","year":"2008","journal-title":"CA Cancer J Clin"},{"key":"ref1027","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.cgh.2009.10.003","article-title":"Efficacy of annual colonoscopic surveillance in individuals with hereditary nonpolyposis colorectal cancer","volume":"8","author":"C Engel","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref1028","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1136\/bmj.38606.794560.EB","article-title":"Prevention of colorectal cancer by colonoscopic surveillance in individuals with a family history of colorectal cancer: 16 year, prospective, follow-up study","volume":"331","author":"I Dove-Edwin","year":"2005","journal-title":"BMJ"},{"key":"ref1029","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/BF02053699","article-title":"The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC)","volume":"34","author":"H F Vasen","year":"1991","journal-title":"Dis Colon Rectum"},{"issue":"05","key":"ref1030","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1016\/j.clnu.2021.02.005","article-title":"ESPEN practical guideline: Clinical Nutrition in cancer","volume":"40","author":"M Muscaritoli","year":"2021","journal-title":"Clin Nutr"},{"issue":"01","key":"ref1031","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1200\/JCO.2014.56.1894","article-title":"Diagnostic criteria for the classification of cancer-associated weight loss","volume":"33","author":"L Martin","year":"2015","journal-title":"J Clin Oncol"},{"issue":"12","key":"ref1032","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1200\/JCO.2012.45.2722","article-title":"Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index","volume":"31","author":"L Martin","year":"2013","journal-title":"J Clin Oncol"},{"issue":"01","key":"ref1033","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1080\/01635581.2013.741752","article-title":"The impact of nutritional status, nutritional risk, and nutritional treatment on clinical outcome of 2248 hospitalized cancer patients: a multi-center, prospective cohort study in Chinese teaching hospitals","volume":"65","author":"H Pan","year":"2013","journal-title":"Nutr Cancer"},{"issue":"04","key":"ref1034","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.nut.2014.12.027","article-title":"Which screening method is appropriate for older cancer patients at risk for malnutrition?","volume":"31","author":"E Isenring","year":"2015","journal-title":"Nutrition"},{"issue":"03","key":"ref1035","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.clnu.2013.06.015","article-title":"Nutritional care; do process and structure indicators influence malnutrition prevalence over time?","volume":"33","author":"J Meijers","year":"2014","journal-title":"Clin Nutr"},{"issue":"06","key":"ref1036","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.clnu.2012.03.006","article-title":"Poor performance of mandatory nutritional screening of in-hospital patients","volume":"31","author":"N Geiker","year":"2012","journal-title":"Clin Nutr"},{"issue":"09","key":"ref1037","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1089\/jpm.2011.0098","article-title":"Clinical outcomes and contributors to weight loss in a cancer cachexia clinic","volume":"14","author":"Fabbro E Del","year":"2011","journal-title":"J Palliat Med"},{"issue":"06","key":"ref1038","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3747\/co.20.1612","article-title":"A prospective evaluation of an interdisciplinary nutrition-rehabilitation program for patients with advanced cancer","volume":"20","author":"B Gagnon","year":"2013","journal-title":"Curr Oncol"},{"issue":"S 02","key":"ref1039","first-page":"S41","article-title":"Nutritional support in patients with oesophageal cancer","volume":"18","author":"F Bozzetti","year":"2010","journal-title":"Support Care Cancer"},{"issue":"06","key":"ref1040","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.clnu.2007.03.011","article-title":"Pathophysiology of cancer cachexia: much more than host-tumour interaction?","volume":"26","author":"R Skipworth","year":"2007","journal-title":"Clin Nutr"},{"issue":"05","key":"ref1041","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"K Fearon","year":"2011","journal-title":"Lancet Oncol"},{"issue":"02","key":"ref1042","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.clnu.2009.12.004","article-title":"Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) \u201ccachexia-anorexia in chronic wasting diseases\u201d and \u201cnutrition in geriatrics\u201d","volume":"29","author":"M Muscaritoli","year":"2010","journal-title":"Clin Nutr"},{"issue":"02","key":"ref1043","doi-asserted-by":"crossref","first-page":"563S","DOI":"10.1093\/jn\/133.2.563S","article-title":"Teaching nutrition skills to primary care practitioners","volume":"133","author":"C Eaton","year":"2003","journal-title":"J Nutr"},{"issue":"02","key":"ref1044","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/jhn.12036","article-title":"Using a wiki platform to promote guidelines internationally and maintain their currency: evidence-based guidelines for the nutritional management of adult patients with head and neck cancer","volume":"26","author":"T Brown","year":"2013","journal-title":"J Hum Nutr Diet"},{"issue":"09","key":"ref1045","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/j.jada.2007.06.014","article-title":"The Diet Quality Index-Revised: a tool to promote and evaluate dietary change among older cancer survivors enrolled in a home-based intervention trial","volume":"107","author":"Snyder D Clutter","year":"2007","journal-title":"J Am Diet Assoc"},{"key":"ref1046","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/1747-0080.12013","article-title":"Updated evidence-based practice guidelines for the nutritional management of patients receiving radiation therapy and\/or chemotherapy","volume":"70","author":"E Isenring","year":"2013","journal-title":"Nutrition & Dietetics"},{"issue":"05","key":"ref1047","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/jnci\/djr556","article-title":"Oral nutritional interventions in malnourished patients with cancer: a systematic review and meta-analysis","volume":"104","author":"C Baldwin","year":"2012","journal-title":"J Natl Cancer Inst"},{"issue":"09","key":"ref1048","doi-asserted-by":"crossref","first-page":"e108687","DOI":"10.1371\/journal.pone.0108687","article-title":"Nutritional advice in older patients at risk of malnutrition during treatment for chemotherapy: a two-year randomized controlled trial","volume":"9","author":"I Bourdel-Marchasson","year":"2014","journal-title":"PLoS One"},{"issue":"07","key":"ref1049","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1007\/s11605-019-04170-8","article-title":"Is the Enhanced Recovery After Surgery (ERAS) Program Effective and Safe in Laparoscopic Colorectal Cancer Surgery? A Meta-Analysis of Randomized Controlled Trials","volume":"23","author":"X Ni","year":"2019","journal-title":"J Gastrointest Surg"},{"issue":"09","key":"ref1050","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1097\/DCR.0000000000001160","article-title":"Enhanced Recovery Protocols for Adults Undergoing Colorectal Surgery: A Systematic Review and Meta-analysis","volume":"61","author":"N Greer","year":"2018","journal-title":"Dis Colon Rectum"},{"issue":"06","key":"ref1051","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1097\/DCR.0000000000001007","article-title":"Randomized Controlled Trial of Extended Perioperative Counseling in Enhanced Recovery After Colorectal Surgery","volume":"61","author":"H Forsmo","year":"2018","journal-title":"Dis Colon Rectum"},{"key":"ref1052","doi-asserted-by":"crossref","first-page":"3527","DOI":"10.1200\/JCO.2006.06.0855","article-title":"Physical activity and survival after colorectal cancer diagnosis","volume":"24","author":"J A Meyerhardt","year":"2006","journal-title":"J Clin Oncol"},{"key":"ref1053","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.1200\/JCO.2006.06.0863","article-title":"Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803","volume":"24","author":"J A Meyerhardt","year":"2006","journal-title":"J Clin Oncol"},{"issue":"19","key":"ref1054","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1002\/cam4.4746","article-title":"Impact of physical exercise in advanced-stage cancer patients: Systematic review and meta-analysis","volume":"11","author":"S Rodr\u00edguez-Ca\u00f1amero","year":"2022","journal-title":"Cancer Med"},{"issue":"03","key":"ref1055","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.critrevonc.2013.07.001","article-title":"Effect of physical exercise on muscle mass and strength in cancer patients during treatment--a systematic review","volume":"88","author":"G Stene","year":"2013","journal-title":"Crit Rev Oncol Hematol"},{"issue":"01","key":"ref1056","doi-asserted-by":"crossref","first-page":"28784","DOI":"10.1038\/s41598-024-79958-z","article-title":"The effect of resistance training on patients with secondary sarcopenia: a systematic review and meta-analysis","volume":"14","author":"F Cheng","year":"2024","journal-title":"Sci Rep"},{"issue":"08","key":"ref1057","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00066-013-0392-4","article-title":"Counseling cancer patients on complementary and alternative medicine Background, theory, and implementation of nationwide counseling facilities","volume":"189","author":"J H\u00fcbner","year":"2013","journal-title":"Strahlenther Onkol"},{"issue":"04","key":"ref1058","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1055\/s-0035-1545850","article-title":"Development and Validation of a Standardized Questionnaire and Standardized Diary for Use in Integrative Medicine Consultations in Gynecologic Oncology","volume":"75","author":"C Hack","year":"2015","journal-title":"Geburtshilfe Frauenheilkd"},{"issue":"03","key":"ref1059","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1177\/1534735411423920","article-title":"How many cancer patients use complementary and alternative medicine: a systematic review and metaanalysis","volume":"11","author":"M Horneber","year":"2012","journal-title":"Integr Cancer Ther"},{"issue":"02","key":"ref1060","first-page":"943","article-title":"User rate of complementary and alternative medicine (CAM) of patients visiting a counseling facility for CAM of a German comprehensive cancer center","volume":"34","author":"J Huebner","year":"2014","journal-title":"Anticancer Res"},{"key":"ref1061","first-page":"11","article-title":"Predictive factors for the use of complementary and alternative medicine (CAM) in radiation oncology","volume":"1","author":"O Micke","year":"2008"},{"issue":"04","key":"ref1062","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/annonc\/mdi110","article-title":"Use of complementary and alternative medicine in cancer patients: a European survey","volume":"16","author":"A Molassiotis","year":"2005","journal-title":"Ann Oncol"},{"key":"ref1064","first-page":"25","article-title":"Manual Patienteninformation \u2013 Empfehlungen zur Erstellung evidenzbasierter Patienteninformationen","author":"S S\u00e4nger","year":"2006","journal-title":"\u00e4zq Schriftenreihe"},{"issue":"06","key":"ref1066","first-page":"CD011129","article-title":"Early palliative care for adults with advanced cancer","volume":"6","author":"M Haun","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"09","key":"ref1067","first-page":"660","article-title":"[Integration of palliative care into intensive care : Systematic review]","volume":"66","author":"K Adler","year":"2017","journal-title":"Anaesthesist"},{"issue":"06","key":"ref1068","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1017\/S1478951513001338","article-title":"Early integration of palliative care in hospitals: A systematic review on methods, barriers, and outcome","volume":"12","author":"K Dalgaard","year":"2014","journal-title":"Palliat Support Care"},{"issue":"03","key":"ref1069","first-page":"99","article-title":"A review of the trials which examine early integration of outpatient and home palliative care for patients with serious illnesses","volume":"4","author":"M Davis","year":"2015","journal-title":"Ann Palliat Med"},{"key":"ref1070","doi-asserted-by":"crossref","first-page":"j2925","DOI":"10.1136\/bmj.j2925","article-title":"Effect of specialist palliative care services on quality of life in adults with advanced incurable illness in hospital, hospice, or community settings: systematic review and meta-analysis","volume":"357","author":"J Gaertner","year":"2017","journal-title":"BMJ"},{"issue":"01","key":"ref1071","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1634\/theoncologist.2014-0312","article-title":"Integration of oncology and palliative care: a systematic review","volume":"20","author":"D Hui","year":"2015","journal-title":"Oncologist"},{"issue":"07","key":"ref1072","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1634\/theoncologist.2016-0006","article-title":"Referral Criteria for Outpatient Palliative Cancer Care: A Systematic Review","volume":"21","author":"D Hui","year":"2016","journal-title":"Oncologist"},{"issue":"01","key":"ref1073","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2174\/1574887110666151014141650","article-title":"Early Palliative Care in Advanced Oncologic and Non-Oncologic Chronic Diseases: A Systematic Review of Literature","volume":"11","author":"D Tassinari","year":"2016","journal-title":"Rev Recent Clin Trials"},{"issue":"02","key":"ref1076","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/sj.bjc.6602908","article-title":"Disarming the guarded prognosis: predicting survival in newly referred patients with incurable cancer","volume":"94","author":"M Stockler","year":"2006","journal-title":"Br J Cancer"},{"issue":"09","key":"ref1078","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/pon.916","article-title":"Cancer caregiving and subjective stress: a multi-site, multi-dimensional analysis","volume":"14","author":"J Gaugler","year":"2005","journal-title":"Psychooncology"},{"issue":"02","key":"ref1079","first-page":"145","article-title":"The emerging role and needs of family caregivers in cancer care","volume":"2","author":"M Glajchen","year":"2004","journal-title":"J Support Oncol"},{"issue":"S 11","key":"ref1080","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1002\/cncr.28057","article-title":"Informal caregiving for cancer patients","volume":"119","author":"F Romito","year":"2013","journal-title":"Cancer"},{"issue":"02","key":"ref1081","first-page":"619","article-title":"Male coping processes as demonstrated in the context of a cancer-related social support group","volume":"21","author":"S Trapp","year":"2013","journal-title":"Support Care Cancer"},{"issue":"7059","key":"ref1082","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1136\/bmj.313.7059.724","article-title":"Information needs of cancer patients in west Scotland: cross sectional survey of patients\u02bc views","volume":"313","author":"C Meredith","year":"1996","journal-title":"BMJ"},{"issue":"08","key":"ref1083","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.ejca.2009.01.007","article-title":"A systematic review on barriers hindering adequate cancer pain management and interventions to reduce them: a critical appraisal","volume":"45","author":"W Oldenmenger","year":"2009","journal-title":"Eur J Cancer"},{"issue":"07","key":"ref1085","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1089\/jpm.2010.0018","article-title":"Prognostic significance of the \u201csurprise\u201d question in cancer patients","volume":"13","author":"A Moss","year":"2010","journal-title":"J Palliat Med"},{"issue":"01","key":"ref1086","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1200\/JCO.2016.70.1474","article-title":"Integration of Palliative Care Into Standard Oncology Care: American Society of Clinical Oncology Clinical Practice Guideline Update","volume":"35","author":"B Ferrell","year":"2017","journal-title":"J Clin Oncol"},{"issue":"08","key":"ref1092","first-page":"CD008465","article-title":"Exercise interventions on health-related quality of life for people with cancer during active treatment","volume":"2012","author":"S Mishra","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"04","key":"ref1093","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/bjc.2013.750","article-title":"Interventions to improve exercise behaviour in sedentary people living with and beyond cancer: a systematic review","volume":"110","author":"L Bourke","year":"2014","journal-title":"Br J Cancer"},{"issue":"04","key":"ref1094","first-page":"243","article-title":"Nutrition and physical activity guidelines for cancer survivors","volume":"62","author":"C Rock","year":"2012","journal-title":"CA Cancer J Clin"},{"issue":"08","key":"ref1095","first-page":"CD007566","article-title":"Exercise interventions on health-related quality of life for cancer survivors","volume":"2012","author":"S Mishra","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"03","key":"ref1096","first-page":"CD007730","article-title":"Multidimensional rehabilitation programmes for adult cancer survivors","volume":"2013","author":"D Scott","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"09","key":"ref1097","first-page":"CD007569","article-title":"Interventions to enhance return-to-work for cancer patients","volume":"2015","author":"A de Boer","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"ref1098","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ijsu.2018.06.031","article-title":"A meta-analysis of the prevalence of Low Anterior Resection Syndrome and systematic review of risk factors","volume":"56","author":"A Croese","year":"2018","journal-title":"Int J Surg"},{"issue":"01","key":"ref1099","doi-asserted-by":"crossref","first-page":"055","DOI":"10.1016\/j.jcol.2014.02.004","article-title":"Functional results after treatment for rectal cancer","volume":"34","author":"K Emmertsen","year":"2014","journal-title":"Journal of Coloproctology"},{"issue":"03","key":"ref1100","doi-asserted-by":"crossref","first-page":"778","DOI":"10.3390\/cancers15030778","article-title":"Management of Low Anterior Resection Syndrome (LARS) Following Resection for Rectal Cancer","volume":"15","author":"H Rosen","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"05","key":"ref1101","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1097\/SLA.0b013e31824f1c21","article-title":"Low anterior resection syndrome score: development and validation of a symptom-based scoring system for bowel dysfunction after low anterior resection for rectal cancer","volume":"255","author":"K Emmertsen","year":"2012","journal-title":"Ann Surg"},{"key":"ref1102","doi-asserted-by":"crossref","first-page":"892452","DOI":"10.3389\/fsurg.2022.892452","article-title":"The Association Between Dietary Intake and Improvement of LARS Among Rectal Cancer Patients After Sphincter-Saving Surgery-A Descriptive Cohort Study","volume":"9","author":"W Liu","year":"2022","journal-title":"Front Surg"},{"issue":"07","key":"ref1103","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.3390\/jcm9072181","article-title":"Effects of PrObiotics on the Symptoms and Surgical ouTComes after Anterior REsection of Colon Cancer (POSTCARE): A Randomized, Double-Blind, Placebo-Controlled Trial","volume":"9","author":"I Park","year":"2020","journal-title":"J Clin Med"},{"issue":"03","key":"ref1104","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3393\/ac.2014.30.3.109","article-title":"Pelvic floor rehabilitation to improve functional outcome after a low anterior resection: a systematic review","volume":"30","author":"W Visser","year":"2014","journal-title":"Ann Coloproctol"},{"issue":"12","key":"ref1105","first-page":"CD004323","article-title":"Quality of life after rectal resection for cancer, with or without permanent colostomy","volume":"12","author":"J Pachler","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"04","key":"ref1106","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/ajg.2010.53","article-title":"Long-term efficacy of biofeedback therapy for dyssynergic defecation: randomized controlled trial","volume":"105","author":"S Rao","year":"2010","journal-title":"Am J Gastroenterol"},{"issue":"07","key":"ref1107","first-page":"CD002111","article-title":"Biofeedback and\/or sphincter exercises for the treatment of faecal incontinence in adults","author":"C Norton","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"22","key":"ref1108","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.3748\/wjg.v13.i22.3101","article-title":"Anal plugs and retrograde colonic irrigation are helpful in fecal incontinence or constipation","volume":"13","author":"M Cazemier","year":"2007","journal-title":"World J Gastroenterol"},{"issue":"08","key":"ref1109","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.apmr.2015.03.013","article-title":"Improvement of fecal incontinence and quality of life by electrical stimulation and biofeedback for patients with low rectal cancer after intersphincteric resection","volume":"96","author":"L Kuo","year":"2015","journal-title":"Arch Phys Med Rehabil"},{"key":"ref1111","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1002\/cncr.23958","article-title":"Rates and predictors of chemotherapy use for stage III colon cancer: a systematic review","volume":"113","author":"D A Etzioni","year":"2008","journal-title":"Cancer"},{"key":"ref1112","first-page":"270","article-title":"[Deficits in management of patients with colorectal carcinoma in Germany Results of multicenter documentation of therapy algorithms]","volume":"97","author":"A Grothey","year":"2002","journal-title":"Med Klin (Munich)"},{"issue":"S 01","key":"ref1113","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1007\/s10198-009-0194-x","article-title":"Cancer management and reimbursement aspects in Germany: an overview demonstrated by the case of colorectal cancer","volume":"10","author":"J M von der Schulenburg","year":"2010","journal-title":"Eur J Health Econ"},{"key":"ref1114","first-page":"287","article-title":"[Hope and disappointment in cancer medicine]","volume":"101","author":"G Adler","year":"2007","journal-title":"Z Arztl Fortbild Qualitatssich"},{"key":"ref1115","first-page":"1117","article-title":"What are the unmet supportive care needs of people with cancer? A systematic review","volume":"17","author":"J D Harrison","year":"2009","journal-title":"Support Care Cancer"},{"key":"ref1116","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/j.1365-2648.2008.04927.x","article-title":"Nurse-led vs conventional physician-led follow-up for patients with cancer: systematic review","volume":"65","author":"R Lewis","year":"2009","journal-title":"J Adv Nurs"},{"key":"ref1117","first-page":"1343","article-title":"A mixed-method evaluation of nurse-led community-based supportive cancer care","volume":"16","author":"D M Howell","year":"2008","journal-title":"Support Care Cancer"},{"key":"ref1118","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/intqhc\/mzn061","article-title":"Implementation of integrated care for patients with cancer: a systematic review of interventions and effects","volume":"21","author":"M Ouwens","year":"2009","journal-title":"Int J Qual Health Care"},{"key":"ref1119","first-page":"1543","article-title":"Reduction of chemotherapy-induced anorexia, nausea, and emesis through a structured nursing intervention: a cluster-randomized multicenter trial","volume":"17","author":"P Jahn","year":"2009","journal-title":"Support Care Cancer"},{"key":"ref1120","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1745-6215-11-29","article-title":"Improvement of pain related self management for oncologic patients through a trans institutional modular nursing intervention: protocol of a cluster randomized multicenter trial","volume":"11","author":"P Jahn","year":"2010","journal-title":"Trials"},{"key":"ref1121","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1002\/cncr.24963","article-title":"Patient-reported acute gastrointestinal symptoms during concurrent chemoradiation treatment for rectal cancer","volume":"116","author":"R C Chen","year":"2010","journal-title":"Cancer"},{"issue":"01","key":"ref1122","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa2502760","article-title":"Structured Exercise after Adjuvant Chemotherapy for Colon Cancer","volume":"393","author":"K Courneya","year":"2025","journal-title":"N Engl J Med"},{"issue":"04","key":"ref1124","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/ijc.33312","article-title":"Prognostic significance of postsurgery circulating tumor DNA in nonmetastatic colorectal cancer: Individual patient pooled analysis of three cohort studies","volume":"148","author":"J Tie","year":"2021","journal-title":"Int J Cancer"},{"key":"ref1125","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/jnci\/djh034","article-title":"Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability","volume":"96","author":"A Umar","year":"2004","journal-title":"J Natl Cancer Inst"}],"container-title":["Zeitschrift f\u00fcr Gastroenterologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2853-0320.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T22:34:47Z","timestamp":1792622087000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2853-0320"}},"subtitle":["Version 3.2 \u2013 M\u00e4rz 2026 \u2013 AWMF-Registernummer: 021-007OL"],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":1089,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10,21]]},"published-print":{"date-parts":[[2026,10]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2853-0320","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0044-2771","1439-7803"],"issn-type":[{"value":"0044-2771","type":"print"},{"value":"1439-7803","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10]]}}}